<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86002</article-id><article-id pub-id-type="doi">10.7554/eLife.86002</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-302564"><name><surname>Sherif</surname><given-names>Zaki A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1772-7041</contrib-id><email>zaki.sherif@howard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303026"><name><surname>Gomez</surname><given-names>Christian R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5323-9507</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303029"><name><surname>Connors</surname><given-names>Thomas J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255385"><name><surname>Henrich</surname><given-names>Timothy J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303028"><name><surname>Reeves</surname><given-names>William Brian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5191-5866</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>RECOVER Mechanistic Pathway Task Force<contrib-group><contrib><name><surname>Julg</surname><given-names>Boris D</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/002pd6e78</institution-id><institution>Infectious Disease Division, Massachusetts General Hospital, Ragon Institute of MGH, MIT and Harvard</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Bradfute</surname><given-names>Steven B</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e5dc168</institution-id><institution>Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center</institution></institution-wrap><addr-line><named-content content-type="city">Albuquerque</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Coombs</surname><given-names>K</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>NIH RECOVER Research Initiative: Patient representative</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Kim</surname><given-names>C</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>NIH RECOVER Research Initiative: Patient representative</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Jagannathan</surname><given-names>Pras</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University</institution></institution-wrap><addr-line><named-content content-type="city">Standford</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Bime</surname><given-names>Christian</given-names></name><aff><institution>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, University of Arizona College of Medicine</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Quinlan</surname><given-names>Erin Burke</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00190t495</institution-id><institution>National Center for Complementary and Integrative Health, National Institutes of Health</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Portman</surname><given-names>Michael A</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01njes783</institution-id><institution>Seattle Children’s Hospital, Division of Pediatric Cardiology, Department of Pediatrics, University of Washington</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Gennaro</surname><given-names>Maria Laura</given-names></name><aff><institution>Public Health Research Institute and Department of Medicine, Rutgers New Jersey Medical School</institution><addr-line><named-content content-type="city">Newark</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Rehman</surname><given-names>Jalees</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/047426m28</institution-id><institution>Department of Biochemistry and Molecular Genetics, University of Illinois, College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Chen</surname><given-names>Benjamin K</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Mohandas</surname><given-names>Sindhu</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>Department of Pediatrics, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><xref ref-type="fn" rid="con1"/></contrib></contrib-group></collab><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05gt1vc06</institution-id><institution>Department of Biochemistry &amp; Molecular Biology, Howard University College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Washington, District of Columbia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>Division of Lung Diseases, National Institutes of Health (NIH), National Heart, Lung and Blood Institute (NHLBI)</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Department of Pediatrics, Division of Critical Care, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Division of Experimental Medicine, University of California</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00v97ad02</institution-id><institution>Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, University of Texas</institution></institution-wrap><addr-line><named-content content-type="city">San Antonio</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rosen</surname><given-names>Clifford J</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03d1wq758</institution-id><institution>Maine Medical Center Research Institute</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>22</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e86002</elocation-id><history><date date-type="received" iso-8601-date="2023-01-09"><day>09</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-03-10"><day>10</day><month>03</month><year>2023</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86002-v2.pdf"/><abstract><p>COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional malaise, and cognitive dysfunction that last for months and impact everyday functioning, is referred to as Long COVID under the general category of post-acute sequelae of SARS-CoV-2 infection (PASC). PASC is highly heterogenous and may be associated with multisystem tissue damage/dysfunction including acute encephalitis, cardiopulmonary syndromes, fibrosis, hepatobiliary damages, gastrointestinal dysregulation, myocardial infarction, neuromuscular syndromes, neuropsychiatric disorders, pulmonary damage, renal failure, stroke, and vascular endothelial dysregulation. A better understanding of the pathophysiologic mechanisms underlying PASC is essential to guide prevention and treatment. This review addresses potential mechanisms and hypotheses that connect SARS-CoV-2 infection to long-term health consequences. Comparisons between PASC and other virus-initiated chronic syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome will be addressed. Aligning symptoms with other chronic syndromes and identifying potentially regulated common underlining pathways may be necessary for understanding the true nature of PASC. The discussed contributors to PASC symptoms include sequelae from acute SARS-CoV-2 injury to one or more organs, persistent reservoirs of the replicating virus or its remnants in several tissues, re-activation of latent pathogens such as Epstein–Barr and herpes viruses in COVID-19 immune-dysregulated tissue environment, SARS-CoV-2 interactions with host microbiome/virome communities, clotting/coagulation dysregulation, dysfunctional brainstem/vagus nerve signaling, dysautonomia or autonomic dysfunction, ongoing activity of primed immune cells, and autoimmunity due to molecular mimicry between pathogen and host proteins. The individualized nature of PASC symptoms suggests that different therapeutic approaches may be required to best manage specific patients.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>angiotensin-converting enzyme</kwd><kwd>PASC</kwd><kwd>pathobiological mechanisms</kwd><kwd>pathophysiological mechanisms</kwd><kwd>post-viral syndromes</kwd><kwd>Long COVID</kwd><kwd>tissue damage</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>OT2HL161847-01</award-id><principal-award-recipient><name><surname>Sherif</surname><given-names>Zaki A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>PASC (post-acute sequelae of SARS-CoV-2 infection) is an enduring and debilitating illness caused by a persistent virus that promotes inflammation, coagulation, and autoimmunity complications in millions of patients initially diagnosed with COVID-19, but with no known standardized treatment regimen.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>PASC co, which encompasses Long COVID or post-COVID syndrome, is a condition marked by the continuation of COVID-19 symptoms—or the emergence of new ones—4 or more weeks after infection with SARS-CoV-2 (<ext-link ext-link-type="uri" xlink:href="http://www.CDC.gov">http://www.CDC.gov</ext-link>), or those persistently symptomatic for &gt;30 days from onset of infection (<ext-link ext-link-type="uri" xlink:href="http://www.NIH.gov">http://www.NIH.gov</ext-link>). Alternatively, the World Health Organization describes PASC (or Post COVID-19 condition) as occurring in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis (<ext-link ext-link-type="uri" xlink:href="http://www.WHO.int">http://www.WHO.int</ext-link>). The current PASC definition in the NIH RECOVER (REsearching COVID to Enhance Recovery) Initiative program is: ‘<italic>ongoing, relapsing, or new symptoms, or other health effects occurring after the acute phase of SARS-CoV-2 infection (i.e., present four or more weeks after the acute infection</italic>)’. The RECOVER Initiative is an NIH-funded project whose goal is to rapidly improve our understanding of and ability to predict, treat, and prevent PASC (post-acute sequelae of SARS-CoV-2), including Long COVID.</p><p>The symptoms of PASC whether in hospitalized or non-hospitalized patients are numerous and diverse and include shortness of breath, chest pain, cognitive impairment, and fever, among others (<xref ref-type="bibr" rid="bib132">Michelen et al., 2021</xref>). Reports also reveal that there are wide and country-specific variations in the prevalence of PASC ranging from 3.3% in the UK, 13.9% in the USA, to 39% in Denmark and the Faroe Islands (<xref ref-type="bibr" rid="bib126">Mantovani et al., 2022</xref>; <xref ref-type="bibr" rid="bib148">Perlis et al., 2022</xref>; <xref ref-type="bibr" rid="bib149">Petersen et al., 2022</xref>; <xref ref-type="bibr" rid="bib191">Subramanian et al., 2022</xref>). The pathophysiologic mechanisms underlying PASC remain to be determined. However, the clinical features and epidemiology may provide insights into possible mechanisms. Although PASC may be a consequence of long-term organ damage attributable to acute-phase infection, it is postulated that specific mechanistic pathways exacerbate the initial illness adversely affecting many organs and resulting in the development of later symptoms. As such, this multifactorial condition displays over 200 symptoms and affects multiple tissues, organs, and biological systems (i.e., ears, eyes, head, nose, throat, kidney, brain, cardiopulmonary, endocrine, gastrointestinal (GI), musculoskeletal, neuropsychiatric, and systemic) to varying degrees. So far, immune dysregulation, autoimmunity, dysautonomia, endothelial dysfunction (ED), occult viral persistence, reactivation of pre-existing chronic viral infections as well as coagulopathies are some of the main underlying pathophysiological mechanisms described (<xref ref-type="bibr" rid="bib2">Ahamed and Laurence, 2022</xref>; <xref ref-type="bibr" rid="bib8">Al-Ramadan et al., 2021</xref>; <xref ref-type="bibr" rid="bib10">Amenta et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Camargo-Martínez et al., 2021</xref>; <xref ref-type="bibr" rid="bib32">Carod-Artal, 2021</xref>; <xref ref-type="bibr" rid="bib41">Choutka et al., 2022</xref>; <xref ref-type="bibr" rid="bib46">Cortés-Telles et al., 2021</xref>; <xref ref-type="bibr" rid="bib52">Doykov et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Fernández-de-Las-Peñas et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Gottschalk et al., 2023</xref>; <xref ref-type="bibr" rid="bib117">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib126">Mantovani et al., 2022</xref>; <xref ref-type="bibr" rid="bib129">McFarland et al., 2021</xref>; <xref ref-type="bibr" rid="bib139">Oronsky et al., 2023</xref>; <xref ref-type="bibr" rid="bib184">Silva Andrade et al., 2021</xref>; <xref ref-type="bibr" rid="bib187">Song et al., 2021</xref>; <xref ref-type="bibr" rid="bib204">Toniolo et al., 2021</xref>; <xref ref-type="bibr" rid="bib206">Touyz et al., 2021</xref>; <xref ref-type="bibr" rid="bib207">Townsend et al., 2021</xref>; <xref ref-type="bibr" rid="bib224">Wirth and Scheibenbogen, 2021</xref>; <xref ref-type="bibr" rid="bib225">Wong et al., 2021</xref>). Although PASC has been described as ‘a mysterious mix of symptoms with no clear pattern’, it bears similarities to other post-viral syndromes, and to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), certain phenotypic clusters are emerging in the literature.</p><p>This review will delineate the current knowledge about the underlying mechanisms and/or biological pathways responsible for tissue damage including pulmonary, cardiac, GI, neuronal, vascular, etc. associated with COVID-19 and the subsequent generation of symptoms. It will highlight the underlying causes of PASC and suggest ways to understand the clinical symptomatology for improved diagnostic and therapeutic procedures for the condition. We will also postulate on the pathophysiology and pathobiology of PASC by providing working hypotheses that could aid in further exploration of this multifaceted syndrome. This review will attempt to decipher the possible underlying tissue injury mechanisms for long-term residual illness post-SARS-CoV-2 infection.</p></sec><sec id="s2"><title>Insight into PASC disease pattern</title><p>Epidemiological studies in the UK and USA have found similar symptoms, but differing rates and durations of Long COVID (<xref ref-type="bibr" rid="bib82">Groff et al., 2021</xref>). A UK study discovered that SARS-CoV-2 infection was linked to 62 symptoms lasting beyond 12 weeks, including anosmia, hair loss, sneezing, ejaculation difficulties, and reduced libido. The risk of Long COVID was higher among women, ethnic minorities, those with lower socio-economic status, smokers, obese individuals, and those with underlying health conditions, and increased with decreasing age (<xref ref-type="bibr" rid="bib191">Subramanian et al., 2022</xref>). In contrast, Long COVID affects 7.3% of 3042 US survey respondents, equivalent to 18.8 million adults. Impacts on daily activities were severe for 25.3% of those with Long COVID and 28.9% had SARS-CoV-2 infection over a year ago. Women, those with comorbidities, and those unvaccinated or not boosted were at higher risk (<xref ref-type="bibr" rid="bib163">Robertson et al., 2022</xref>). Studies from the USA and Europe have found that the prevalence of Long COVID is higher among women and those with multiple chronic conditions (<xref ref-type="bibr" rid="bib39">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="bib66">Fernández-de-Las-Peñas et al., 2022</xref>; <xref ref-type="bibr" rid="bib163">Robertson et al., 2022</xref>; <xref ref-type="bibr" rid="bib201">Thompson et al., 2022</xref>). However, there is variation in risk factor data due to differences in study design, population studied, and definition of Long COVID. Often, studies lack a COVID-free control group, focus on hospitalized or healthcare-seeking populations, and have different definitions of Long COVID. These studies emphasize the high burden of Long COVID and the need for further research on its prevalence and risk factors.</p></sec><sec id="s3"><title>Clinical manifestations of PASC that require mechanistic understanding</title><p>The clinical manifestations of PASC vary widely. Common PASC symptoms include fatigue, dyspnea, cough, ‘brain fog’, headaches, sleep disturbance, impaired smell and taste, palpitations, chest pain, and orthostatic dizziness (<xref ref-type="bibr" rid="bib49">Davis et al., 2021</xref>; <xref ref-type="bibr" rid="bib94">Hernandez-Romieu et al., 2022</xref>; <xref ref-type="bibr" rid="bib143">Ozonoff et al., 2022</xref>; <xref ref-type="bibr" rid="bib185">Sneller et al., 2022</xref>; <xref ref-type="bibr" rid="bib192">Sudre et al., 2021</xref>). Using machine-learning algorithms, Estiri et al. uncovered 33 phenotypes of PASC and it is likely that multiple different pathophysiologic mechanisms account for this heterogeneity (<xref ref-type="bibr" rid="bib58">Estiri et al., 2021</xref>). Indeed, detailed multi-omic profiling of COVID-19 patients revealed unique associations between immunological signatures and specific PASC endotypes (<xref ref-type="bibr" rid="bib190">Su et al., 2022</xref>). Future mechanistic studies will need to recognize the heterogeneity of the disorder. PASC is more common in individuals who suffered a severe vs mild acute COVID-19 illness (<xref ref-type="bibr" rid="bib94">Hernandez-Romieu et al., 2022</xref>; <xref ref-type="bibr" rid="bib114">LaVergne et al., 2021</xref>; <xref ref-type="bibr" rid="bib230">Xie et al., 2021</xref>). In such patients, the illness shares features of post-intensive care syndrome (PICS) (<xref ref-type="bibr" rid="bib160">Rawal et al., 2017</xref>) and findings observed in survivors of the SARS and MERS coronavirus epidemics (<xref ref-type="bibr" rid="bib78">Greenhalgh et al., 2020</xref>; <xref ref-type="bibr" rid="bib195">Tansey et al., 2007</xref>). Pathophysiologic mechanisms in this group may include the effects of SARS-CoV-2 infection, reactivation of other viruses such as the Epstein–Barr virus (EBV), autoimmunity, incomplete recovery from acute organ injury (e.g., lung, heart, kidney, brain, thrombosis), effects of treatments (e.g., mechanical ventilation, steroids), and exacerbation of pre-existing conditions (e.g., pre-diabetes, CKD, CHF). However, individuals with mild COVID-19 (<xref ref-type="bibr" rid="bib12">Augustin et al., 2021</xref>; <xref ref-type="bibr" rid="bib58">Estiri et al., 2021</xref>), and even individuals with no serologic evidence of prior SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib109">Krishna et al., 2022</xref>; <xref ref-type="bibr" rid="bib185">Sneller et al., 2022</xref>), can experience PASC symptoms, suggesting that some features of PASC may represent responses to the stress of the pandemic, for example, social isolation, anxiety, loss of friends or family, work stress, and financial stress, in addition to the viral infection itself. The prevalence of PASC appears to be lower in the more recent COVID ‘waves’, especially with the Omicron variant, and lower in people who were vaccinated prior to contracting COVID-19 (<xref ref-type="bibr" rid="bib14">Azzolini et al., 2022</xref>; <xref ref-type="bibr" rid="bib243">Zisis et al., 2022</xref>), suggesting that SARS-CoV-2 variants, availability of newer treatments and immune responses may impact the pathogenesis of PASC. For example, recent research suggests that the use of nirmatrelvir/ritonavir during acute SARS-CoV-2 infection reduces the risk of PASC regardless of vaccination status or history of prior infection (<xref ref-type="bibr" rid="bib231">Xie et al., 2022</xref>). Long COVID may also manifest as residual or new organ dysfunction which could be the result of acute organ injury during the COVID-19 infection, for example, ARDS, acute kidney injury, or myocarditis, or the result of chronic inflammation, ED, or autoimmunity triggered by the infection. The high incidence of new-onset type I diabetes after COVID-19 infection, for example, could be due to direct viral injury of pancreatic beta cells, induction of autoimmunity to beta cells or glucose-regulating pathways or decreases in peripheral insulin sensitivity associated with chronic inflammation that is exhibited in PASC patients (<xref ref-type="bibr" rid="bib17">Barrett et al., 2022</xref>; <xref ref-type="bibr" rid="bib166">Rubino et al., 2020</xref>). There are commonalities of clinical manifestations and symptoms between COVID-19 and Long COVID-19 that require detailed mechanistic understandings (<xref ref-type="bibr" rid="bib49">Davis et al., 2021</xref>; <xref ref-type="bibr" rid="bib131">Mehandru and Merad, 2022</xref>).</p></sec><sec id="s4"><title>Commonalities with ME/CFS and other post-infection syndromes</title><p>Many PASC features resemble (ME/CFS), which is also commonly preceded by viral infections, prompting some to ask whether PASC and ME/CFS are similar diseases (<xref ref-type="bibr" rid="bib25">Bornstein et al., 2022</xref>; <xref ref-type="bibr" rid="bib197">Tate et al., 2022</xref>). Fatigue, exertion intolerance, and post-exertional malaise are among the most frequent symptoms cited for PASC. These same symptoms manifesting in PASC patients had been designated as ‘core criteria’ of ME/CFS by the National Academy of Medicine in a 2015 report (<ext-link ext-link-type="uri" xlink:href="https://batemanhornecenter.org/wp-content/uploads/filebase/providers/Recognizing-PVS-and-Tools-ECHO-5_3_2022-V2.pdf">https://batemanhornecenter.org/wp-content/uploads/filebase/providers/Recognizing-PVS-and-Tools-ECHO-5_3_2022-V2.pdf</ext-link>). It is estimated that about half of people with Long COVID will meet the criteria for ME/CFS, whether they are given that specific diagnosis or not. It is also important to note the multiple types of tissues and organs adversely affected by ME/CFS including cardiovascular problems, central nervous system (CNS), immune system disturbances, ion transport dysfunction, cell energy metabolism, GI dysfunction, cognitive impairment, myalgia, arthralgia, orthostatic intolerance, and chronic inflammation (<xref ref-type="bibr" rid="bib159">Rasa et al., 2018</xref>), are also commonly reported in PASC patients. The trigger for COVID-19 is the SARS-CoV-2 infection. ME/CFS is a complex disease frequently triggered by an infection with EBV (the virus that causes mononucleosis) or parvovirus B19 even though various other viral and nonviral triggers have also been reported (<xref ref-type="bibr" rid="bib42">Chu et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Fluge et al., 2021</xref>; <xref ref-type="bibr" rid="bib99">Jason et al., 2022</xref>; <xref ref-type="bibr" rid="bib188">Sotzny et al., 2018</xref>). The evidence is clear that in COVID-19 and potentially in PASC patients, the initial SARS-CoV-2 infection resurrects latent viruses such as EBV (<xref ref-type="bibr" rid="bib68">Fluge et al., 2021</xref>), which could trigger ME/CFS. Although EBV has been associated with post-viral fatigue in ME/CFS, the mechanisms leading to post-viral fatigue syndrome and Long COVID (PASC) are unresolved. The similarities raise two questions: <italic>Do these two multi-symptomatic diseases share common molecular and pathophysiological pathways in their disruption of homeostasis post-infection? Although the triggers may be different, because of their overlapping symptoms, could there be a common pathobiological explanation?</italic> Indeed, the lessons learned from three decades of studying ME/CFS should help with identification of a variety of conceptually distinct medical comorbid conditions found in PASC.</p><p>Postural orthostatic tachycardia syndrome (POTS), which can be seen after other viral infections has also been observed in PASC and may point toward autoimmune dysfunction of the autonomic system, including autoantibodies to acetylcholine and adrenergic receptors (<xref ref-type="bibr" rid="bib22">Blitshteyn and Whitelaw, 2021</xref>; <xref ref-type="bibr" rid="bib68">Fluge et al., 2021</xref>). However, a recent German study reports that PASC is not associated with autoantibodies (<xref ref-type="bibr" rid="bib177">Schultheiss et al., 2022</xref>). Nevertheless, SARS-CoV-2 may be responsible for PASC symptoms by activating the host’s immune response and leading to long-term autoantibody production. Autoantibodies were isolated in acute COVID-19 patients by several research teams including Wang et al. who used REAP to screen a group of 194 SARS-CoV-2-positive COVID-19 patients for autoantibodies against 2770 extracellular proteins. Results showed that COVID-19 patients had a significant increase in autoantibody reactivity compared to uninfected controls (<xref ref-type="bibr" rid="bib100">Jiang et al., 2023</xref>; <xref ref-type="bibr" rid="bib219">Wang et al., 2021</xref>). It is currently not well understood what role autoantibodies may play in the pathophysiology of Long COVID or PASC. Evidence linking autoantibodies to Long COVID as an etiological factor is limited and further research is needed to fully understand their role in the development of PASC. Similarities between PASC symptoms and those of Mast Cell Activation Syndrome (MCAS) have also been noted (<xref ref-type="bibr" rid="bib4">Akin, 2017</xref>; <xref ref-type="bibr" rid="bib22">Blitshteyn and Whitelaw, 2021</xref>; <xref ref-type="bibr" rid="bib176">Schieffer and Schieffer, 2022</xref>).</p><p>Longitudinal studies need to be conducted to determine the similarities and differences between PASC and ME/CFS and other post-infectious syndromes by frequently collecting biological samples (as it is being implemented by the RECOVER study—<ext-link ext-link-type="uri" xlink:href="https://recovercovid.org">https://recovercovid.org</ext-link>), and up-to-date information on the presence of the infectious agent and the severity of various symptoms. Such studies should also include continual laboratory studies of the immune system, metabolism, gene structure and function, and transcriptome, as well as tests of cognition, sleep, and the functioning of the nervous system, heart, and cardiovascular system.</p></sec><sec id="s5"><title>Mechanisms of emerging PASC pathogeneses</title><p>Although the COVID-19 pandemic disproportionately affected patients who had comorbid diabetes mellitus, it is now clear from numerous studies across the globe that COVID-19 causes dysregulation of glucose homeostasis leading to new-onset hyperglycemia and type I diabetes (<xref ref-type="bibr" rid="bib71">Genç et al., 2021</xref>) in patients with no previous risk factors for diabetes mellitus (<xref ref-type="bibr" rid="bib23">Bode et al., 2020</xref>; <xref ref-type="bibr" rid="bib174">Sathish et al., 2021c</xref>; <xref ref-type="bibr" rid="bib173">Sathish and Chandrika Anton, 2021b</xref>; <xref ref-type="bibr" rid="bib203">Tittel et al., 2020</xref>; <xref ref-type="bibr" rid="bib211">Unsworth et al., 2020</xref>; <xref ref-type="bibr" rid="bib220">Watson, 2022</xref>). New-onset COVID-induced type 1 or 2 diabetes has also been documented in children (<xref ref-type="bibr" rid="bib203">Tittel et al., 2020</xref>; <xref ref-type="bibr" rid="bib209">Trieu et al., 2021</xref>; <xref ref-type="bibr" rid="bib211">Unsworth et al., 2020</xref>). This novel form of COVID-induced diabetes with anomalous glycemic parameters and heightened rates of DKA (diabetic ketoacidosis), occurs in severely ill patients with higher mortality rates and poorer outcomes compared to COVID-19 patients with pre-existing diabetes (<xref ref-type="bibr" rid="bib35">Chandrashekhar Joshi and Pozzilli, 2022</xref>). The underlying pathobiological mechanism for this induced diabetes in COVID-19 patients has not been clearly delineated although it is suspected that SARS-CoV-2 could damage the beta cells of the pancreas and precipitate insulin resistance (<xref ref-type="bibr" rid="bib9">Aluganti Narasimhulu and Singla, 2022</xref>). There are some plausible mechanisms that underlie this new diabetes onset. SARS-CoV-2 infection can damage beta cells or increase glucose levels via oxidative stress and inflammation; the virus can also bind the angiotensin-converting enzyme receptor 2 (ACE2), on acinar cells and cause tissue detriment and pulmonary fibrosis via increasing concentration of the fibrosis-promoting Angiotensin II (<xref ref-type="bibr" rid="bib134">Morganstein et al., 2021</xref>) and hyperglycemia can inhibit lymphocyte proliferation to repair the tissue damage. The initial binding of the virus to ACE2 requires the presence of transmembrane serine protease 2 (TMPRSS2), a protein that is regulated by androgens. The ACE2 mRNA is also expressed in several endocrine glands, including the pancreas, ovaries, testes, and thyroid gland (<xref ref-type="bibr" rid="bib115">Lazartigues et al., 2020</xref>). At postmortem, both follicular and parafollicular cells of the thyroid gland were extensively damaged in patients who died of COVID (<xref ref-type="bibr" rid="bib222">Wei et al., 2007</xref>). These systems, which are physiologically regulated by ACE2 upon viral infection, induce acute cardiopulmonary failure, and coagulopathy. Furthermore, the overexpression of the ACE2 receptor can deregulate these systems and cause cardiovascular instability (renin–angiotensin system), acute inflammatory pulmonary edema (kinin–kallikrein system), and thromboembolism (coagulation system) (<xref ref-type="bibr" rid="bib183">Sidarta-Oliveira et al., 2020</xref>). In fact, ACE2 gene therapy in gene knockout mice promoted better survival and function of the beta cells, as well as improved glucose homeostasis (<xref ref-type="bibr" rid="bib19">Bindom et al., 2010</xref>). Additionally, a downregulation of the transcription factor REST (RE1-silencing transcription factor) observed in COVID-19 patients is linked to the altered gene expression of glucose and lipid metabolism involving apelin, myostatin myeloperoxidase (peptides and proteins important for the insulin signaling pathway) (<xref ref-type="bibr" rid="bib93">He et al., 2021</xref>). COVID-19 patients also harbored upregulated short-chain fatty acids, propionic acid, and isobutyric acid, which are possibly linked to insulin resistance (<xref ref-type="bibr" rid="bib93">He et al., 2021</xref>).</p><p>Stress is another factor that can be induced by a viral infection, which causes elevated glucose levels in subjects with diabetes via the secretion of glucocorticoids and catecholamines contributing to further impairment of the immune system (<xref ref-type="bibr" rid="bib218">Wang et al., 2020</xref>). In addition, the incidence of DKA observed in COVID-induced diabetic patients was unusually high in the absence of autoantibodies suggesting that acute viral-induced pancreatic damage might have occurred (<xref ref-type="bibr" rid="bib120">Li et al., 2020b</xref>; <xref ref-type="bibr" rid="bib215">Vellanki and Umpierrez GE - Center ofDiabetes and Metabolism, Emory University School of Medicine, 2021</xref>). There are also a few reports of cases that have described autoantibody-negative insulin-dependent diabetes (<xref ref-type="bibr" rid="bib95">Hollstein et al., 2020</xref>; <xref ref-type="bibr" rid="bib110">Kuchay et al., 2020</xref>). Mechanistically, the consequence of stress caused by SARS-CoV-2 infection may be explained by the stimulation of a signaling pathway designated as the integrated stress response (ISR) that promotes the activation of a family of serine/threonine kinases that is, double-stranded RNA-dependent protein kinase (PKR) and PKR-like ER kinase (PERK), and the subsequent induction of serine phosphorylation of insulin receptor substrates (IRS) which leads to downregulation of the insulin signaling pathway. Both the viral components (RNA or proteins) of SARS-CoV-2 and ‘cytokine storm’, which activates a family of serine/threonine kinases linked to the ISR and is represented by pro-inflammatory cytokines such as IL-6 and tumor necrosis factor (TNF-α, can cause insulin resistance <xref ref-type="bibr" rid="bib171">Santos et al., 2021</xref>). Moreover, insulin resistance can be caused by the downregulation of insulin receptors in skeletal muscle via virally induced interferon gamma (IFN-γ) (<xref ref-type="bibr" rid="bib178">Sestan et al., 2018</xref>). This could be an additional contributor to the insulin resistance syndrome that has been described in COVID-induced diabetes patients.</p><p>There are also several other postulated mechanisms including molecular mimicry, that may explain the rise in autoimmune diabetes following COVID-19 infection. SARS-CoV-2 also downregulates ACE2, which degrades Angiotensin II. These mechanisms of unrestricted actions of Angiotensin II lead to deleterious effects including inflammatory activity by increasing the infiltration of macrophages and monocytes, reducing blood flow to pancreatic islets, and promoting the instability of the beta cells leading to glycemic dysregulation (<xref ref-type="bibr" rid="bib31">Carlsson et al., 1998</xref>; <xref ref-type="bibr" rid="bib37">Chee et al., 2020</xref>; <xref ref-type="bibr" rid="bib133">Montezano et al., 2014</xref>). There is emerging evidence showing that the new-onset diabetes is also a feature of Long COVID (<xref ref-type="bibr" rid="bib172">Sathish et al., 2021a</xref>) even though the precise mechanism might be multifaceted. It is essential to collect biospecimens to design mechanistic studies that might shed light on the underlying causes precipitating the various types of symptoms experienced by Long COVID sufferers and specifically to follow-up COVID-related diabetes patients by implementing longitudinal and prospective cohort studies to distinguish between COVID-induced diabetes from conventional diabetes. There is a digital registry that is specifically designed to establish the extent and characteristics of new-onset, COVID-19-related diabetes, and to investigate its pathogenesis and outcomes (<ext-link ext-link-type="uri" xlink:href="http://covidiab.e-dendrite.com">http://covidiab.e-dendrite.com</ext-link>).</p></sec><sec id="s6"><title>Molecular mechanisms of respiratory PASC</title><p>The upper respiratory system is the primary site of the SARS-CoV-2 viral infection. In the scenario of an excessive inflammatory response, the consequence can be irreversible lung fibrosis and the compromise of respiratory effector function (<xref ref-type="bibr" rid="bib194">Tanni et al., 2021</xref>). Fibrotic remodeling with characteristic findings consists of fibroblast proliferation, micro-honeycombing, and airspace obliteration, which were uncovered in pulmonary postmortem findings in a series of COVID-19 cases (<xref ref-type="bibr" rid="bib83">Grosse et al., 2020</xref>). This suggested a link to respiratory distress syndrome (ARDS) as a long-term complication of COVID-19. In addition to ARDS, fibrotic remodeling resulting in respiratory symptoms can originate from pathologic conditions including dyspnea, and even from hospitalization, intensive care unit stays, use of high-flow oxygen support, and need for mechanical ventilation (<xref ref-type="bibr" rid="bib80">Grillo et al., 2021</xref>). Additional mechanisms include epithelial and endothelial to mesenchymal transition and the ‘cytokine storm’. Prolonged exposure to supplemental oxygen is known to lead to increased oxidative stress and could maintain the inflammatory status favorable for activation of post-COVID-19 pulmonary fibrosis (<xref ref-type="bibr" rid="bib73">George et al., 2020</xref>). A fraction of PASC patients present with fatigue, exercise limitation, persistent chest pain, and breathlessness. These symptoms may be caused in part by compromised cardiorespiratory function, lung vascular damage in microvessels, and hemodynamic complications such as resolved thrombus (<xref ref-type="bibr" rid="bib108">Kosuge et al., 2012</xref>; <xref ref-type="bibr" rid="bib232">Yaméogo et al., 2011</xref>). Fatigue and breathlessness may also be caused by chronic overstimulation of the ergoreflex, activated by exercise to centrally couple ventilation and cardiovascular function to exercise intensity (<xref ref-type="bibr" rid="bib193">Sze et al., 2022</xref>). Exaggerated ergoreflex leads to excessive response relative to work performed, and to the sensation of breathlessness and fatigue. The hypercatabolic state, cytokine storm, and stimulation of the renin–angiotensin–aldosterone system by SARS-CoV-2 use of ACE2 to facilitate cell entry might cause a reduction in skeletal muscle mass and function, excessive ergoreflex, and sensations of fatigue and breathlessness (<xref ref-type="bibr" rid="bib130">Medina-Enríquez et al., 2020</xref>). Further study of the mechanistic involvement and interactions between respiratory systems and extrapulmonary systems with reciprocal crosstalk and influence is needed.</p><p>Pulmonary dysfunctions are among the most destructive events associated with impaired immune responses caused by SARS-CoV-2 infection. The resulting cytokine storm activates defense events that stimulate biochemical pathways that eventually lead to the production of tissue injury markers and the collapse of lung tissue (<xref ref-type="bibr" rid="bib150">Piazza et al., 2020</xref>; <xref ref-type="bibr" rid="bib170">Sakr et al., 2020</xref>; <xref ref-type="bibr" rid="bib183">Sidarta-Oliveira et al., 2020</xref>). These hematological changes form pulmonary thrombi and capillary microthrombi, which may represent thromboembolism instead of thrombosis in bone marrow emboli and septic pulmonary thromboembolism (<xref ref-type="bibr" rid="bib1">Ackermann et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">D’Errico et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Grosse et al., 2020</xref>; <xref ref-type="bibr" rid="bib106">Khan et al., 2020</xref>). Transcriptomic analyses of coexpression data from human lung cells have shown that there are three physiological systems directly involved in the pathogenesis of COVID-19: (1) the kinin–kallikrein system; (2) the renin–system angiotensin; and (3) the coagulation system coexpressed with the ACE2 receptor in alveolar cells (<xref ref-type="bibr" rid="bib183">Sidarta-Oliveira et al., 2020</xref>). These systems, which are physiologically regulated by ACE2 upon viral infection of the lungs, induce acute cardiovascular failure, coagulopathy, acute inflammatory pulmonary edema (kinin–kallikrein system), and thromboembolism (coagulation system) (<xref ref-type="bibr" rid="bib183">Sidarta-Oliveira et al., 2020</xref>). Hyperinflammation induced by immunopathogenic, and biochemical mechanisms of SARS-CoV-2 suggests that cytokines and chemokines contribute to alveolar endothelial damage that promotes apoptosis of alveolar cells (pneumocyte type I) and degeneration of pulmonary pneumocyte type II alveolar cells (<xref ref-type="bibr" rid="bib97">Hussman, 2020</xref>). These cell types are operationally connected via narrow junctions that control the transfer of ions, minerals, and fluid through the epithelium (<xref ref-type="bibr" rid="bib1">Ackermann et al., 2020</xref>). SARS-CoV-2 infects ACE2-expressing pneumocyte type II cells, which act as epithelial immune cells and produce TNF, IL-6, IL-1β, and MCP-1.</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref> depicts the initial entry of SARS-CoV-2 into the host cell by binding to ACE2 receptor in the respiratory tract and causing disruption of homeostasis by persisting in several organ systems and leading to the eventual development of PASC in a subset of patients. The depiction is for immunological, neurological, and pulmonary dysregulations, which may likely contribute to the hyperactivation of monocyte-derived macrophages in both acute and post-acute phases of the disease. Type I IFN-γ production is delayed leading to increased sensing of microbial threats. This in turn enhances the release of monocyte chemokines by alveolar epithelial cells (pneumocyte types 1 and 2), which direct blood monocytes into the lungs. There are several signaling molecules that induce monocytes to differentiate into pro-inflammatory macrophages via activation of Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathways. Activated T cells and natural killer cells enhance the recruitment and stimulation of macrophages (derived from monocytes) through the production of granulocyte–macrophage colony-stimulating factor (GM-CSF), IFN-γ, and TNF (see <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>SARS-CoV-2’s entry into the respiratory system and its binding to ACE2 receptor produces a cascade of host responses ranging from chronic inflammation to endothelial dysregulation.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86002-fig1-v2.tif"/></fig><p>Alveolar macrophages lead to the activation and release of cytokine and chemokine and aggregation of neutrophils and monocytes that produce toxic mediators resulting in the death of the alveolar cells, fibrin deposition, hyaline membrane formation, the influx of red blood cells, alveolar edema, and dyspnea (<xref ref-type="bibr" rid="bib1">Ackermann et al., 2020</xref>; <xref ref-type="bibr" rid="bib6">Al-Khawaga and Abdelalim, 2020</xref>).</p><p>Whole-transcriptome sequencing of postmortem lung tissue from COVID-19 patients reveals two distinct molecular signatures: Lung damage caused by a massive metabolic reprogramming due to the upregulation of the unfolded protein response, steroid biosynthesis, and complement activation; and secondarily, ‘cytokine release syndrome’ (CRS) represented by the upregulation of cytokines such as IL-1 and CCL19, but absence of complement activation (<xref ref-type="bibr" rid="bib26">Budhraja et al., 2022</xref>). Although most patients cleared the viral infection, they succumbed to acute dysbiosis overrepresented by <italic>Staphylococcus cohnii</italic> in ‘classical’ patients and <italic>Pasteurella multocida</italic> in CRS patients (<xref ref-type="bibr" rid="bib26">Budhraja et al., 2022</xref>).</p><p>The association between insulin resistance and lung dysfunction in humans has also been documented in the literature. Another recent study confirmed other previous studies that revealed that the insulin/insulin-like growth factor 1 (IGF) signaling pathway, which plays an important role in energy metabolism, is impaired in organs and tissues of severe COVID-19 patients (<xref ref-type="bibr" rid="bib182">Shin et al., 2022</xref>). AKT/mTOR/MAPK pathway and ligand/receptor interactions that initiate cellular signaling through IRS/PI3K lie downstream of insulin/IGF signaling pathway but are also additional molecular pathways that are associated with energy uptake and utilization. An impaired IGF pathway engenders insulin resistance or abnormal insulin/IGF response, which also leads to an enhanced metabolic syndrome manifestation such as diabetes, hyperglycemia, hyperlipidemia, and obesity. A COVID-19-impaired insulin/IGF signaling pathway is also associated with the downregulation of various metabolic pathways including the citrate cycle, lipid metabolism, beta-oxidation, amino acid metabolism, carbohydrate metabolism, and respiratory electron transport chain affecting the adipose tissue, liver, lungs, and pancreas resulting in the development of multiorgan dysfunction (<xref ref-type="bibr" rid="bib182">Shin et al., 2022</xref>).</p><sec id="s6-1"><title>Is a persistent virus responsible for the ongoing multi-tissue symptoms?</title><p>One of the theories of PASC is viral persistence in the tissues. Therefore, some of the mechanisms that could potentially contribute to PASC’s lingering symptoms are viral-specific pathophysiologic alterations, immunologic aberrations, and inflammation, especially in patients with comorbidities that stimulate excessive cytokine release, lead to destructive immune response and result in autoimmune phenomena and molecular mimicry that causes autoimmunity (<xref ref-type="bibr" rid="bib136">Nalbandian et al., 2021</xref>). The CRS is a major cause of tissue damage in the pathophysiology of COVID-19 (<xref ref-type="bibr" rid="bib233">Ye et al., 2020</xref>), is characterized by the activation of innate immunity which along with the epithelial and endothelial cells release several cytokines to block the viral replication. A secondary cytokine cascade is induced downstream by the sustained release of primary cytokines such as IL-6, the most important CRS causative cytokine, or by immune cell signaling (<xref ref-type="bibr" rid="bib86">Guo and Thomas, 2017</xref>; <xref ref-type="bibr" rid="bib164">Ronco and Reis, 2020</xref>). In SARS-CoV-2 infection, virus-induced ACE2 downregulation leads to reduced production of Angiotensin 1–7 and accumulation of Angiotensin II, contributing to pulmonary edema, and inflammation (<xref ref-type="bibr" rid="bib216">Verdecchia et al., 2020</xref>).</p></sec></sec><sec id="s7"><title>Endocrine system pathophysiology</title><sec id="s7-1"><title>What are the potential clinical impacts of SARS-CoV-2 on the endocrine system and the observed symptoms in PASC patients?</title><p>There is a large body of research that implicates viral disruption of multiple endocrine glands and their function even though the degree to which endocrine dysfunction contributes to the symptoms experienced by PASC patients remains to be fully elucidated. In a persistent viral environment, the endocrine system not only possesses the requisite ACE2 receptor, but also the TMPRSS2 protein necessary to provide the virion cellular access to dysregulate glandular function that may extend beyond the acute phase of SARS-CoV-2 infection into the Long COVID or post-acute phase. <italic>Can fatigue, the most common reported symptom in PASC, be explained by endocrine dysregulation?</italic> Some of the most frequently reported symptoms of Long COVID such as fatigue, cognitive impairment, and postural hypotension, are also reported by patients with adrenal insufficiency (<xref ref-type="bibr" rid="bib105">Kaltsas et al., 2010</xref>). However, the fatigue in PASC does not seem to be explained by insufficient adrenal function (<xref ref-type="bibr" rid="bib44">Clarke et al., 2022</xref>). Moreover, many studies, while offering hypotheses on new-onset diabetes (<xref ref-type="bibr" rid="bib72">Gentile et al., 2020</xref>) and thyroid disorders (<xref ref-type="bibr" rid="bib210">Trimboli et al., 2021</xref>) reported endocrine disorders that were unrelated to organ damage.</p><p>On the other hand, there is one area that has not received much attention with respect to endocrine-disrupting chemicals (EDCs) such as phthalates, bisphenols, organochlorine pesticides, and perfluorinated alkane substances that degrade the immune system and make children and adults susceptible to suspected hormonal mode of vulnerability (<xref ref-type="bibr" rid="bib54">Drucker, 2020</xref>) including COVID-19 (<xref ref-type="bibr" rid="bib208">Trasande et al., 2016</xref>), as supported by experimental studies (<xref ref-type="bibr" rid="bib43">Cipelli et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Couleau et al., 2015</xref>). The investigators conducted biological associations of major EDCs to proteins and diseases known as important COVID-19 comorbidities from the GeneCards and DisGeNET databases, and among the several pathways dysregulated by COVID-19, they found the Th17 and the AGE/RAGE signaling pathways were statistically significant and very auspicious (<xref ref-type="bibr" rid="bib229">Wu et al., 2021</xref>).</p></sec></sec><sec id="s8"><title>Hematologic pathologies and their mechanisms</title><sec id="s8-1"><title>Are there signaling pathways affected by elevated cytokines in the hematological system?</title><p>The elevation of certain cytokines in COVID-19 patients (i.e., IL-6, IL-1β, and IFN-γ), may also be due to the presence of the virus or its remnants in PASC patients. The cytokines can stimulate many processes involved in the activation of immune cells because of changes in the vascular environment, thus promoting greater adhesion and blood procoagulation (<xref ref-type="bibr" rid="bib200">Teuwen et al., 2020</xref>), and activating dispersed intravascular coagulation and the development of thromboembolic states that can antagonistically affect different tissues, particularly those that are more vulnerable to ischemic processes, such as cardiovascular, cerebrovascular, and pulmonary tissues (<xref ref-type="bibr" rid="bib75">Giustino et al., 2020</xref>). When the virus binds to the ACE2 receptor and enters the cell, a decreased density of the receptor on the vascular tissue ensues leading to negative regulation of ACE2 activity and subsequent accumulation of Angiotensin II, which causes vasoconstriction, profibrotic, pro-inflammatory effects, as well as tissue fibrosis (<xref ref-type="bibr" rid="bib75">Giustino et al., 2020</xref>). Therefore, this signaling stimulates immune cell inflammatory processes that can lead to pulmonary degeneration, pulmonary fibrosis, and loss of function accompanied by delayed hypoxemia and anoxia. These cytokines are important activators of the JAK/STAT pathway and NF-κB signaling (<xref ref-type="bibr" rid="bib103">Jose and Manuel, 2020</xref>). IL-6, which induces the expression of Angiotensin I is itself expressed via JAK/STAT, which creates a progressive feedback loop and results (<xref ref-type="bibr" rid="bib103">Jose and Manuel, 2020</xref>) in the rapid transmission of extracellular signals from IFNs, cytokines, and hormones, supporting changes in downstream gene expression via STAT-related transcription factors (<xref ref-type="bibr" rid="bib141">O’Shea et al., 2015</xref>). There are multiple JAKs and STATs that have been noted to impact this pathway, resulting in differential biological outcomes. The cascades of phosphorylation and activation of JAK proteins and the recruitment of STAT proteins, induce STAT dimerization and translocation to the nucleus, where they bind to specific DNA sequences and regulate gene expression (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib141">O’Shea et al., 2015</xref>).</p></sec><sec id="s8-2"><title>Do COVID-19 and Long COVID share signaling pathways that are aberrant?</title><p>Some of the potential signaling pathways involved in COVID-19 and PASC pathophysiology involve Toll-like receptors (TLR-3 and TLR-7/8) that recognize SARS-CoV-2 RNA and recruit the inflammatory cascade via type I and II IFN gene expression and NF-κB nuclear translocation (<xref ref-type="bibr" rid="bib167">Sabroe et al., 2008</xref>; <xref ref-type="bibr" rid="bib205">Totura et al., 2015</xref>). This stimulates the expression of multiple pro-inflammatory genes including pro-IL-1β, pro-IL-18, TNF, and IL-6 (<xref ref-type="bibr" rid="bib118">Li and Verma, 2002</xref>; <xref ref-type="bibr" rid="bib177">Schultheiss et al., 2022</xref>; <xref ref-type="bibr" rid="bib199">Tergaonkar et al., 2005</xref>). The virus, which may persist as an infectious agent in many different tissues, is also recognized by cytoplasmic NLRP3 that together with ASC and caspase-1 (Casp-1) forms the inflammasome complex leading to the cleavage and release of mature forms of IL-1β and IL-18 (<xref ref-type="bibr" rid="bib241">Zhao and Zhao, 2020</xref>). The binding of cytokines IL-1β, IL-18, and TNF to specific receptors promotes further NF-κB nuclear translocation and phosphorylation of p38 MAPK. The activation of p38 MAPK leads to further expression of pro-inflammatory cytokines and chemokines (<xref ref-type="bibr" rid="bib62">Feng et al., 2019</xref>; <xref ref-type="bibr" rid="bib81">Grimes and Grimes, 2020</xref>). IL-6, an important player in COVID-19, binds IL-6R and gp130 receptors to activate JAK/STAT-3 pathway and then contributes to the CRS observed in COVID-19 (<xref ref-type="bibr" rid="bib240">Zhang et al., 2020</xref>) and possibly in Long COVID patients. The increased release of inflammatory cytokines IL-1 and IL-6 by the activated M1 phenotype macrophages and the disproportionate activity of Angiotensin II generate endothelial activation, increased permeability, and coexpression of adhesion molecules, helping in the formation of a prothrombotic phenotype (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib3">Aird, 2007</xref>; <xref ref-type="bibr" rid="bib56">Escher et al., 2020</xref>). The common hematological abnormalities present mostly in severe COVID-19 patients are lymphopenia, thrombocytopenia, and elevated <sc>D</sc>-dimer levels (<xref ref-type="bibr" rid="bib156">Rahman et al., 2021</xref>).</p></sec></sec><sec id="s9"><title>Dysautonomia in PASC</title><sec id="s9-1"><title>What do we know about autonomic dysfunction in PASC?</title><p>Although the direct link between COVID-19 and dysautonomia is still theoretical, there may be a connection between neuronal injury of the autonomic pathway and a post-infectious immune-induced mechanism. This neurotrophic virus has multiple indirect routes including the autonomic nervous system by using axonal transport via the olfactory nerve (<xref ref-type="bibr" rid="bib119">Li et al., 2020a</xref>), via the ACE2 in brainstem and systemic blood circulation (<xref ref-type="bibr" rid="bib15">Baig et al., 2020</xref>), and via immune injury (<xref ref-type="bibr" rid="bib227">Wu and Yang, 2020</xref>). The stress induced by the virus may trigger the enhancement of the sympathetic nervous system promoting neuro-hormonal stimulation and activation of pro-inflammatory cytokines (<xref ref-type="bibr" rid="bib7">Al-Kuraishy et al., 2021</xref>). The typical symptoms experienced by PASC patients such as fatigue, chest pain, palpitations, dyspnea, post-exertional malaise, and ‘brain fog’ are also experienced by patients with orthostatic intolerance and syncope, which suggests the involvement of the autonomic nervous system. Additionally, cardiovascular autonomic dysfunction (CVAD) that appears to be common in PASC is similarly observed in inappropriate sinus tachycardia and POTS. Many POTS patients suffer from fatigue and what is often called ‘brain fog’. Tiny clots (micro-clots) in the brain could explain cognitive ailments arising from clots destroying small fiber nerve cells and driving dysautonomia. It should be emphasized that a growing body of evidence suggests that POTS may be an autoimmune disorder even though POTS is a rare medical condition whose etiology is yet to be established. Its clinical manifestations include the presence of antinuclear antibodies and elevations of ganglionic, adrenergic, and muscarinic acetylcholine receptor antibodies (<xref ref-type="bibr" rid="bib85">Gunning et al., 2019</xref>). Therefore, the onset of tachycardia following SARS-CoV-2, or any other viral infection can be more frequently explained as a physiological response of a perfectly normal autonomic nervous system. POTS is difficult to identify. It is misdiagnosed in up to 75% of patients and viral infection is recognized as a trigger in up to 41% of cases (<xref ref-type="bibr" rid="bib180">Shaw et al., 2019</xref>). It has been recently suggested that post-COVID-19 tachycardia syndrome would represent a distinct disease entity, different from classical POTS. There is also autonomic neuropathy that affects the heart, which leads to the proposal that PASC might be the clinical expression of COVID-related CVAD (<xref ref-type="bibr" rid="bib20">Bisaccia et al., 2021</xref>).</p><p>The most common PASC symptom, fatigue, shares some distinct features with CFS. Studies on CFS patients showed impaired cerebral blood flow (<xref ref-type="bibr" rid="bib212">van Campen et al., 2020</xref>) and reduced heart rate variability (<xref ref-type="bibr" rid="bib57">Escorihuela et al., 2020</xref>; <xref ref-type="bibr" rid="bib137">Nelson et al., 2019</xref>), even though these findings could not be confirmed in PASC patients. Furthermore, less than 50% of patients with PASC-related fatigue met the diagnostic criteria for CFS. This suggests that PASC is not just a COVID-19-related manifestation of CFS but a specific pathophysiological entity with a specific CVAD phenotype. But then the follow-up question would be: <italic>When does CVAD occur in COVID-19 patients and how long does it last?</italic></p></sec></sec><sec id="s10"><title>Cardiovascular diseases associated with COVID-19—focus on hypertension</title><p>Chest pain, dyspnea, and heart palpitations are some of the key symptoms that draw attention to the cardiovascular system (<xref ref-type="bibr" rid="bib76">Gluckman et al., 2022</xref>). However, cardiovascular disease (CVD) also includes congenital heart disease, coronary artery disease, hypertension (HTN), peripheral artery disease, stroke, and heart failure. Regardless of the severity of COVID-19, many patients have a complicated course of COVID-19 with regard to CVD. This is especially true for viral pneumonia (remembering that COVID-19 is primarily a respiratory infectious disease) that may result in severe systemic inflammation, acute myocardial infarction (MI), acute heart failure, cardiac arrest, venous thromboembolism (VTE), tachyarrhythmias, and stroke (<xref ref-type="bibr" rid="bib16">Baldi et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Basso et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Gao et al., 2020</xref>; <xref ref-type="bibr" rid="bib111">Lala et al., 2020</xref>; <xref ref-type="bibr" rid="bib146">Parohan et al., 2020</xref>; <xref ref-type="bibr" rid="bib181">Shi et al., 2020</xref>; <xref ref-type="bibr" rid="bib217">Wallentin et al., 2020</xref>; <xref ref-type="bibr" rid="bib242">Zhou et al., 2020</xref>). In a single-centered observational study, up to 329 days following diagnosis with COVID-19, approximately 75% reported persistent cardiac symptoms (<xref ref-type="bibr" rid="bib76">Gluckman et al., 2022</xref>). In the absence of validated biomarkers for PASC, imaging evidence using cardiac magnetic resonance (CMR) was obtained for myocardial inflammation, pericardial enhancement, and diffuse myocardial edema. Similarly, various abnormalities on CMR as well positron emission tomography have been reported in COVID-19 patients, even in the absence of cardiac symptoms (<xref ref-type="bibr" rid="bib91">Hanneman et al., 2022</xref>; <xref ref-type="bibr" rid="bib155">Puntmann et al., 2020</xref>). There are indicators of CVD such as cardiomyocyte injury, quantified by cardiac troponin (cTn) concentrations, heart failure, quantified by N-terminal pro B-type natriuretic peptide (NT-proBNP), and hemodynamic cardiac stress, quantified by natriuretic peptide concentrations that were detected in COVID-19 patients (<xref ref-type="bibr" rid="bib67">Flores et al., 2019</xref>; <xref ref-type="bibr" rid="bib111">Lala et al., 2020</xref>; <xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>; <xref ref-type="bibr" rid="bib146">Parohan et al., 2020</xref>; <xref ref-type="bibr" rid="bib181">Shi et al., 2020</xref>; <xref ref-type="bibr" rid="bib242">Zhou et al., 2020</xref>). The potential mechanisms underlying elevations in acute cTn and therefore myocardial injury from non-ischemic causes in COVID-19 patients include direct effect on myocardial cells via ACE2 receptor, cytokine storm, and hypoxia-induced apoptosis as well as myocarditis, Takotsubo syndrome, and pulmonary embolism. The rise in cTn from ischemic causes in COVID-19 patients include type I MI, and type II MI comprising shock, hypoxia, and tachycardia (<xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>).</p><sec id="s10-1"><title>As there is a COVID-19-induced diabetes, is there a similar COVID-19-induced CVD like hypertension?</title><p>There are two types of HTNs. Essential HTN (aka primary hypertension) is the most common form that is generally idiopathic with undefined mechanisms although it correlates with family history, salt retention, sedentary lifestyle, obesity, smoking, and stress (<xref ref-type="bibr" rid="bib33">Carretero and Oparil, 2000</xref>). Secondary HTN, on the other hand, is directly linked to comorbid pathophysiological disorders, such as renal, endocrine, and neurological diseases and pregnancy (<xref ref-type="bibr" rid="bib161">Rimoldi et al., 2014</xref>; <xref ref-type="bibr" rid="bib165">Rossier et al., 2017</xref>; <xref ref-type="bibr" rid="bib202">Tita et al., 2022</xref>). Both types of HTN are associated with an increased risk of severe COVID-19 and higher mortality rate in these patients (<xref ref-type="bibr" rid="bib122">Lippi et al., 2020</xref>). In one study, 31 days after SARS-CoV-2 infection, new-onset HTN (i.e., ≥140 mm Hg systolic BP and/or ≥90 mm Hg diastolic BP) was observed in a small number of patients (<xref ref-type="bibr" rid="bib5">Akpek, 2022</xref>). Considering that ACE2 plays a negative role in RAAS, a decrease in the ACE2 because of COVID-19, and an increase in the Angiotensin II level, may lead to increase in blood pressure (<xref ref-type="bibr" rid="bib5">Akpek, 2022</xref>). In a larger control study, 190 patients without prior HTN had higher Angiotensin II level with 8.42% patients recording a rise in blood pressure and a significantly increased level of the cTnI (cardiac troponin I), procalcitonin, and angiotensin (<xref ref-type="bibr" rid="bib38">Chen et al., 2021</xref>). It is important to note that the cTn concentration in a COVID-19 patient must be seen as the combination of the presence of pre-existing cardiac disease and the acute myocardial injury induced by COVID-19 and its complications (<xref ref-type="bibr" rid="bib111">Lala et al., 2020</xref>; <xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>). These findings suggest that COVID-19 increases systolic and diastolic BP and may cause new-onset HTN. Altogether, these findings and others regarding cardiovascular symptoms call into question our understanding of viral-mediated myocardial (and pericardial) involvement (<xref ref-type="bibr" rid="bib88">Halushka and Vander Heide, 2021</xref>; <xref ref-type="bibr" rid="bib91">Hanneman et al., 2022</xref>; <xref ref-type="bibr" rid="bib147">Pellegrini et al., 2021</xref>; <xref ref-type="bibr" rid="bib155">Puntmann et al., 2020</xref>; <xref ref-type="bibr" rid="bib221">Webster et al., 2021</xref>; <xref ref-type="bibr" rid="bib237">Yousif and Premraj, 2022</xref>). They additionally raise inquiries about our poor knowledge of the pathophysiology of cardiovascular manifestations and predisposing risk factors associated with Long COVID/PASC whose long-term cardiovascular consequences remain unknown.</p></sec></sec><sec id="s11"><title>ED related to COVID-19—lesson for PASC</title><sec id="s11-1"><title>Does SARS-CoV-2-mediated endothelial damage result in ED that extends to PASC? Could there be endothelial biomarkers in patients with PASC?</title><p>A study, which assessed the function of the peripheral endothelia via the reactive hyperemia index (RHI) using peripheral arterial tonometry in PASC patients and age- and sex-matched healthy controls (HCs), showed that there is ample evidence for impaired perfusion and ED (<xref ref-type="bibr" rid="bib68">Fluge et al., 2021</xref>; <xref ref-type="bibr" rid="bib175">Scherbakov et al., 2020</xref>). The ED causes inflammation, an intensified immune response, and excessive cytokine release all of which may lead to widespread multiorgan manifestations of the disease (<xref ref-type="bibr" rid="bib142">Ostergaard, 2021</xref>). It is also noteworthy to mention that the SARS-CoV-2 infection of endothelial cells restructures the cells’ architecture and morphology leading to apoptosis that could persist several weeks after the acute infection. The importance of the endothelium in long-term cardiovascular complications in convalescent patients was underscored by The Working Group on Atherosclerosis and Vascular Biology together with the Council of Basic Cardiovascular Science of the European Society of Cardiology (<xref ref-type="bibr" rid="bib59">Evans et al., 2020</xref>). In the TUN-EndCOV study, a multivariate analysis showed that ED is an independent risk factor of Long COVID-19 (<xref ref-type="bibr" rid="bib36">Charfeddine et al., 2021</xref>; <xref ref-type="bibr" rid="bib104">Jud et al., 2021</xref>).</p></sec><sec id="s11-2"><title>Are there biomarkers for endothelial dysregulation?</title><p>In a study involving ED and altered endothelial biomarkers in patients with PASC and ME/CFS, 38% of the PASC ME/CFS patients and 31% Long COVID patients (without MS/CFS) showed ED defined by a diminished RHI (&lt;1.67), but none of the HCs exhibited this finding (<xref ref-type="bibr" rid="bib87">Haffke et al., 2022</xref>). A positive correlation of RHI was found with age, blood pressure, and BMI in PASC but not ME/CFS patients. In a larger cohort of patients and HCs, including post-COVID re-convalescents (PCHCs), Endothelin-1 (ET-1), Angiopoietin-2 (Ang-2), Endocan (ESM-1), IL-8, ACE, and ACE2 were analyzed as endothelial biomarkers. The ET-1 concentration was significantly elevated in both ME/CFS and PASC patients compared to HCs and PCHCs. The serum Angiotensin II concentration was lower in both PCS patients and PCHCs compared to HCs (<xref ref-type="bibr" rid="bib87">Haffke et al., 2022</xref>). The study authors concluded that a diminished RHI and altered endothelial biomarkers were evidence of ED for a subset of PASC patients suggesting that clinical parameters could be used in association with RHI and varying biomarker profiles to delineate the discrete pathological mechanisms among patient subgroups. In another study designed to understand the role of the ED in COVID-19 and PASC, plasma levels of two proteins released by activated endothelial cells, soluble P-Selectin (sP-Sel) (also released by activated platelets) and von Willebrand factor (VWF) antigen (measures amount of the clotting factor, VWF), and <sc>D</sc>-dimer (a biomarker of systemic thrombosis), were measured (<xref ref-type="bibr" rid="bib140">Osburn et al., 2022</xref>). Moreover, these endothelial biomarker levels were compared with the levels of pro-inflammatory cytokine and chemokines, and vascular inflammation biomarkers. The study reports that sP-Sel, VWF, and <sc>D</sc>-dimer were increased in individuals with COVID-19 pulmonary disease and correlated with proinflammatory cytokines and chemokines, suggesting that COVID-19 is a vascular disease which involves endothelial injury in the context of an inflammatory state (<xref ref-type="bibr" rid="bib140">Osburn et al., 2022</xref>). A similar study also contends that activated coagulation as quantified by <sc>D</sc>-dimers is more prominent in COVID-19 as in other pneumonias (<xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>). <italic>How can this information help physicians in selecting patients for the appropriate treatment?</italic> Endothelialitis and VTE play a cardinal role in COVID-19. Consequently, successive measurements of <sc>D</sc>-dimers may help physicians in the selection of patients for VTE imaging and the administration of the appropriate dosage of anticoagulation for prophylactic or therapeutic purposes.</p><p>Mechanistically, the inflammatory mediators, reactive oxygen species, matrix metalloproteases, the glycocalyx, fragments, and the viral proteins may contribute to endothelial glycocalyx damage in COVID-19 (<xref ref-type="bibr" rid="bib239">Zha et al., 2022</xref>). Heparin sulfate (HS) has been shown to regulate the activation of the bradykinin pathway, which is involved in local inflammation and vascular permeability (<xref ref-type="bibr" rid="bib27">Buijsers et al., 2020</xref>). Elevated plasma heparanase activity in COVID-19 patients can lead to the activation of bradykinin pathway by the cleaving of HS and can subsequently trigger the inflammatory response and vascular leakage. Other potential mechanisms that account for coagulopathy in COVID-19 and cause endothelial function as well as cardiovascular disorders include plasmin-mediated increased binding of SARS-CoV-2 to ACE2 receptors, elevated levels of fibrinogen and an unnecessary fibrin polymerization, cytokine-mediated disseminated intravascular coagulation, activation of thrombin and suppression of fibrinolysis by plasminogen activators and PAI-1 inhibitors in ARDS, inhibition of plasmin by antiplasmins, and direct viral infection/endotheliitis (<xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>). All these demonstrations of endothelial dysregulation have convinced some scientists to consider COVID-19 not just a respiratory disease, but a vascular one as well. The rationale is that ACE2 is the doorway for SARS-CoV-2 to bind to and infect cells, and COVID-19 is associated with several acute clotting syndromes that precipitate debilitating symptoms in PASC patients.</p></sec></sec><sec id="s12"><title>Potential mechanisms for neurocognitive impairment in PASC</title><p>SARS-CoV-2 can infect the brain, causing neuroinflammation (<xref ref-type="bibr" rid="bib145">Pan et al., 2020</xref>). Moreover, inflammation elsewhere in the body can activate the innate immune system (<xref ref-type="fig" rid="fig1">Figure 1</xref>) in the brain via both humoral and retrograde neural signals, largely involving the vagus nerve (<xref ref-type="bibr" rid="bib152">Poon et al., 2015</xref>; <xref ref-type="bibr" rid="bib213">VanElzakker, 2013</xref>). Different study model systems such as autopsies, animals and organoids used to study the infective potential of the SARS-CoV-2 virus show that SARS-CoV-2 can reach and infect neurons and cells of the CNS and produce neuroinflammation (<xref ref-type="bibr" rid="bib127">Matschke et al., 2020</xref>; <xref ref-type="bibr" rid="bib186">Song et al., 2020</xref>). Neuropsychological symptoms are frequent in PASC survivors of COVID-19 who often experience lingering neurological symptoms analogous to cancer-therapy-related cognitive impairment, which involves white matter microglial reactivity and consequent neural dysregulation. SARS-CoV-2 infection has been shown to affect white-matter-selective microglial reactivity in mice and humans by impairing hippocampal neurogenesis, decreasing oligodendrocytes, and promoting myelin loss with a concomitant increase in CSF cytokines/chemokines including CCL11 (<xref ref-type="bibr" rid="bib63">Fernández-Castañeda et al., 2022a</xref>). Accordingly, cognitive impairment manifested even with mild COVID symptoms parallel the neuropathophysiology that is observed in people with cancer therapy (<xref ref-type="bibr" rid="bib64">Fernández-Castañeda et al., 2022b</xref>). The question remains: <italic>How does the virus manage to get to the brain?</italic> One potential pathway to reach the CNS is via hematogenous dissemination from severely infected upper and lower respiratory system by way of systemic inflammation that raises the permeability of blood–brain barrier (BBB) and permit circulating non-BBB-crossing molecules to adversely affect brain function (<xref ref-type="bibr" rid="bib154">Proal and VanElzakker, 2021</xref>). More importantly for PASC, during acute infection this porousness can also allow for viral neuroinvasion that may persist past the acute infection phase. Although the mechanism is not well known, this neuroinvasion can occur directly or indirectly through host immune cells infected with the virus and are actively transported into the CNS (<xref ref-type="bibr" rid="bib48">Dando et al., 2014</xref>; <xref ref-type="bibr" rid="bib113">Lauer et al., 2018</xref>). A large MRI registry study that examined changes in the brain before and a mean of 141 days following SAR-CoV-2 identified reductions global brain size and gray matter thickness in orbitofrontal cortex/parahippocampal gyrus. Importantly, the study also identified increased markers of tissue damage in regions associated with the primary olfactory cortex following infection. These data suggest that COVID-19 has profound impact on the brain, especially the olfactory cortex, which may explain changes of taste and smell and may indicate CNS infection from direct extension from the olfactory system (<xref ref-type="bibr" rid="bib51">Douaud et al., 2022</xref>).</p><sec id="s12-1"><title>What could explain neurological symptoms in PASC patients?</title><p>Concerning pathophysiology, virus neurotropism leading to sustained neuroinflammation of central and peripheral nervous systems could explain neurocognitive impairment or symptoms of mental health disorders, as has been proposed by numerous studies detailed in a review (<xref ref-type="bibr" rid="bib34">Castanares-Zapatero et al., 2022</xref>). It is also likely that central, peripheral, psychological, and physiological factors play a role in the development of PASC fatigue. A chronicle of Long COVID describes that congestion of the glymphatic system and the subsequent toxic build-up within the CNS, caused by an increased resistance to cerebrospinal fluid drainage through the cribriform plate because of olfactory neuron damage, may contribute to PASC fatigue (<xref ref-type="bibr" rid="bib226">Wostyn, 2021</xref>). Emotional and cognitive disturbances could also be partially traced back to metabolic changes linked to tissue damage, repair, and immune function in multiple areas of the nervous system (<xref ref-type="bibr" rid="bib96">Holmes et al., 2021</xref>). To support this hypothesis, use of animal models of COVID has proven valuable. In the golden hamster model of SARS-CoV-2 infection, sustained inflammatory pathology correlated with behavioral abnormalities not found in influenza A virus infection (<xref ref-type="bibr" rid="bib69">Frere et al., 2022</xref>). Exclusive features included anosmia and anxiety-like behaviors, a unique neural transcriptional profile, and a persistent neuroimmune response reminiscent to what has been observed in humans (<xref ref-type="bibr" rid="bib69">Frere et al., 2022</xref>). In this study, differential gene expression data revealed significant enrichments for metabolic, synaptic signaling, neural plasticity, and immune-related pathways. These data provide validity for modeling and dissecting the physiopathology of neuropsychiatric symptoms of PASC. In addition, these results set a benchmark for comparison between PASC and other clinical conditions. Other neuropsychological symptoms of PASC such as ME/CFS, and ‘brain fog’ could be explained by direct integration of viral genome into mitochondrial DNA, impairing energy metabolism, and oxygen availability and utilization (<xref ref-type="bibr" rid="bib229">Wu et al., 2021</xref>). Metabolic fitness can also be altered by impaired autophagy, which relates to inadequate clearance of debris by microglia (<xref ref-type="bibr" rid="bib13">Awogbindin et al., 2021</xref>). As an indirect effect, it has been proposed that impaired pulmonary function leads to decreased systemic oxygenation, including the CNS. Alternatively, when lingering, systemic inflammation may disrupt the brain–blood barrier, cause inflammatory damage, and neurocognitive deficit (<xref ref-type="bibr" rid="bib189">Stefano et al., 2022</xref>). SARS-CoV-2 may also enter taste buds through ACE2 protein found in some taste receptor cells, causing taste changes, and disrupted stem cells. Further research is needed to understand this process (<xref ref-type="bibr" rid="bib53">Doyle et al., 2021</xref>). Though there are several hypotheses, the exact mechanisms, and the attempt to identity a unifying pathophysiological cause (e.g., neuroinflammation) of many of the described symptoms of PASC remain elusive (<xref ref-type="bibr" rid="bib197">Tate et al., 2022</xref>). Progress in this direction is needed as the neuropsychiatric manifestations of PASC may increase the risk long-term of neurocognitive diseases (e.g., dementia) with common mechanistic features (<xref ref-type="bibr" rid="bib125">Liu et al., 2022</xref>).</p></sec></sec><sec id="s13"><title>GI effects of COVID-19 and Long COVID</title><p>The extrapulmonary disease that SARS-CoV-2 inflicts upon the body also extends to the GI tract where there is evidence that the virus may persist where the ACE2 receptor is highly expressed (<xref ref-type="bibr" rid="bib179">Settanni et al., 2021</xref>). Given that the severity of COVID-19 is typically engendered by a set of comorbidities such as HTN, diabetes, obesity, and/or advanced age, the GI symptoms, such as diarrhea, vomiting, or abdominal pain during the early phases of the disease can be debilitating (<xref ref-type="bibr" rid="bib112">Lamers et al., 2020</xref>). Symptoms can last for years as is the case for post-infectious irritable bowel syndrome (PI-IBS), which is punctuated by the persistence of abdominal discomfort, bloating and diarrhea that continue despite clearance of the inciting pathogen, usually bacterial origin (<xref ref-type="bibr" rid="bib55">Dunlop et al., 2003</xref>; <xref ref-type="bibr" rid="bib107">Kim et al., 2006</xref>; <xref ref-type="bibr" rid="bib179">Settanni et al., 2021</xref>). Again, the culprit in all these acute and post-acute COVID-19 symptoms including the impairment of bowel physiology may be a dysregulation of ACE2-mediated functions due to a competitive mechanism of the virus on ACE2 receptor or from a downregulation of its anti-inflammatory activity. To date, there is a dearth of data on the GI sequelae of SARS-CoV-2 infection. This may be due to the uncertainty over COVID-19’s path of action on the gut physiology.</p><sec id="s13-1"><title>Is it viral persistence or its aftereffects?</title><p>It is conceivable that recovery from COVID-19 may not absolve the GI tract of functional bowel diseases that may precipitate due to potential pathophysiological alterations such as disruption of the intestinal barrier, dysbiosis, mucosal microinflammation, post-infectious states, immune dysregulation, and psychological stress (<xref ref-type="bibr" rid="bib179">Settanni et al., 2021</xref>). The undermining of the intestinal homeostasis by the virus not only may perturb the microbial composition but also increase inflammatory cytokines. For example, SARS-CoV-2 infection has been shown to lead to persistent altered gut mucosal integrity and microbial translocation resulting in increased NF-κB signaling and generalized inflammation in those with PASC (<xref ref-type="bibr" rid="bib74">Giron et al., 2022</xref>). Inflammation can be potentially more harmful to the gut than the virus itself. The virus initiates a cascade of immune reactions that are self-activating via autoantibodies with the host cytokine pathways triggering adverse microbiota interactions in a continuous and circuitous manner. For this reason, it is crucial to investigate how intestinal bacteria respond to SARS-CoV-2 infection and the effect of their metabolic products to help determine novel biomarkers of the disease and its long-term impact on the GI tract to enable new therapeutic targets.</p></sec></sec><sec id="s14"><title>Potential biological underpinnings of pediatric PASC</title><p>While much of our current understanding of PASC comes from adults, one of the first PASC phenotypes occurred in children. Shortly after the emergence of SARS-CoV-2, rare cases of multisystem inflammatory syndrome in children (MIS-C) were documented (<xref ref-type="bibr" rid="bib162">Riphagen et al., 2020</xref>). It is now understood that MIS-C occurs weeks after SARS-CoV-2 infection and is characterized by persistent fevers, massive inflammation, and multiorgan involvement including long-term neurologic complications. The most striking clinical manifestation is profound myocardial dysfunction resulting in shock; however, extracardiac organ system dysfunction is also common, particularly GI (<xref ref-type="bibr" rid="bib40">Cheung et al., 2020</xref>; <xref ref-type="bibr" rid="bib61">Feldstein et al., 2020</xref>; <xref ref-type="bibr" rid="bib162">Riphagen et al., 2020</xref>). The mechanisms which underlie MIS-C are not fully understood but emerging evidence points toward immune system dysfunction. Acute MIS-C is defined by massive elevations in inflammatory cytokines, particularly those related to myeloid recruitment and mucosal immunity (<xref ref-type="bibr" rid="bib45">Consiglio et al., 2020</xref>; <xref ref-type="bibr" rid="bib84">Gruber et al., 2020</xref>). The production of autoreactive antibodies is also characteristic of acute MIS-C with antibodies specific for endothelial proteins detected in many patients (<xref ref-type="bibr" rid="bib45">Consiglio et al., 2020</xref>; <xref ref-type="bibr" rid="bib84">Gruber et al., 2020</xref>; <xref ref-type="bibr" rid="bib157">Ramaswamy et al., 2021</xref>). Aberrant activation of T cells is a consistent finding as well (<xref ref-type="bibr" rid="bib214">Vella et al., 2021</xref>), with a potentially pathognomonic role for biased expansions of T cell clones (<xref ref-type="bibr" rid="bib153">Porritt et al., 2021</xref>). Activated T lymphocyte cell expansions resemble those seen following bacterial superantigen stimulation with additional evidence suggesting that motifs from the SARS-CoV-2 spike protein may be capable of promoting autoimmunity (<xref ref-type="bibr" rid="bib138">Noval Rivas et al., 2022</xref>). These immune derangements along with elevated biomarkers suggesting mucosal barrier breakdown have been linked to detectable antigenic persistence in circulation (<xref ref-type="bibr" rid="bib235">Yonker et al., 2021</xref>), suggesting an additional role for viral persistence in the pathogenesis of MIS-C. Treatment for MIS-C has included steroids, intravenous immunoglobulin, and monoclonal antibodies targeting IL-6 and IL-1Ra (<xref ref-type="bibr" rid="bib61">Feldstein et al., 2020</xref>). Fortunately, following treatment for MIS-C, short to mid-range reported health outcomes have been excellent (<xref ref-type="bibr" rid="bib60">Farooqi et al., 2021</xref>; <xref ref-type="bibr" rid="bib128">Matsubara et al., 2022</xref>). Pediatric PASC outside of MIS-C has been more difficult to quantify, with estimates ranging from 4% to 25% of previously infected children experiencing PASC symptoms (<xref ref-type="bibr" rid="bib98">Izquierdo-Pujol et al., 2022</xref>). Risk factors for development of pediatric PASC include severity of acute infection, younger age (&lt;5 years), and presence of chronic health conditions (<xref ref-type="bibr" rid="bib158">Rao et al., 2022</xref>). In case reports or small series, endothelial damage and encephalomyelitis have been identified in children with PASC (<xref ref-type="bibr" rid="bib28">Buonsenso et al., 2021</xref>; <xref ref-type="bibr" rid="bib121">Lindan et al., 2021</xref>) but underlying mechanisms remain undefined. Based on our current knowledge of MIS-C and the evidence that pediatric immune responses to SARS-CoV-2 are distinct from adults (<xref ref-type="bibr" rid="bib151">Pierce et al., 2020</xref>; <xref ref-type="bibr" rid="bib223">Weisberg et al., 2021</xref>; <xref ref-type="bibr" rid="bib236">Yoshida et al., 2022</xref>), understanding immune responses in pediatric PASC must be prioritized. To better characterize pediatric PASC subtypes and define the mechanisms giving rise to persistent symptomatology, awareness, and identification followed by study enrollment of relatively rare cases is critical to maximize our ability to understand and treat this emerging pediatric health threat.</p></sec><sec id="s15"><title>Unanswered questions about PASC</title><p>What are PASC factors? When can the factors be assayed in the course of disease progression? Are these factors interrelated or independent? What are the immune and genomic signatures of PASC? What is the eventual public disease burden of PASC? What does PASC mean for patients and what can be done about it? The unknowns about PASC are too numerous to list. We still do not know if there is a correlation between PASC and the duration/frequency/severity of the initial SARS-CoV-2 infection. Also, the subsequent iterations of the virus (i.e., omicron variants) with factors like age, gender, demographics, and comorbidities are not clear. The longitudinal collection of biospecimens and deep phenotyping of PASC subjects in the RECOVER study will provide a rich set of resources to answer key prognostic, epidemiologic and pathophysiologic questions about PASC and will serve as a platform for testing interventions to prevent or treat PASC.</p><p>We urgently need comprehensive epidemiologic studies via surveys/questionnaires and by interrogating the electronic health record databases and through longitudinal study enrollment that allow for a more complete understanding of the prevalence ad incidence of PASC within various populations. Furthermore, comprehensive examination of blood and tissues using synergistic methods such as proteomics, metabolomics, transcriptomics, viral nucleic acid and protein testing, and virus-specific and auto-reactive antibody characterization will be needed. Additionally, comprehensive immunophenotyping of PASC can be performed to identify cell markers and to provide further pathophysiologic understanding of the interplay between immune responses, inflammation, and PASC phenotypes. It must also be noted that the mechanisms underlying Long COVID/PASC may not be uniform across all individuals. Among the more prominent sociodemographic and clinical risk factors, the severity of acute COVID-19 infection, female sex, advanced age, pre-existing diabetes mellitus, more than five early symptoms, early dyspnea, and prior psychiatric disorders have been identified (<xref ref-type="bibr" rid="bib30">Carfì et al., 2020</xref>; <xref ref-type="bibr" rid="bib191">Subramanian et al., 2022</xref>; <xref ref-type="bibr" rid="bib234">Yong, 2021</xref>). Additional variables that need to be considered include the variant of SARS-CoV-2 infection and those who develop PASC and the role of vaccination and antiviral therapy in acute infection (<xref ref-type="bibr" rid="bib11">Antonelli et al., 2022</xref>; <xref ref-type="bibr" rid="bib116">Ledford, 2022</xref>). Double-vaccinated participants with COVID-19 caused by the Omicron BA.1, BA.4, and BA.5 variants were less likely to develop PASC, as compared to those infected by the Delta variant. It is also likely that most of the symptoms and pathologies associated with COVID-19 persist in Long COVID perhaps because of the spike protein, which is also the target of the vaccination. The currently known and suspected mechanisms and molecular features for COVID and potentially for Long COVID/PASC pathologies are shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Proposed molecular, pathobiological, and pathophysiological mechanisms related to Long COVID symptoms.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Dysregulated system</th><th align="left" valign="bottom">Mechanism</th><th align="left" valign="bottom">Biological/molecular factor<xref ref-type="table-fn" rid="table1fn1">*</xref></th><th align="left" valign="bottom">Signaling pathway</th><th align="left" valign="bottom">Reference</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Autonomic</italic></td><td align="left" valign="bottom">Autoimmune dysfunction of the autonomic nervous system; cardiovascular autonomic dysfunction (CVAD); post-intensive care syndrome (PICS); orthostatic intolerance (OI); syncope; postural orthostatic tachycardia syndrome (POTS)-like dysfunction; (ME/CFS)-like dysfunction; antinuclear antibodies</td><td align="left" valign="bottom"><bold>↑</bold>Ganglionic, adrenergic, and muscarinic acetylcholine receptor antibodies<break/><bold>↑</bold>G-protein-coupled receptor autoantibodies</td><td align="left" valign="bottom">Sympathetic nervous system;<break/>cytokine storms; activation of renin–angiotensin system</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Al-Kuraishy et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Baig et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Bisaccia et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Escorihuela et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Gunning et al., 2019</xref>; <xref ref-type="bibr" rid="bib119">Li et al., 2020a</xref>; <xref ref-type="bibr" rid="bib137">Nelson et al., 2019</xref>; <xref ref-type="bibr" rid="bib180">Shaw et al., 2019</xref>; <xref ref-type="bibr" rid="bib212">van Campen et al., 2020</xref>; <xref ref-type="bibr" rid="bib227">Wu and Yang, 2020</xref>;</td></tr><tr><td align="left" valign="bottom"><italic>Cardiovascular</italic></td><td align="left" valign="bottom">Myocardial hypertrophy; focal myocardial fibrosis; acute myocardial infarction; cardiac hypertrophy; endothelial dysfunction and coagulation activation; neutrophil extracellular traps (NETs); inflammation-coagulation (Factor XII); direct complement activation (inflammation)</td><td align="left" valign="bottom"><bold>↑</bold>Thrombin<break/><bold>↓</bold>Plasmin<break/><bold>↓</bold>Fibrinolysis<break/><bold>↑</bold> NT-proBNP<break/><bold>↑</bold>cTnI<break/><bold>↑</bold>Serum lactate dehydrogenase<break/><bold>↑</bold>Creatine kinase</td><td align="left" valign="bottom">Aryl hydrocarbon receptor (AhR) signaling through an IDO-Kyn-dependent pathway (hypoxia induction)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Baldi et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Basso et al., 2020</xref>; <xref ref-type="bibr" rid="bib67">Flores et al., 2019</xref>; <xref ref-type="bibr" rid="bib70">Gao et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Hanneman et al., 2022</xref>; <xref ref-type="bibr" rid="bib111">Lala et al., 2020</xref>; <xref ref-type="bibr" rid="bib124">Liu et al., 2020b</xref>; <xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>; <xref ref-type="bibr" rid="bib146">Parohan et al., 2020</xref>; <xref ref-type="bibr" rid="bib155">Puntmann et al., 2020</xref>; <xref ref-type="bibr" rid="bib181">Shi et al., 2020</xref>; <xref ref-type="bibr" rid="bib217">Wallentin et al., 2020</xref></td></tr><tr><td align="left" valign="bottom"><italic>Endocrine</italic></td><td align="left" valign="bottom">Damage to thyroid gland; thyroiditis/thyrotoxicosis</td><td align="left" valign="bottom"><bold>↓</bold>Thyroxin-3, <bold>↑</bold>ACE2, <bold>↑</bold>TMPRSS2</td><td align="left" valign="bottom">The Th17 and the AGE/RAGE signaling pathways</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Clarke et al., 2022</xref>; <xref ref-type="bibr" rid="bib115">Lazartigues et al., 2020</xref>; <xref ref-type="bibr" rid="bib222">Wei et al., 2007</xref>; <xref ref-type="bibr" rid="bib229">Wu et al., 2021</xref></td></tr><tr><td align="left" valign="bottom"><italic>Endothelial</italic></td><td align="left" valign="bottom">Endothelialitis; thromboembolism; endothelial glycocalyx damage</td><td align="left" valign="bottom"><bold>↑</bold>sP-Sel, vWF, and <sc>D</sc>-dimer<break/><bold>↑</bold> Endothelin-1 (ET-1)<break/><bold>↓</bold> Angiotensin II<break/><bold>↑</bold>Proinflammatory cytokines and chemokines<break/><bold>↑</bold>Plasma heparinase</td><td align="left" valign="bottom">Bradykinin pathway</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Buijsers et al., 2020</xref>; <xref ref-type="bibr" rid="bib67">Flores et al., 2019</xref>; <xref ref-type="bibr" rid="bib135">Mueller et al., 2021</xref>; <xref ref-type="bibr" rid="bib140">Osburn et al., 2022</xref>; <xref ref-type="bibr" rid="bib175">Scherbakov et al., 2020</xref>; <xref ref-type="bibr" rid="bib239">Zha et al., 2022</xref></td></tr><tr><td align="left" valign="bottom"><italic>Gastrointestinal</italic></td><td align="left" valign="bottom">Impaired barrier function; gut inflammation, altered serotonin metabolism and gut microbiota dysbiosis, <italic>Ruminococcus gnavus</italic> positively correlated with inflammatory markers; Clostridia was negatively correlated, fungal translocation leading to NF-κB activation and inflammation</td><td align="left" valign="bottom"><bold>↑</bold> Ruminococcus gnavus,<break/><bold>↑</bold>Fecal calprotectin<break/><bold>↑</bold>Plasma serotonin (5-hydroxytrytamine, 5-HT)</td><td align="left" valign="bottom">Interferon gamma (IFN<italic>-</italic>γ) signaling</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Chandrashekhar Joshi and Pozzilli, 2022</xref>; <xref ref-type="bibr" rid="bib74">Giron et al., 2022</xref>; <xref ref-type="bibr" rid="bib177">Schultheiss et al., 2022</xref></td></tr><tr><td align="left" valign="bottom"><italic>Hematological</italic></td><td align="left" valign="bottom">Vascular dysregulation; hypercoagulopathy; endothelialitis; hemostatic changes that leave the endothelium inflamed, pre-adhesive, and prothrombotic; thrombocytopenia, deep vein thrombosis</td><td align="left" valign="bottom"><bold>↑</bold>Plasminogen activator inhibitor factor I (PAI)<break/><bold>↑</bold>Tissue factor (TF)<break/><bold>↑</bold>von Willebrand factor (vWF)<break/><bold>↑</bold><sc>D</sc>-dimer<break/><bold>↓</bold>Hb<break/><bold>↑</bold>GM-CSF</td><td align="left" valign="bottom">p38 MAPK;<break/>Antibody-dependent cellular toxicity</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Aird, 2007</xref>; <xref ref-type="bibr" rid="bib24">Boisramé-Helms et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Giustino et al., 2020</xref>; <xref ref-type="bibr" rid="bib89">Hamming et al., 2004</xref>; <xref ref-type="bibr" rid="bib90">Hamming et al., 2007</xref>; <xref ref-type="bibr" rid="bib97">Hussman, 2020</xref>; <xref ref-type="bibr" rid="bib123">Liu et al., 2020a</xref>; <xref ref-type="bibr" rid="bib156">Rahman et al., 2021</xref>; <xref ref-type="bibr" rid="bib162">Riphagen et al., 2020</xref>; <xref ref-type="bibr" rid="bib238">Zachariah et al., 2020</xref></td></tr><tr><td align="left" valign="bottom"><italic>Immunological</italic></td><td align="left" valign="bottom">Dysregulated and heightened immune system; prolonged inflammation leading to multiorgan dysfunction; cytokine release syndrome (CRS); Mast Cell Activation Syndrome (MCAS); neutrophil extracellular traps (NETs); pattern recognition receptors (PRRs) including Toll-like receptor (TLR); retinoic acid-inducible gene-I (RIG-I)-like receptors; oxidative stress</td><td align="left" valign="bottom"><bold>↑</bold>IL-1β, IL-2, IL-6 <bold>↑</bold>IL- 8, IL-10<break/><bold>↑</bold>IL-IL-12, IL-17 <bold>↑</bold>IL-18<break/><bold>↑</bold>IFN-γ, NF-κB;<break/><bold>↑</bold>IFN-I and IFN-III<break/><bold>↑</bold>TNF,<break/><bold>↑</bold>CXCL-10,<break/><bold>↑</bold>p38 MAPK<break/><bold>↑</bold>JAKs and STATs<break/><bold>↑</bold>GM-CSF<break/><bold>↑</bold>TGF- β<break/><bold>↑</bold>ESR</td><td align="left" valign="bottom">JAK/STAT; Toll-like receptor pathways (TLR-3 and TLR 7/8); AKT/mTOR/MAPK pathway; FcyRIIA;<break/>NF-κB p65 and p38 MAPK, 1/2 (STAT1/2) pathway</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Blanco-Melo et al., 2020</xref>; <xref ref-type="bibr" rid="bib62">Feng et al., 2019</xref>; <xref ref-type="bibr" rid="bib86">Guo and Thomas, 2017</xref>; <xref ref-type="bibr" rid="bib103">Jose and Manuel, 2020</xref>; <xref ref-type="bibr" rid="bib118">Li and Verma, 2002</xref>; <xref ref-type="bibr" rid="bib141">O’Shea et al., 2015</xref>; <xref ref-type="bibr" rid="bib144">Pablos et al., 2020</xref>; <xref ref-type="bibr" rid="bib164">Ronco and Reis, 2020</xref>; <xref ref-type="bibr" rid="bib196">Tarentino and Maley, 1975</xref>; <xref ref-type="bibr" rid="bib198">Tay et al., 2020</xref>; <xref ref-type="bibr" rid="bib199">Tergaonkar et al., 2005</xref>; <xref ref-type="bibr" rid="bib205">Totura et al., 2015</xref>; <xref ref-type="bibr" rid="bib224">Wirth and Scheibenbogen, 2021</xref>; <xref ref-type="bibr" rid="bib233">Ye et al., 2020</xref>; <xref ref-type="bibr" rid="bib240">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="bib241">Zhao and Zhao, 2020</xref></td></tr><tr><td align="left" valign="bottom"><italic>Neurological</italic></td><td align="left" valign="bottom">Neuro-inflammation; coagulopathy; micro-thrombosis; aberrant immune response; metabolic brain disorders; stroke; Guillain–Barré syndrome; hemodynamic and coagulation disorders; arrhythmia; nervous system damage</td><td align="left" valign="bottom"><bold>↑</bold>IL-18, IL-6, and IL-8<break/><bold>↑</bold>CCL-11<break/><bold>↑</bold>Neurofilament light (NFL)<break/><bold>↑</bold>Glial fibrillary acidic protein (GFAP)</td><td align="left" valign="bottom">Humoral and retrograde neural signals;<break/>blood–brain barrier (BBB)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Awogbindin et al., 2021</xref>; <xref ref-type="bibr" rid="bib34">Castanares-Zapatero et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Dando et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Fernández-Castañeda et al., 2022a</xref>; <xref ref-type="bibr" rid="bib64">Fernández-Castañeda et al., 2022b</xref>; <xref ref-type="bibr" rid="bib69">Frere et al., 2022</xref>; <xref ref-type="bibr" rid="bib96">Holmes et al., 2021</xref>; <xref ref-type="bibr" rid="bib113">Lauer et al., 2018</xref>; <xref ref-type="bibr" rid="bib127">Matschke et al., 2020</xref>; <xref ref-type="bibr" rid="bib145">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib152">Poon et al., 2015</xref>; <xref ref-type="bibr" rid="bib154">Proal and VanElzakker, 2021</xref>; <xref ref-type="bibr" rid="bib169">Sahin et al., 2022</xref>; <xref ref-type="bibr" rid="bib186">Song et al., 2020</xref> ; <xref ref-type="bibr" rid="bib197">Tate et al., 2022</xref>; <xref ref-type="bibr" rid="bib213">VanElzakker, 2013</xref>; <xref ref-type="bibr" rid="bib226">Wostyn, 2021</xref>; <xref ref-type="bibr" rid="bib228">Wu et al., 2020</xref></td></tr><tr><td align="left" valign="bottom"><italic>Pancreatic</italic></td><td align="left" valign="bottom">Direct insulin resistance and beta cell damage; indirect autoimmunity inflammation; stress and steroid-induced hyperglycemia</td><td align="left" valign="bottom"><bold>↑</bold>PKR, PERK, ISR via viral RNA and Cytokine storm, IRS<break/><bold>↑</bold>IL-6 and TNF-α<break/><bold>↓</bold>REST (RE1-silencing transcription factor)<break/><bold>↑</bold>Amylase and lipase<break/><bold>↑</bold>HLA<break/><bold>↑</bold>Propionic acid<break/><bold>↑</bold>Isobutyric acid</td><td align="left" valign="bottom">Insulin signaling pathway, ISR</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib182">Shin et al., 2022</xref></td></tr><tr><td align="left" valign="bottom"><italic>Renal</italic></td><td align="left" valign="bottom">Glomerulopathy; microangiopathy</td><td align="left" valign="bottom"><bold>↑</bold>ACE2 receptor,<break/><bold>↑</bold>IFN-I and IFN-III</td><td align="left" valign="bottom">Renin–angiotensin–aldosterone system (RAAS) disorders</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Blanco-Melo et al., 2020</xref>; <xref ref-type="bibr" rid="bib89">Hamming et al., 2004</xref>; <xref ref-type="bibr" rid="bib92">Harmer et al., 2002</xref>; <xref ref-type="bibr" rid="bib136">Nalbandian et al., 2021</xref> <xref ref-type="bibr" rid="bib198">Tay et al., 2020</xref>; <xref ref-type="bibr" rid="bib244">Zou et al., 2020</xref></td></tr><tr><td align="left" valign="bottom"><italic>Respiratory</italic></td><td align="left" valign="bottom">Pulmonary fibrosis; pulmonary thromboembolism; pneumonia; pulmonary vascular damage; cytokine release syndrome; dysbiosis (increased <italic>Staphylococcus cohnii</italic> and <italic>Pasteurella multocida</italic>); lipid metabolism; beta-oxidation; amino acid metabolism; and carbohydrate metabolism;<break/>hyperactivated T-lymphocytes and inflammatory macrophages; NETosis</td><td align="left" valign="bottom"><bold>↑</bold>TNF-α, IL-1<break/><bold>↑</bold>IL-IL-1β, IL-6<break/><bold>↑</bold>IL-12<break/><bold>↑</bold>MCP-1<break/><bold>↑</bold>GM-CSF<break/><bold>↑</bold>CCL19<break/><bold>↑</bold>CCR6 + Th17<break/><bold>↑</bold>IL-8 (CXCL8)</td><td align="left" valign="bottom">Insulin/IGF signaling pathway<break/>Citrate cycle; respiratory electron transport chain;<break/>Th17 cell differentiation pathway</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Ackermann et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Budhraja et al., 2022</xref>; <xref ref-type="bibr" rid="bib50">D’Errico et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">George et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Griffin et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Grosse et al., 2020</xref>; <xref ref-type="bibr" rid="bib101">Jin et al., 2021</xref>; <xref ref-type="bibr" rid="bib102">Jonigk et al., 2022</xref>; <xref ref-type="bibr" rid="bib108">Kosuge et al., 2012</xref>; <xref ref-type="bibr" rid="bib130">Medina-Enríquez et al., 2020</xref>; <xref ref-type="bibr" rid="bib134">Morganstein et al., 2021</xref>; <xref ref-type="bibr" rid="bib170">Sakr et al., 2020</xref>; <xref ref-type="bibr" rid="bib182">Shin et al., 2022</xref>; <xref ref-type="bibr" rid="bib183">Sidarta-Oliveira et al., 2020</xref>; <xref ref-type="bibr" rid="bib216">Verdecchia et al., 2020</xref>; <xref ref-type="bibr" rid="bib230">Xie et al., 2021</xref>; <xref ref-type="bibr" rid="bib232">Yaméogo et al., 2011</xref>; <xref ref-type="bibr" rid="bib233">Ye et al., 2020</xref></td></tr><tr><td align="left" valign="bottom"><italic>Multisystem Inflammatory Syndrome in Children (MIS-C</italic>)</td><td align="left" valign="bottom">Kawasaki disease; cardiac involvement with macrophage activation; persistent T-cell immune response; mucosal barrier breakdown</td><td align="left" valign="bottom"><bold>↑</bold>IL-6 and IL-1Ra</td><td align="char" char="." valign="bottom">???</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Feldstein et al., 2020</xref>; <xref ref-type="bibr" rid="bib168">Sadanandam et al., 2020</xref></td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p><bold>↑</bold> and <bold>↓</bold> arrows indicate increased and decreased levels, respectively, of biological and/or molecular factors.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s16"><title>Prevailing hypotheses for PASC</title><p>There are various hypotheses underlying Long COVID/PASC symptoms. The first points to the immune system going haywire after the initial virus infection, triggering a long-lasting inflammatory response that inflicts havoc on multiple organ systems. The second hypothesis is that this long-lasting inflammation may be due to the continued presence of virus or viral particles in organs such as the gut but may also be due to the reactivation of latent pathogens such as EBV, the most common cause of mononucleosis. The third hypothesis states that COVID-19 elicits a radical response analogous to an autoimmune disease that causes antibodies to target and destroy the body’s own tissues. The fourth leading hypothesis stipulates the formation of microclots, tiny blood clots that cause coagulopathy and lead to thrombosis. Therefore, the conclusion from this review on tissue damage is that there may be more than a single mechanism in motion for Long COVID (PASC) patients who experience a constellation of symptoms. Certain mechanisms may dominate over others in individual patients. There may be potential biomarkers or signaling pathways for different tissues or organs affected as well as therapeutic applications mostly in the form of inhibitors of the presumptive biomarkers of various tissues presented in <xref ref-type="table" rid="table1">Table 1</xref>, that could be employed for PASC sufferers until the underlying individual or collective mechanisms giving rise to their symptoms are clearly delineated. Furthermore, there is an urgent need to design experimental protocols that can distinctively identify the underlying mechanisms or pathways that are responsible for the clinical manifestations exhibited by Long COVID or PASC patients.</p></sec><sec id="s17"><title>Authorship</title><p>Authorship has been determined according to ICMJE recommendations.</p></sec></body><back><sec sec-type="additional-information" id="s18"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Supervision, Writing – original draft, Writing – review and editing, wrote the original manuscript including the table and figure and revised the final version that was resubmitted to eLife</p></fn><fn fn-type="con" id="con2"><p>Writing – review and editing, Conceptualization</p></fn><fn fn-type="con" id="con3"><p>Writing – review and editing, Conceptualization</p></fn><fn fn-type="con" id="con4"><p>Writing – review and editing, Conceptualization</p></fn><fn fn-type="con" id="con5"><p>Writing – review and editing, Conceptualization</p></fn><fn fn-type="con" id="con6"><p>Conceptualization</p></fn></fn-group></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the Researching Covid to Enhance Recovery (RECOVER) Initiative (OT2HL161847-01) through the American Rescue Plan Act of 2021 (Sec. 2401). We would like to thank the National Community Engagement Group (NCEG), all patient, caregiver, and community Representatives, and all the participants enrolled in the RECOVER Initiative. This work was made possible through support from the National Institutes of Health, New York University Langone Health, Research Triangle Institute, and the RECOVER Initiative’s Mechanistic Pathways task force. We thank K Coombs as a patient representative on our committee. <xref ref-type="fig" rid="fig1">Figure 1</xref> was designed using the Biorender program. Funding: This research was funded by the National Institutes of Health (NIH) Agreement OTA OT2HL161847 (contract number 01) as part of the Researching COVID to Enhance Recovery (RECOVER) research program.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackermann</surname><given-names>M</given-names></name><name><surname>Verleden</surname><given-names>SE</given-names></name><name><surname>Kuehnel</surname><given-names>M</given-names></name><name><surname>Haverich</surname><given-names>A</given-names></name><name><surname>Welte</surname><given-names>T</given-names></name><name><surname>Laenger</surname><given-names>F</given-names></name><name><surname>Vanstapel</surname><given-names>A</given-names></name><name><surname>Werlein</surname><given-names>C</given-names></name><name><surname>Stark</surname><given-names>H</given-names></name><name><surname>Tzankov</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>WW</given-names></name><name><surname>Li</surname><given-names>VW</given-names></name><name><surname>Mentzer</surname><given-names>SJ</given-names></name><name><surname>Jonigk</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19</article-title><source>New England Journal of Medicine</source><volume>383</volume><fpage>120</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2015432</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahamed</surname><given-names>J</given-names></name><name><surname>Laurence</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches</article-title><source>The Journal of Clinical Investigation</source><volume>132</volume><elocation-id>e161167</elocation-id><pub-id pub-id-type="doi">10.1172/JCI161167</pub-id><pub-id pub-id-type="pmid">35912863</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aird</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Phenotypic heterogeneity of the endothelium: II. representative vascular beds</article-title><source>Circulation Research</source><volume>100</volume><fpage>174</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000255690.03436.ae</pub-id><pub-id pub-id-type="pmid">17272819</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akin</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mast cell activation syndromes</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>140</volume><fpage>349</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2017.06.007</pub-id><pub-id pub-id-type="pmid">28780942</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akpek</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Does COVID-19 cause hypertension?</article-title><source>Angiology</source><volume>73</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1177/00033197211053903</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Khawaga</surname><given-names>S</given-names></name><name><surname>Abdelalim</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients</article-title><source>Stem Cell Research &amp; Therapy</source><volume>11</volume><fpage>437</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1186/s13287-020-01963-6</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Kuraishy</surname><given-names>HM</given-names></name><name><surname>Al-Gareeb</surname><given-names>AI</given-names></name><name><surname>Qusti</surname><given-names>S</given-names></name><name><surname>Alshammari</surname><given-names>EM</given-names></name><name><surname>Gyebi</surname><given-names>GA</given-names></name><name><surname>Batiha</surname><given-names>GE-S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Covid-19-induced dysautonomia: A menace of sympathetic storm</article-title><source>ASN Neuro</source><volume>13</volume><elocation-id>17590914211057635</elocation-id><pub-id pub-id-type="doi">10.1177/17590914211057635</pub-id><pub-id pub-id-type="pmid">34755562</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ramadan</surname><given-names>A</given-names></name><name><surname>Rabab’h</surname><given-names>O</given-names></name><name><surname>Shah</surname><given-names>J</given-names></name><name><surname>Gharaibeh</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Acute and post-acute neurological complications of COVID-19</article-title><source>Neurology International</source><volume>13</volume><fpage>102</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.3390/neurolint13010010</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aluganti Narasimhulu</surname><given-names>C</given-names></name><name><surname>Singla</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mechanisms of COVID-19 pathogenesis in diabetes</article-title><source>American Journal of Physiology.Heart and Circulatory Physiology</source><volume>323</volume><fpage>H403</fpage><lpage>H420</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00204.2022</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amenta</surname><given-names>EM</given-names></name><name><surname>Spallone</surname><given-names>A</given-names></name><name><surname>Rodriguez-Barradas</surname><given-names>MC</given-names></name><name><surname>El Sahly</surname><given-names>HM</given-names></name><name><surname>Atmar</surname><given-names>RL</given-names></name><name><surname>Kulkarni</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Postacute COVID-19: an overview and approach to classification</article-title><source>Open Forum Infectious Diseases</source><volume>7</volume><elocation-id>faa509</elocation-id><pub-id pub-id-type="doi">10.1093/ofid/ofaa509</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>M</given-names></name><name><surname>Pujol</surname><given-names>JC</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Ourselin</surname><given-names>S</given-names></name><name><surname>Steves</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Risk of long COVID associated with delta versus omicron variants of SARS-cov-2</article-title><source>Lancet</source><volume>399</volume><fpage>2263</fpage><lpage>2264</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(22)00941-2</pub-id><pub-id pub-id-type="pmid">35717982</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname><given-names>M</given-names></name><name><surname>Schommers</surname><given-names>P</given-names></name><name><surname>Stecher</surname><given-names>M</given-names></name><name><surname>Dewald</surname><given-names>F</given-names></name><name><surname>Gieselmann</surname><given-names>L</given-names></name><name><surname>Gruell</surname><given-names>H</given-names></name><name><surname>Horn</surname><given-names>C</given-names></name><name><surname>Vanshylla</surname><given-names>K</given-names></name><name><surname>Cristanziano</surname><given-names>VD</given-names></name><name><surname>Osebold</surname><given-names>L</given-names></name><name><surname>Roventa</surname><given-names>M</given-names></name><name><surname>Riaz</surname><given-names>T</given-names></name><name><surname>Tschernoster</surname><given-names>N</given-names></name><name><surname>Altmueller</surname><given-names>J</given-names></name><name><surname>Rose</surname><given-names>L</given-names></name><name><surname>Salomon</surname><given-names>S</given-names></name><name><surname>Priesner</surname><given-names>V</given-names></name><name><surname>Luers</surname><given-names>JC</given-names></name><name><surname>Albus</surname><given-names>C</given-names></name><name><surname>Rosenkranz</surname><given-names>S</given-names></name><name><surname>Gathof</surname><given-names>B</given-names></name><name><surname>Fätkenheuer</surname><given-names>G</given-names></name><name><surname>Hallek</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>F</given-names></name><name><surname>Suárez</surname><given-names>I</given-names></name><name><surname>Lehmann</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study</article-title><source>The Lancet Regional Health. Europe</source><volume>6</volume><elocation-id>100122</elocation-id><pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100122</pub-id><pub-id pub-id-type="pmid">34027514</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awogbindin</surname><given-names>IO</given-names></name><name><surname>Ben-Azu</surname><given-names>B</given-names></name><name><surname>Olusola</surname><given-names>BA</given-names></name><name><surname>Akinluyi</surname><given-names>ET</given-names></name><name><surname>Adeniyi</surname><given-names>PA</given-names></name><name><surname>Di Paolo</surname><given-names>T</given-names></name><name><surname>Tremblay</surname><given-names>MÈ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Microglial implications in SARS-cov-2 infection and COVID-19: lessons from viral RNA neurotropism and possible relevance to parkinson’s disease</article-title><source>Frontiers in Cellular Neuroscience</source><volume>15</volume><elocation-id>670298</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2021.670298</pub-id><pub-id pub-id-type="pmid">34211370</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzolini</surname><given-names>E</given-names></name><name><surname>Levi</surname><given-names>R</given-names></name><name><surname>Sarti</surname><given-names>R</given-names></name><name><surname>Pozzi</surname><given-names>C</given-names></name><name><surname>Mollura</surname><given-names>M</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Rescigno</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Association between bnt162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers</article-title><source>JAMA</source><volume>328</volume><fpage>676</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1001/jama.2022.11691</pub-id><pub-id pub-id-type="pmid">35796131</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>AM</given-names></name><name><surname>Khaleeq</surname><given-names>A</given-names></name><name><surname>Ali</surname><given-names>U</given-names></name><name><surname>Syeda</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms</article-title><source>ACS Chemical Neuroscience</source><volume>11</volume><fpage>995</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00122</pub-id><pub-id pub-id-type="pmid">32167747</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldi</surname><given-names>E</given-names></name><name><surname>Sechi</surname><given-names>GM</given-names></name><name><surname>Mare</surname><given-names>C</given-names></name><name><surname>Canevari</surname><given-names>F</given-names></name><name><surname>Brancaglione</surname><given-names>A</given-names></name><name><surname>Primi</surname><given-names>R</given-names></name><name><surname>Klersy</surname><given-names>C</given-names></name><name><surname>Palo</surname><given-names>A</given-names></name><name><surname>Contri</surname><given-names>E</given-names></name><name><surname>Ronchi</surname><given-names>V</given-names></name><name><surname>Beretta</surname><given-names>G</given-names></name><name><surname>Reali</surname><given-names>F</given-names></name><name><surname>Parogni</surname><given-names>P</given-names></name><name><surname>Facchin</surname><given-names>F</given-names></name><name><surname>Bua</surname><given-names>D</given-names></name><name><surname>Rizzi</surname><given-names>U</given-names></name><name><surname>Bussi</surname><given-names>D</given-names></name><name><surname>Ruggeri</surname><given-names>S</given-names></name><name><surname>Oltrona Visconti</surname><given-names>L</given-names></name><name><surname>Savastano</surname><given-names>S</given-names></name><collab>Lombardia CARe Researchers</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Out-of-hospital cardiac arrest during the covid-19 outbreak in italy</article-title><source>The New England Journal of Medicine</source><volume>383</volume><fpage>496</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2010418</pub-id><pub-id pub-id-type="pmid">32348640</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>CE</given-names></name><name><surname>Koyama</surname><given-names>AK</given-names></name><name><surname>Alvarez</surname><given-names>P</given-names></name><name><surname>Chow</surname><given-names>W</given-names></name><name><surname>Lundeen</surname><given-names>EA</given-names></name><name><surname>Perrine</surname><given-names>CG</given-names></name><name><surname>Pavkov</surname><given-names>ME</given-names></name><name><surname>Rolka</surname><given-names>DB</given-names></name><name><surname>Wiltz</surname><given-names>JL</given-names></name><name><surname>Bull-Otterson</surname><given-names>L</given-names></name><name><surname>Gray</surname><given-names>S</given-names></name><name><surname>Boehmer</surname><given-names>TK</given-names></name><name><surname>Gundlapalli</surname><given-names>AV</given-names></name><name><surname>Siegel</surname><given-names>DA</given-names></name><name><surname>Kompaniyets</surname><given-names>L</given-names></name><name><surname>Goodman</surname><given-names>AB</given-names></name><name><surname>Mahon</surname><given-names>BE</given-names></name><name><surname>Tauxe</surname><given-names>RV</given-names></name><name><surname>Remley</surname><given-names>K</given-names></name><name><surname>Saydah</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Risk for newly diagnosed diabetes &gt;30 days after SARS-cov-2 infection among persons aged</article-title><source>MMWR.Morbidity and Mortality Weekly Report</source><volume>71</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm7102e2</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>C</given-names></name><name><surname>Leone</surname><given-names>O</given-names></name><name><surname>Rizzo</surname><given-names>S</given-names></name><name><surname>De Gaspari</surname><given-names>M</given-names></name><name><surname>van der Wal</surname><given-names>AC</given-names></name><name><surname>Aubry</surname><given-names>MC</given-names></name><name><surname>Bois</surname><given-names>MC</given-names></name><name><surname>Lin</surname><given-names>PT</given-names></name><name><surname>Maleszewski</surname><given-names>JJ</given-names></name><name><surname>Stone</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study</article-title><source>European Heart Journal</source><volume>41</volume><fpage>3827</fpage><lpage>3835</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehaa664</pub-id><pub-id pub-id-type="pmid">32968776</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindom</surname><given-names>SM</given-names></name><name><surname>Hans</surname><given-names>CP</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Boulares</surname><given-names>AH</given-names></name><name><surname>Lazartigues</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice</article-title><source>Diabetes</source><volume>59</volume><fpage>2540</fpage><lpage>2548</lpage><pub-id pub-id-type="doi">10.2337/db09-0782</pub-id><pub-id pub-id-type="pmid">20660625</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisaccia</surname><given-names>G</given-names></name><name><surname>Ricci</surname><given-names>F</given-names></name><name><surname>Recce</surname><given-names>V</given-names></name><name><surname>Serio</surname><given-names>A</given-names></name><name><surname>Iannetti</surname><given-names>G</given-names></name><name><surname>Chahal</surname><given-names>AA</given-names></name><name><surname>Ståhlberg</surname><given-names>M</given-names></name><name><surname>Khanji</surname><given-names>MY</given-names></name><name><surname>Fedorowski</surname><given-names>A</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know?</article-title><source>Journal of Cardiovascular Development and Disease</source><volume>8</volume><elocation-id>156</elocation-id><pub-id pub-id-type="doi">10.3390/jcdd8110156</pub-id><pub-id pub-id-type="pmid">34821709</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Melo</surname><given-names>D</given-names></name><name><surname>Nilsson-Payant</surname><given-names>BE</given-names></name><name><surname>Liu</surname><given-names>W-C</given-names></name><name><surname>Uhl</surname><given-names>S</given-names></name><name><surname>Hoagland</surname><given-names>D</given-names></name><name><surname>Møller</surname><given-names>R</given-names></name><name><surname>Jordan</surname><given-names>TX</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Panis</surname><given-names>M</given-names></name><name><surname>Sachs</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Lim</surname><given-names>JK</given-names></name><name><surname>Albrecht</surname><given-names>RA</given-names></name><name><surname>tenOever</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Imbalanced host response to SARS-cov-2 drives development of COVID-19</article-title><source>Cell</source><volume>181</volume><fpage>1036</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.026</pub-id><pub-id pub-id-type="pmid">32416070</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blitshteyn</surname><given-names>S</given-names></name><name><surname>Whitelaw</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients</article-title><source>Immunologic Research</source><volume>69</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1007/s12026-021-09185-5</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>B</given-names></name><name><surname>Garrett</surname><given-names>V</given-names></name><name><surname>Messler</surname><given-names>J</given-names></name><name><surname>McFarland</surname><given-names>R</given-names></name><name><surname>Crowe</surname><given-names>J</given-names></name><name><surname>Booth</surname><given-names>R</given-names></name><name><surname>Klonoff</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the united states</article-title><source>Journal of Diabetes Science and Technology</source><volume>14</volume><fpage>813</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1177/1932296820924469</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boisramé-Helms</surname><given-names>J</given-names></name><name><surname>Kremer</surname><given-names>H</given-names></name><name><surname>Schini-Kerth</surname><given-names>V</given-names></name><name><surname>Meziani</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Endothelial dysfunction in sepsis</article-title><source>Current Vascular Pharmacology</source><volume>11</volume><fpage>150</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.2174/1570161111311020005</pub-id><pub-id pub-id-type="pmid">23506494</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Voit-Bak</surname><given-names>K</given-names></name><name><surname>Donate</surname><given-names>T</given-names></name><name><surname>Rodionov</surname><given-names>RN</given-names></name><name><surname>Gainetdinov</surname><given-names>RR</given-names></name><name><surname>Tselmin</surname><given-names>S</given-names></name><name><surname>Kanczkowski</surname><given-names>W</given-names></name><name><surname>Muller</surname><given-names>GM</given-names></name><name><surname>Achleitner</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Licinio</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name><name><surname>Thuret</surname><given-names>S</given-names></name><name><surname>Bechmann</surname><given-names>N</given-names></name><name><surname>Straube</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis?</article-title><source>Molecular Psychiatry</source><volume>27</volume><fpage>34</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01148-4</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budhraja</surname><given-names>A</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Gheware</surname><given-names>A</given-names></name><name><surname>Abhilash</surname><given-names>D</given-names></name><name><surname>Rajagopala</surname><given-names>S</given-names></name><name><surname>Pakala</surname><given-names>S</given-names></name><name><surname>Sumit</surname><given-names>M</given-names></name><name><surname>Ray</surname><given-names>A</given-names></name><name><surname>Subramaniam</surname><given-names>A</given-names></name><name><surname>Mathur</surname><given-names>P</given-names></name><name><surname>Nambirajan</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Wig</surname><given-names>N</given-names></name><name><surname>Trikha</surname><given-names>A</given-names></name><name><surname>Guleria</surname><given-names>R</given-names></name><name><surname>Sarkar</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>I</given-names></name><name><surname>Jain</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality</article-title><source>Disease Models &amp; Mechanisms</source><volume>15</volume><elocation-id>dmm049572</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.049572</pub-id><pub-id pub-id-type="pmid">35438176</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buijsers</surname><given-names>B</given-names></name><name><surname>Yanginlar</surname><given-names>C</given-names></name><name><surname>de Nooijer</surname><given-names>A</given-names></name><name><surname>Grondman</surname><given-names>I</given-names></name><name><surname>Maciej-Hulme</surname><given-names>ML</given-names></name><name><surname>Jonkman</surname><given-names>I</given-names></name><name><surname>Janssen</surname><given-names>NAF</given-names></name><name><surname>Rother</surname><given-names>N</given-names></name><name><surname>de Graaf</surname><given-names>M</given-names></name><name><surname>Pickkers</surname><given-names>P</given-names></name><name><surname>Kox</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Nijenhuis</surname><given-names>T</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Hilbrands</surname><given-names>L</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>Duivenvoorden</surname><given-names>R</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>van der Vlag</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Increased plasma heparanase activity in COVID-19 patients</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>575047</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.575047</pub-id><pub-id pub-id-type="pmid">33123154</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buonsenso</surname><given-names>D</given-names></name><name><surname>Di Giuda</surname><given-names>D</given-names></name><name><surname>Sigfrid</surname><given-names>L</given-names></name><name><surname>Pizzuto</surname><given-names>DA</given-names></name><name><surname>Di Sante</surname><given-names>G</given-names></name><name><surname>De Rose</surname><given-names>C</given-names></name><name><surname>Lazzareschi</surname><given-names>I</given-names></name><name><surname>Sali</surname><given-names>M</given-names></name><name><surname>Baldi</surname><given-names>F</given-names></name><name><surname>Chieffo</surname><given-names>DPR</given-names></name><name><surname>Munblit</surname><given-names>D</given-names></name><name><surname>Valentini</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-cov-2 infection</article-title><source>The Lancet. Child &amp; Adolescent Health</source><volume>5</volume><fpage>677</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/S2352-4642(21)00196-6</pub-id><pub-id pub-id-type="pmid">34339624</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camargo-Martínez</surname><given-names>W</given-names></name><name><surname>Lozada-Martínez</surname><given-names>I</given-names></name><name><surname>Escobar-Collazos</surname><given-names>A</given-names></name><name><surname>Navarro-Coronado</surname><given-names>A</given-names></name><name><surname>Moscote-Salazar</surname><given-names>L</given-names></name><name><surname>Pacheco-Hernández</surname><given-names>A</given-names></name><name><surname>Janjua</surname><given-names>T</given-names></name><name><surname>Bosque-Varela</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Post-COVID 19 neurological syndrome: implications for sequelae’s treatment</article-title><source>Journal of Clinical Neuroscience</source><volume>88</volume><fpage>219</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.jocn.2021.04.001</pub-id><pub-id pub-id-type="pmid">33992187</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carfì</surname><given-names>A</given-names></name><name><surname>Bernabei</surname><given-names>R</given-names></name><name><surname>Landi</surname><given-names>F</given-names></name><collab>Gemelli Against COVID-19 Post-Acute Care Study Group</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Persistent symptoms in patients after acute COVID-19</article-title><source>JAMA</source><volume>324</volume><fpage>603</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.12603</pub-id><pub-id pub-id-type="pmid">32644129</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>PO</given-names></name><name><surname>Berne</surname><given-names>C</given-names></name><name><surname>Jansson</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats</article-title><source>Diabetologia</source><volume>41</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/s001250050880</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carod-Artal</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.[Sindrome post-COVID-19: epidemiologia, criterios diagnosticos y mecanismos patogenicos implicados]</article-title><source>Revista de Neurologia</source><volume>72</volume><fpage>384</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.33588/rn.7211.2021230</pub-id><pub-id pub-id-type="pmid">34042167</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carretero</surname><given-names>OA</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Essential hypertension: part I: definition and etiology</article-title><source>Circulation</source><volume>101</volume><fpage>329</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1161/01.cir.101.3.329</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castanares-Zapatero</surname><given-names>D</given-names></name><name><surname>Chalon</surname><given-names>P</given-names></name><name><surname>Kohn</surname><given-names>L</given-names></name><name><surname>Dauvrin</surname><given-names>M</given-names></name><name><surname>Detollenaere</surname><given-names>J</given-names></name><name><surname>Maertens de Noordhout</surname><given-names>C</given-names></name><name><surname>Primus-de Jong</surname><given-names>C</given-names></name><name><surname>Cleemput</surname><given-names>I</given-names></name><name><surname>Van den Heede</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pathophysiology and mechanism of long COVID: A comprehensive review</article-title><source>Annals of Medicine</source><volume>54</volume><fpage>1473</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1080/07853890.2022.2076901</pub-id><pub-id pub-id-type="pmid">35594336</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrashekhar Joshi</surname><given-names>S</given-names></name><name><surname>Pozzilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>COVID-19 induced diabetes: A novel presentation</article-title><source>Diabetes Research and Clinical Practice</source><volume>191</volume><elocation-id>110034</elocation-id><pub-id pub-id-type="doi">10.1016/j.diabres.2022.110034</pub-id><pub-id pub-id-type="pmid">35940303</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charfeddine</surname><given-names>S</given-names></name><name><surname>Ibn Hadj Amor</surname><given-names>H</given-names></name><name><surname>Jdidi</surname><given-names>J</given-names></name><name><surname>Torjmen</surname><given-names>S</given-names></name><name><surname>Kraiem</surname><given-names>S</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Bahloul</surname><given-names>A</given-names></name><name><surname>Kallel</surname><given-names>N</given-names></name><name><surname>Moussa</surname><given-names>N</given-names></name><name><surname>Touil</surname><given-names>I</given-names></name><name><surname>Ghrab</surname><given-names>A</given-names></name><name><surname>Elghoul</surname><given-names>J</given-names></name><name><surname>Meddeb</surname><given-names>Z</given-names></name><name><surname>Thabet</surname><given-names>Y</given-names></name><name><surname>Kammoun</surname><given-names>S</given-names></name><name><surname>Bouslama</surname><given-names>K</given-names></name><name><surname>Milouchi</surname><given-names>S</given-names></name><name><surname>Abdessalem</surname><given-names>S</given-names></name><name><surname>Abid</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? insights from TUN-endcov study</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>8</volume><elocation-id>745758</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.745758</pub-id><pub-id pub-id-type="pmid">34917659</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chee</surname><given-names>YJ</given-names></name><name><surname>Ng</surname><given-names>SJH</given-names></name><name><surname>Yeoh</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Diabetic ketoacidosis precipitated by covid-19 in a patient with newly diagnosed diabetes mellitus</article-title><source>Diabetes Research and Clinical Practice</source><volume>164</volume><elocation-id>108166</elocation-id><pub-id pub-id-type="doi">10.1016/j.diabres.2020.108166</pub-id><pub-id pub-id-type="pmid">32339533</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Barajas-Martinez</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hypertension as a sequela in patients of SARS-cov-2 infection</article-title><source>PLOS ONE</source><volume>16</volume><elocation-id>e0250815</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0250815</pub-id><pub-id pub-id-type="pmid">33909683</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Haupert</surname><given-names>SR</given-names></name><name><surname>Zimmermann</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Mukherjee</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review</article-title><source>The Journal of Infectious Diseases</source><volume>226</volume><fpage>1593</fpage><lpage>1607</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiac136</pub-id><pub-id pub-id-type="pmid">35429399</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>EW</given-names></name><name><surname>Zachariah</surname><given-names>P</given-names></name><name><surname>Gorelik</surname><given-names>M</given-names></name><name><surname>Boneparth</surname><given-names>A</given-names></name><name><surname>Kernie</surname><given-names>SG</given-names></name><name><surname>Orange</surname><given-names>JS</given-names></name><name><surname>Milner</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City</article-title><source>JAMA</source><volume>324</volume><fpage>294</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.10374</pub-id><pub-id pub-id-type="pmid">32511676</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choutka</surname><given-names>J</given-names></name><name><surname>Jansari</surname><given-names>V</given-names></name><name><surname>Hornig</surname><given-names>M</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Unexplained post-acute infection syndromes</article-title><source>Nature Medicine</source><volume>28</volume><fpage>911</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01810-6</pub-id><pub-id pub-id-type="pmid">35585196</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>L</given-names></name><name><surname>Valencia</surname><given-names>IJ</given-names></name><name><surname>Garvert</surname><given-names>DW</given-names></name><name><surname>Montoya</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome</article-title><source>Frontiers in Pediatrics</source><volume>7</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2019.00012</pub-id><pub-id pub-id-type="pmid">30805319</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipelli</surname><given-names>R</given-names></name><name><surname>Harries</surname><given-names>L</given-names></name><name><surname>Okuda</surname><given-names>K</given-names></name><name><surname>Yoshihara</surname><given-names>S</given-names></name><name><surname>Melzer</surname><given-names>D</given-names></name><name><surname>Galloway</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bisphenol A modulates the metabolic regulator oestrogen-related receptor-α in T-cells</article-title><source>Reproduction</source><volume>147</volume><fpage>419</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1530/REP-13-0423</pub-id><pub-id pub-id-type="pmid">24231368</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>SA</given-names></name><name><surname>Abbara</surname><given-names>A</given-names></name><name><surname>Dhillo</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of COVID-19 on the endocrine system: a mini-review</article-title><source>Endocrinology</source><volume>163</volume><elocation-id>bqab203</elocation-id><pub-id pub-id-type="doi">10.1210/endocr/bqab203</pub-id><pub-id pub-id-type="pmid">34543404</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consiglio</surname><given-names>CR</given-names></name><name><surname>Cotugno</surname><given-names>N</given-names></name><name><surname>Sardh</surname><given-names>F</given-names></name><name><surname>Pou</surname><given-names>C</given-names></name><name><surname>Amodio</surname><given-names>D</given-names></name><name><surname>Rodriguez</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Zicari</surname><given-names>S</given-names></name><name><surname>Ruggiero</surname><given-names>A</given-names></name><name><surname>Pascucci</surname><given-names>GR</given-names></name><name><surname>Santilli</surname><given-names>V</given-names></name><name><surname>Campbell</surname><given-names>T</given-names></name><name><surname>Bryceson</surname><given-names>Y</given-names></name><name><surname>Eriksson</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Marchesi</surname><given-names>A</given-names></name><name><surname>Lakshmikanth</surname><given-names>T</given-names></name><name><surname>Campana</surname><given-names>A</given-names></name><name><surname>Villani</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>P</given-names></name><name><surname>Landegren</surname><given-names>N</given-names></name><name><surname>Palma</surname><given-names>P</given-names></name><name><surname>Brodin</surname><given-names>P</given-names></name><collab>CACTUS Study Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The immunology of multisystem inflammatory syndrome in children with COVID-19</article-title><source>Cell</source><volume>183</volume><fpage>968</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.016</pub-id><pub-id pub-id-type="pmid">32966765</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortés-Telles</surname><given-names>A</given-names></name><name><surname>López-Romero</surname><given-names>S</given-names></name><name><surname>Figueroa-Hurtado</surname><given-names>E</given-names></name><name><surname>Pou-Aguilar</surname><given-names>YN</given-names></name><name><surname>Wong</surname><given-names>AW</given-names></name><name><surname>Milne</surname><given-names>KM</given-names></name><name><surname>Ryerson</surname><given-names>CJ</given-names></name><name><surname>Guenette</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea</article-title><source>Respiratory Physiology &amp; Neurobiology</source><volume>288</volume><elocation-id>103644</elocation-id><pub-id pub-id-type="doi">10.1016/j.resp.2021.103644</pub-id><pub-id pub-id-type="pmid">33647535</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couleau</surname><given-names>N</given-names></name><name><surname>Falla</surname><given-names>J</given-names></name><name><surname>Beillerot</surname><given-names>A</given-names></name><name><surname>Battaglia</surname><given-names>E</given-names></name><name><surname>D’Innocenzo</surname><given-names>M</given-names></name><name><surname>Plançon</surname><given-names>S</given-names></name><name><surname>Laval-Gilly</surname><given-names>P</given-names></name><name><surname>Bennasroune</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Effects of endocrine disruptor compounds, alone or in combination, on human macrophage-like THP-1 cell response</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0131428</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0131428</pub-id><pub-id pub-id-type="pmid">26133781</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dando</surname><given-names>SJ</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>Norton</surname><given-names>R</given-names></name><name><surname>Currie</surname><given-names>BJ</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name><name><surname>Ekberg</surname><given-names>JAK</given-names></name><name><surname>Batzloff</surname><given-names>M</given-names></name><name><surname>Ulett</surname><given-names>GC</given-names></name><name><surname>Beacham</surname><given-names>IR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion</article-title><source>Clinical Microbiology Reviews</source><volume>27</volume><fpage>691</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1128/CMR.00118-13</pub-id><pub-id pub-id-type="pmid">25278572</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>HE</given-names></name><name><surname>Assaf</surname><given-names>GS</given-names></name><name><surname>McCorkell</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Low</surname><given-names>RJ</given-names></name><name><surname>Re’em</surname><given-names>Y</given-names></name><name><surname>Redfield</surname><given-names>S</given-names></name><name><surname>Austin</surname><given-names>JP</given-names></name><name><surname>Akrami</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characterizing long COVID in an international cohort: 7 months of symptoms and their impact</article-title><source>EClinicalMedicine</source><volume>38</volume><elocation-id>101019</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2021.101019</pub-id><pub-id pub-id-type="pmid">34308300</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Errico</surname><given-names>S</given-names></name><name><surname>Zanon</surname><given-names>M</given-names></name><name><surname>Montanaro</surname><given-names>M</given-names></name><name><surname>Radaelli</surname><given-names>D</given-names></name><name><surname>Sessa</surname><given-names>F</given-names></name><name><surname>Di Mizio</surname><given-names>G</given-names></name><name><surname>Montana</surname><given-names>A</given-names></name><name><surname>Corrao</surname><given-names>S</given-names></name><name><surname>Salerno</surname><given-names>M</given-names></name><name><surname>Pomara</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>More than pneumonia: distinctive features of SARS-cov-2 infection from autopsy findings to clinical implications: a systematic review</article-title><source>Microorganisms</source><volume>8</volume><elocation-id>1642</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8111642</pub-id><pub-id pub-id-type="pmid">33114061</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douaud</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Alfaro-Almagro</surname><given-names>F</given-names></name><name><surname>Arthofer</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>McCarthy</surname><given-names>P</given-names></name><name><surname>Lange</surname><given-names>F</given-names></name><name><surname>Andersson</surname><given-names>JLR</given-names></name><name><surname>Griffanti</surname><given-names>L</given-names></name><name><surname>Duff</surname><given-names>E</given-names></name><name><surname>Jbabdi</surname><given-names>S</given-names></name><name><surname>Taschler</surname><given-names>B</given-names></name><name><surname>Keating</surname><given-names>P</given-names></name><name><surname>Winkler</surname><given-names>AM</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Matthews</surname><given-names>PM</given-names></name><name><surname>Allen</surname><given-names>N</given-names></name><name><surname>Miller</surname><given-names>KL</given-names></name><name><surname>Nichols</surname><given-names>TE</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SARS-cov-2 is associated with changes in brain structure in UK Biobank</article-title><source>Nature</source><volume>604</volume><fpage>697</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04569-5</pub-id><pub-id pub-id-type="pmid">35255491</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doykov</surname><given-names>I</given-names></name><name><surname>Hällqvist</surname><given-names>J</given-names></name><name><surname>Gilmour</surname><given-names>KC</given-names></name><name><surname>Grandjean</surname><given-names>L</given-names></name><name><surname>Mills</surname><given-names>K</given-names></name><name><surname>Heywood</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>“The long tail of covid-19” - the detection of a prolonged inflammatory response after a SARS-cov-2 infection in asymptomatic and mildly affected patients</article-title><source>F1000Research</source><volume>9</volume><elocation-id>1349</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.27287.2</pub-id><pub-id pub-id-type="pmid">33391730</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>ME</given-names></name><name><surname>Appleton</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Q-R</given-names></name><name><surname>Yao</surname><given-names>Q</given-names></name><name><surname>Mazucanti</surname><given-names>CH</given-names></name><name><surname>Egan</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-cov-2)</article-title><source>The American Journal of Pathology</source><volume>191</volume><fpage>1511</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2021.05.010</pub-id><pub-id pub-id-type="pmid">34102107</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drucker</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications</article-title><source>Endocrine Reviews</source><volume>41</volume><elocation-id>bnaa011</elocation-id><pub-id pub-id-type="doi">10.1210/endrev/bnaa011</pub-id><pub-id pub-id-type="pmid">32294179</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>SP</given-names></name><name><surname>Jenkins</surname><given-names>D</given-names></name><name><surname>Spiller</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome</article-title><source>The American Journal of Gastroenterology</source><volume>98</volume><fpage>1578</fpage><lpage>1583</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2003.07542.x</pub-id><pub-id pub-id-type="pmid">12873581</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escher</surname><given-names>R</given-names></name><name><surname>Breakey</surname><given-names>N</given-names></name><name><surname>Lammle</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Severe COVID-19 infection associated with endothelial activation</article-title><source>Thrombosis Research</source><volume>190</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.1016/j.thromres.2020.04.014</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escorihuela</surname><given-names>RM</given-names></name><name><surname>Capdevila</surname><given-names>L</given-names></name><name><surname>Castro</surname><given-names>JR</given-names></name><name><surname>Zaragoza</surname><given-names>MC</given-names></name><name><surname>Maurel</surname><given-names>S</given-names></name><name><surname>Alegre</surname><given-names>J</given-names></name><name><surname>Castro-Marrero</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis</article-title><source>Journal of Translational Medicine</source><volume>18</volume><elocation-id>184</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-019-02184-z</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estiri</surname><given-names>H</given-names></name><name><surname>Strasser</surname><given-names>ZH</given-names></name><name><surname>Brat</surname><given-names>GA</given-names></name><name><surname>Semenov</surname><given-names>YR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evolving phenotypes of non-hospitalized patients that indicate long COVID</article-title><source>BMC Medicine</source><volume>19</volume><elocation-id>249</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-021-02115-0</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>PC</given-names></name><name><surname>Rainger</surname><given-names>GE</given-names></name><name><surname>Mason</surname><given-names>JC</given-names></name><name><surname>Guzik</surname><given-names>TJ</given-names></name><name><surname>Osto</surname><given-names>E</given-names></name><name><surname>Stamataki</surname><given-names>Z</given-names></name><name><surname>Neil</surname><given-names>D</given-names></name><name><surname>Hoefer</surname><given-names>IE</given-names></name><name><surname>Fragiadaki</surname><given-names>M</given-names></name><name><surname>Waltenberger</surname><given-names>J</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name><name><surname>Bochaton-Piallat</surname><given-names>M-L</given-names></name><name><surname>Bäck</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelial dysfunction in COVID-19: A position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science</article-title><source>Cardiovascular Research</source><volume>116</volume><fpage>2177</fpage><lpage>2184</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvaa230</pub-id><pub-id pub-id-type="pmid">32750108</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farooqi</surname><given-names>KM</given-names></name><name><surname>Chan</surname><given-names>A</given-names></name><name><surname>Weller</surname><given-names>RJ</given-names></name><name><surname>Mi</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Abrahams</surname><given-names>E</given-names></name><name><surname>Ferris</surname><given-names>A</given-names></name><name><surname>Krishnan</surname><given-names>US</given-names></name><name><surname>Pasumarti</surname><given-names>N</given-names></name><name><surname>Suh</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>AM</given-names></name><name><surname>DiLorenzo</surname><given-names>MP</given-names></name><name><surname>Zachariah</surname><given-names>P</given-names></name><name><surname>Milner</surname><given-names>JD</given-names></name><name><surname>Rosenzweig</surname><given-names>EB</given-names></name><name><surname>Gorelik</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>BR</given-names></name><collab>Columbia University Interdisciplinary MIS-C Follow-up Program and the CUIMC Pediatric/Adult Congenital Heart Research Collaborative</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Longitudinal outcomes for multisystem inflammatory syndrome in children</article-title><source>Pediatrics</source><volume>148</volume><elocation-id>e2021051155</elocation-id><pub-id pub-id-type="doi">10.1542/peds.2021-051155</pub-id><pub-id pub-id-type="pmid">34266903</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldstein</surname><given-names>LR</given-names></name><name><surname>Rose</surname><given-names>EB</given-names></name><name><surname>Horwitz</surname><given-names>SM</given-names></name><name><surname>Collins</surname><given-names>JP</given-names></name><name><surname>Newhams</surname><given-names>MM</given-names></name><name><surname>Son</surname><given-names>MBF</given-names></name><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Kleinman</surname><given-names>LC</given-names></name><name><surname>Heidemann</surname><given-names>SM</given-names></name><name><surname>Martin</surname><given-names>AA</given-names></name><name><surname>Singh</surname><given-names>AR</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Tarquinio</surname><given-names>KM</given-names></name><name><surname>Jaggi</surname><given-names>P</given-names></name><name><surname>Oster</surname><given-names>ME</given-names></name><name><surname>Zackai</surname><given-names>SP</given-names></name><name><surname>Gillen</surname><given-names>J</given-names></name><name><surname>Ratner</surname><given-names>AJ</given-names></name><name><surname>Walsh</surname><given-names>RF</given-names></name><name><surname>Fitzgerald</surname><given-names>JC</given-names></name><name><surname>Keenaghan</surname><given-names>MA</given-names></name><name><surname>Alharash</surname><given-names>H</given-names></name><name><surname>Doymaz</surname><given-names>S</given-names></name><name><surname>Clouser</surname><given-names>KN</given-names></name><name><surname>Giuliano</surname><given-names>JS</given-names><suffix>Jr</suffix></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>RM</given-names></name><name><surname>Maddux</surname><given-names>AB</given-names></name><name><surname>Havalad</surname><given-names>V</given-names></name><name><surname>Ramsingh</surname><given-names>S</given-names></name><name><surname>Bukulmez</surname><given-names>H</given-names></name><name><surname>Bradford</surname><given-names>TT</given-names></name><name><surname>Smith</surname><given-names>LS</given-names></name><name><surname>Tenforde</surname><given-names>MW</given-names></name><name><surname>Carroll</surname><given-names>CL</given-names></name><name><surname>Riggs</surname><given-names>BJ</given-names></name><name><surname>Gertz</surname><given-names>SJ</given-names></name><name><surname>Daube</surname><given-names>A</given-names></name><name><surname>Lansell</surname><given-names>A</given-names></name><name><surname>Coronado Munoz</surname><given-names>A</given-names></name><name><surname>Hobbs</surname><given-names>CV</given-names></name><name><surname>Marohn</surname><given-names>KL</given-names></name><name><surname>Halasa</surname><given-names>NB</given-names></name><name><surname>Patel</surname><given-names>MM</given-names></name><name><surname>Randolph</surname><given-names>AG</given-names></name><collab>Overcoming COVID-19 Investigators</collab><collab>CDC COVID-19 Response Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Multisystem inflammatory syndrome in U.S. children and adolescents</article-title><source>The New England Journal of Medicine</source><volume>383</volume><fpage>334</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2021680</pub-id><pub-id pub-id-type="pmid">32598831</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>P38Mapk plays a pivotal role in the development of acute respiratory distress syndrome</article-title><source>Clinics</source><volume>74</volume><elocation-id>e509</elocation-id><pub-id pub-id-type="doi">10.6061/clinics/2019/e509</pub-id><pub-id pub-id-type="pmid">31411275</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-Castañeda</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Geraghty</surname><given-names>AC</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Wood</surname><given-names>J</given-names></name><name><surname>O’Dea</surname><given-names>MR</given-names></name><name><surname>Dutton</surname><given-names>S</given-names></name><name><surname>Shamardani</surname><given-names>K</given-names></name><name><surname>Nwangwu</surname><given-names>K</given-names></name><name><surname>Mancusi</surname><given-names>R</given-names></name><name><surname>Yalçın</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>KR</given-names></name><name><surname>Acosta-Alvarez</surname><given-names>L</given-names></name><name><surname>Malacon</surname><given-names>K</given-names></name><name><surname>Keough</surname><given-names>MB</given-names></name><name><surname>Ni</surname><given-names>L</given-names></name><name><surname>Woo</surname><given-names>PJ</given-names></name><name><surname>Contreras-Esquivel</surname><given-names>D</given-names></name><name><surname>Toland</surname><given-names>AMS</given-names></name><name><surname>Gehlhausen</surname><given-names>JR</given-names></name><name><surname>Klein</surname><given-names>J</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Israelow</surname><given-names>B</given-names></name><name><surname>Lucas</surname><given-names>C</given-names></name><name><surname>Mao</surname><given-names>T</given-names></name><name><surname>Peña-Hernández</surname><given-names>MA</given-names></name><name><surname>Tabachnikova</surname><given-names>A</given-names></name><name><surname>Homer</surname><given-names>RJ</given-names></name><name><surname>Tabacof</surname><given-names>L</given-names></name><name><surname>Tosto-Mancuso</surname><given-names>J</given-names></name><name><surname>Breyman</surname><given-names>E</given-names></name><name><surname>Kontorovich</surname><given-names>A</given-names></name><name><surname>McCarthy</surname><given-names>D</given-names></name><name><surname>Quezado</surname><given-names>M</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Hefti</surname><given-names>MM</given-names></name><name><surname>Perl</surname><given-names>DP</given-names></name><name><surname>Liddelow</surname><given-names>S</given-names></name><name><surname>Folkerth</surname><given-names>R</given-names></name><name><surname>Putrino</surname><given-names>D</given-names></name><name><surname>Nath</surname><given-names>A</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name><name><surname>Monje</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation</article-title><source>Cell</source><volume>185</volume><fpage>2452</fpage><lpage>2468</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.06.008</pub-id><pub-id pub-id-type="pmid">35768006</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Fernández-Castañeda</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Geraghty</surname><given-names>AC</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Mild Respiratory SARS-Cov-2 Infection Can Cause Multi-Lineage Cellular Dysregulation and Myelin Loss in the Brain</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.01.07.475453</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-de-Las-Peñas</surname><given-names>C</given-names></name><name><surname>Palacios-Ceña</surname><given-names>D</given-names></name><name><surname>Gómez-Mayordomo</surname><given-names>V</given-names></name><name><surname>Cuadrado</surname><given-names>ML</given-names></name><name><surname>Florencio</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification</article-title><source>International Journal of Environmental Research and Public Health</source><volume>18</volume><elocation-id>2621</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18052621</pub-id><pub-id pub-id-type="pmid">33807869</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-de-Las-Peñas</surname><given-names>C</given-names></name><name><surname>Pellicer-Valero</surname><given-names>OJ</given-names></name><name><surname>Navarro-Pardo</surname><given-names>E</given-names></name><name><surname>Palacios-Ceña</surname><given-names>D</given-names></name><name><surname>Florencio</surname><given-names>LL</given-names></name><name><surname>Guijarro</surname><given-names>C</given-names></name><name><surname>Martín-Guerrero</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Symptoms experienced at the acute phase of SARS-cov-2 infection as risk factor of long-term post-COVID symptoms: the LONG-COVID-EXP-CM multicenter study</article-title><source>International Journal of Infectious Diseases</source><volume>116</volume><fpage>241</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2022.01.007</pub-id><pub-id pub-id-type="pmid">35017102</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>D</given-names></name><name><surname>Walter</surname><given-names>J</given-names></name><name><surname>Wussler</surname><given-names>D</given-names></name><name><surname>Kozhuharov</surname><given-names>N</given-names></name><name><surname>Nowak</surname><given-names>A</given-names></name><name><surname>Dinort</surname><given-names>J</given-names></name><name><surname>Badertscher</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Sabti</surname><given-names>Z</given-names></name><name><surname>Lavallaz</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Direct comparison of high-sensitivity cardiac troponin T and I for prediction of mortality in patients with pneumonia</article-title><source>J Clin Chem Lab Med</source><volume>2</volume><elocation-id>1000131</elocation-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fluge</surname><given-names>Ø</given-names></name><name><surname>Tronstad</surname><given-names>KJ</given-names></name><name><surname>Mella</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e150377</elocation-id><pub-id pub-id-type="doi">10.1172/JCI150377</pub-id><pub-id pub-id-type="pmid">34263741</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frere</surname><given-names>JJ</given-names></name><name><surname>Serafini</surname><given-names>RA</given-names></name><name><surname>Pryce</surname><given-names>KD</given-names></name><name><surname>Zazhytska</surname><given-names>M</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Golynker</surname><given-names>I</given-names></name><name><surname>Panis</surname><given-names>M</given-names></name><name><surname>Zimering</surname><given-names>J</given-names></name><name><surname>Horiuchi</surname><given-names>S</given-names></name><name><surname>Hoagland</surname><given-names>DA</given-names></name><name><surname>Møller</surname><given-names>R</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Kodra</surname><given-names>A</given-names></name><name><surname>Overdevest</surname><given-names>JB</given-names></name><name><surname>Canoll</surname><given-names>PD</given-names></name><name><surname>Borczuk</surname><given-names>AC</given-names></name><name><surname>Chandar</surname><given-names>V</given-names></name><name><surname>Bram</surname><given-names>Y</given-names></name><name><surname>Schwartz</surname><given-names>R</given-names></name><name><surname>Lomvardas</surname><given-names>S</given-names></name><name><surname>Zachariou</surname><given-names>V</given-names></name><name><surname>tenOever</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SARS-cov-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery</article-title><source>Science Translational Medicine</source><volume>14</volume><elocation-id>eabq3059</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abq3059</pub-id><pub-id pub-id-type="pmid">35857629</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>J-A</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><collab>Community-Acquired Pneumonia–China Network</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus</article-title><source>Critical Care Medicine</source><volume>48</volume><fpage>451</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000004207</pub-id><pub-id pub-id-type="pmid">32205590</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genç</surname><given-names>S</given-names></name><name><surname>Evren</surname><given-names>B</given-names></name><name><surname>Bozbay</surname><given-names>A</given-names></name><name><surname>Aydın</surname><given-names>EŞ</given-names></name><name><surname>Genç</surname><given-names>Ö</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Could covid-19trigger type 1 diabetes? presentation of covid-19 case presented withdiabetic ketoacidosis</article-title><source>Acta Endocrinol</source><volume>1</volume><fpage>532</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.4183/aeb.2021.532</pub-id><pub-id pub-id-type="pmid">35747858</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>S</given-names></name><name><surname>Strollo</surname><given-names>F</given-names></name><name><surname>Mambro</surname><given-names>A</given-names></name><name><surname>Ceriello</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19, ketoacidosis and new-onset diabetes: are there possible cause and effect relationships among them?</article-title><source>Diabetes, Obesity &amp; Metabolism</source><volume>22</volume><fpage>2507</fpage><lpage>2508</lpage><pub-id pub-id-type="doi">10.1111/dom.14170</pub-id><pub-id pub-id-type="pmid">32790021</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>PM</given-names></name><name><surname>Wells</surname><given-names>AU</given-names></name><name><surname>Jenkins</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy</article-title><source>The Lancet. Respiratory Medicine</source><volume>8</volume><fpage>807</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30225-3</pub-id><pub-id pub-id-type="pmid">32422178</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giron</surname><given-names>LB</given-names></name><name><surname>Peluso</surname><given-names>MJ</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Kenny</surname><given-names>G</given-names></name><name><surname>Zilberstein</surname><given-names>NF</given-names></name><name><surname>Koshy</surname><given-names>J</given-names></name><name><surname>Hong</surname><given-names>KY</given-names></name><name><surname>Rasmussen</surname><given-names>H</given-names></name><name><surname>Miller</surname><given-names>GE</given-names></name><name><surname>Bishehsari</surname><given-names>F</given-names></name><name><surname>Balk</surname><given-names>RA</given-names></name><name><surname>Moy</surname><given-names>JN</given-names></name><name><surname>Hoh</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Goldman</surname><given-names>AR</given-names></name><name><surname>Tang</surname><given-names>HY</given-names></name><name><surname>Yee</surname><given-names>BC</given-names></name><name><surname>Chenna</surname><given-names>A</given-names></name><name><surname>Winslow</surname><given-names>JW</given-names></name><name><surname>Petropoulos</surname><given-names>CJ</given-names></name><name><surname>Kelly</surname><given-names>JD</given-names></name><name><surname>Wasse</surname><given-names>H</given-names></name><name><surname>Martin</surname><given-names>JN</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Keshavarzian</surname><given-names>A</given-names></name><name><surname>Landay</surname><given-names>A</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Henrich</surname><given-names>TJ</given-names></name><name><surname>Abdel-Mohsen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Markers of fungal translocation are elevated during post-acute sequelae of SARS-cov-2 and induce NF-κB signaling</article-title><source>JCI Insight</source><volume>7</volume><elocation-id>e164813</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.164813</pub-id><pub-id pub-id-type="pmid">36134654</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giustino</surname><given-names>G</given-names></name><name><surname>Pinney</surname><given-names>SP</given-names></name><name><surname>Lala</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>VY</given-names></name><name><surname>Johnston-Cox</surname><given-names>HA</given-names></name><name><surname>Mechanick</surname><given-names>JI</given-names></name><name><surname>Halperin</surname><given-names>JL</given-names></name><name><surname>Fuster</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar</article-title><source>Journal of the American College of Cardiology</source><volume>76</volume><fpage>2011</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2020.08.059</pub-id><pub-id pub-id-type="pmid">33092737</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gluckman</surname><given-names>TJ</given-names></name><name><surname>Bhave</surname><given-names>NM</given-names></name><name><surname>Allen</surname><given-names>LA</given-names></name><name><surname>Chung</surname><given-names>EH</given-names></name><name><surname>Spatz</surname><given-names>ES</given-names></name><name><surname>Ammirati</surname><given-names>E</given-names></name><name><surname>Baggish</surname><given-names>AL</given-names></name><name><surname>Bozkurt</surname><given-names>B</given-names></name><name><surname>Cornwell</surname><given-names>WK</given-names></name><name><surname>Harmon</surname><given-names>KG</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lala</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>BD</given-names></name><name><surname>Martinez</surname><given-names>MW</given-names></name><name><surname>Onuma</surname><given-names>O</given-names></name><name><surname>Phelan</surname><given-names>D</given-names></name><name><surname>Puntmann</surname><given-names>VO</given-names></name><name><surname>Rajpal</surname><given-names>S</given-names></name><name><surname>Taub</surname><given-names>PR</given-names></name><name><surname>Verma</surname><given-names>AK</given-names></name><collab>Writing Committee</collab></person-group><year iso-8601-date="2022">2022</year><article-title>2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-cov-2 infection, and return to play: a report of the american college of cardiology solution set oversight committee</article-title><source>Journal of the American College of Cardiology</source><volume>79</volume><fpage>1717</fpage><lpage>1756</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2022.02.003</pub-id><pub-id pub-id-type="pmid">35307156</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>CG</given-names></name><name><surname>Peterson</surname><given-names>D</given-names></name><name><surname>Armstrong</surname><given-names>J</given-names></name><name><surname>Knox</surname><given-names>K</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases</article-title><source>Infectious Agents and Cancer</source><volume>18</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/s13027-023-00485-z</pub-id><pub-id pub-id-type="pmid">36750846</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>T</given-names></name><name><surname>Knight</surname><given-names>M</given-names></name><name><surname>A’Court</surname><given-names>C</given-names></name><name><surname>Buxton</surname><given-names>M</given-names></name><name><surname>Husain</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Management of post-acute covid-19 in primary care</article-title><source>BMJ</source><volume>370</volume><elocation-id>m3026</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.m3026</pub-id><pub-id pub-id-type="pmid">32784198</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>DO</given-names></name><name><surname>Jensen</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Chin</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>K</given-names></name><name><surname>Saad</surname><given-names>J</given-names></name><name><surname>Parnell</surname><given-names>R</given-names></name><name><surname>Awwad</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pulmonary embolism and increased levels of d-dimer in patients with coronavirus disease</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>1941</fpage><lpage>1943</lpage><pub-id pub-id-type="doi">10.3201/eid2608.201477</pub-id><pub-id pub-id-type="pmid">32348233</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grillo</surname><given-names>F</given-names></name><name><surname>Barisione</surname><given-names>E</given-names></name><name><surname>Ball</surname><given-names>L</given-names></name><name><surname>Mastracci</surname><given-names>L</given-names></name><name><surname>Fiocca</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lung fibrosis: an undervalued finding in COVID-19 pathological series</article-title><source>The Lancet.Infectious Diseases</source><volume>21</volume><elocation-id>e72</elocation-id><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30582-X</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimes</surname><given-names>JM</given-names></name><name><surname>Grimes</surname><given-names>KV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>P38 MAPK inhibition: A promising therapeutic approach for COVID-19</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>144</volume><fpage>63</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.05.007</pub-id><pub-id pub-id-type="pmid">32422320</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groff</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>A</given-names></name><name><surname>Ssentongo</surname><given-names>AE</given-names></name><name><surname>Ba</surname><given-names>DM</given-names></name><name><surname>Parsons</surname><given-names>N</given-names></name><name><surname>Poudel</surname><given-names>GR</given-names></name><name><surname>Lekoubou</surname><given-names>A</given-names></name><name><surname>Oh</surname><given-names>JS</given-names></name><name><surname>Ericson</surname><given-names>JE</given-names></name><name><surname>Ssentongo</surname><given-names>P</given-names></name><name><surname>Chinchilli</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Short-term and long-term rates of postacute sequelae of SARS-cov-2 infection: A systematic review</article-title><source>JAMA Network Open</source><volume>4</volume><elocation-id>e2128568</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.28568</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosse</surname><given-names>C</given-names></name><name><surname>Grosse</surname><given-names>A</given-names></name><name><surname>Salzer</surname><given-names>HJF</given-names></name><name><surname>Dünser</surname><given-names>MW</given-names></name><name><surname>Motz</surname><given-names>R</given-names></name><name><surname>Langer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Analysis of cardiopulmonary findings in COVID-19 fatalities: high incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia</article-title><source>Cardiovascular Pathology</source><volume>49</volume><elocation-id>107263</elocation-id><pub-id pub-id-type="doi">10.1016/j.carpath.2020.107263</pub-id><pub-id pub-id-type="pmid">32784110</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>CN</given-names></name><name><surname>Patel</surname><given-names>RS</given-names></name><name><surname>Trachtman</surname><given-names>R</given-names></name><name><surname>Lepow</surname><given-names>L</given-names></name><name><surname>Amanat</surname><given-names>F</given-names></name><name><surname>Krammer</surname><given-names>F</given-names></name><name><surname>Wilson</surname><given-names>KM</given-names></name><name><surname>Onel</surname><given-names>K</given-names></name><name><surname>Geanon</surname><given-names>D</given-names></name><name><surname>Tuballes</surname><given-names>K</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Mouskas</surname><given-names>K</given-names></name><name><surname>O’Donnell</surname><given-names>T</given-names></name><name><surname>Merritt</surname><given-names>E</given-names></name><name><surname>Simons</surname><given-names>NW</given-names></name><name><surname>Barcessat</surname><given-names>V</given-names></name><name><surname>Del Valle</surname><given-names>DM</given-names></name><name><surname>Udondem</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>G</given-names></name><name><surname>Gangadharan</surname><given-names>S</given-names></name><name><surname>Ofori-Amanfo</surname><given-names>G</given-names></name><name><surname>Laserson</surname><given-names>U</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><name><surname>Charney</surname><given-names>AW</given-names></name><name><surname>Gnjatic</surname><given-names>S</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Bogunovic</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)</article-title><source>Cell</source><volume>183</volume><fpage>982</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.034</pub-id><pub-id pub-id-type="pmid">32991843</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunning</surname><given-names>WT</given-names></name><name><surname>Kvale</surname><given-names>H</given-names></name><name><surname>Kramer</surname><given-names>PM</given-names></name><name><surname>Karabin</surname><given-names>BL</given-names></name><name><surname>Grubb</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies</article-title><source>Journal of the American Heart Association</source><volume>8</volume><elocation-id>e013602</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.119.013602</pub-id><pub-id pub-id-type="pmid">31495251</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X-ZJ</given-names></name><name><surname>Thomas</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>New fronts emerge in the influenza cytokine storm</article-title><source>Seminars in Immunopathology</source><volume>39</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1007/s00281-017-0636-y</pub-id><pub-id pub-id-type="pmid">28555383</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffke</surname><given-names>M</given-names></name><name><surname>Freitag</surname><given-names>H</given-names></name><name><surname>Rudolf</surname><given-names>G</given-names></name><name><surname>Seifert</surname><given-names>M</given-names></name><name><surname>Doehner</surname><given-names>W</given-names></name><name><surname>Scherbakov</surname><given-names>N</given-names></name><name><surname>Hanitsch</surname><given-names>L</given-names></name><name><surname>Wittke</surname><given-names>K</given-names></name><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Konietschke</surname><given-names>F</given-names></name><name><surname>Paul</surname><given-names>F</given-names></name><name><surname>Bellmann-Strobl</surname><given-names>J</given-names></name><name><surname>Kedor</surname><given-names>C</given-names></name><name><surname>Scheibenbogen</surname><given-names>C</given-names></name><name><surname>Sotzny</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)</article-title><source>Journal of Translational Medicine</source><volume>20</volume><elocation-id>138</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-022-03346-2</pub-id><pub-id pub-id-type="pmid">35317812</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halushka</surname><given-names>MK</given-names></name><name><surname>Vander Heide</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations</article-title><source>Cardiovascular Pathology</source><volume>50</volume><elocation-id>107300</elocation-id><pub-id pub-id-type="doi">10.1016/j.carpath.2020.107300</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamming</surname><given-names>I</given-names></name><name><surname>Timens</surname><given-names>W</given-names></name><name><surname>Bulthuis</surname><given-names>MLC</given-names></name><name><surname>Lely</surname><given-names>AT</given-names></name><name><surname>Navis</surname><given-names>GJ</given-names></name><name><surname>van Goor</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: A first step in understanding SARS pathogenesis</article-title><source>The Journal of Pathology</source><volume>203</volume><fpage>631</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1002/path.1570</pub-id><pub-id pub-id-type="pmid">15141377</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamming</surname><given-names>I</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Hooper</surname><given-names>NM</given-names></name><name><surname>Korstanje</surname><given-names>R</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Timens</surname><given-names>W</given-names></name><name><surname>Turner</surname><given-names>AJ</given-names></name><name><surname>Navis</surname><given-names>G</given-names></name><name><surname>Goor</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The emerging role of ACE2 in physiology and disease</article-title><source>The Journal of Pathology</source><volume>212</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1002/path.2162</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanneman</surname><given-names>K</given-names></name><name><surname>Houbois</surname><given-names>C</given-names></name><name><surname>Schoffel</surname><given-names>A</given-names></name><name><surname>Gustafson</surname><given-names>D</given-names></name><name><surname>Iwanochko</surname><given-names>RM</given-names></name><name><surname>Wintersperger</surname><given-names>BJ</given-names></name><name><surname>Chan</surname><given-names>R</given-names></name><name><surname>Fish</surname><given-names>JE</given-names></name><name><surname>Howe</surname><given-names>KL</given-names></name><name><surname>Thavendiranathan</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Combined cardiac fluorodeoxyglucose-positron emission tomography/magnetic resonance imaging assessment of myocardial injury in patients who recently recovered from COVID-19</article-title><source>JAMA Cardiology</source><volume>7</volume><fpage>298</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2021.5505</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmer</surname><given-names>D</given-names></name><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>Borman</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Quantitative mrna expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme</article-title><source>FEBS Letters</source><volume>532</volume><fpage>107</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(02)03640-2</pub-id><pub-id pub-id-type="pmid">12459472</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>A</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Mo</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors</article-title><source>Signal Transduction and Targeted Therapy</source><volume>6</volume><elocation-id>427</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-021-00822-x</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Romieu</surname><given-names>AC</given-names></name><name><surname>Carton</surname><given-names>TW</given-names></name><name><surname>Saydah</surname><given-names>S</given-names></name><name><surname>Azziz-Baumgartner</surname><given-names>E</given-names></name><name><surname>Boehmer</surname><given-names>TK</given-names></name><name><surname>Garret</surname><given-names>NY</given-names></name><name><surname>Bailey</surname><given-names>LC</given-names></name><name><surname>Cowell</surname><given-names>LG</given-names></name><name><surname>Draper</surname><given-names>C</given-names></name><name><surname>Mayer</surname><given-names>KH</given-names></name><name><surname>Nagavedu</surname><given-names>K</given-names></name><name><surname>Puro</surname><given-names>JE</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Trick</surname><given-names>WE</given-names></name><name><surname>Wanga</surname><given-names>V</given-names></name><name><surname>Chevinsky</surname><given-names>JR</given-names></name><name><surname>Jackson</surname><given-names>BR</given-names></name><name><surname>Goodman</surname><given-names>AB</given-names></name><name><surname>Cope</surname><given-names>JR</given-names></name><name><surname>Gundlapalli</surname><given-names>AV</given-names></name><name><surname>Block</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-cov-2</article-title><source>JAMA Network Open</source><volume>5</volume><elocation-id>e2147053</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.47053</pub-id><pub-id pub-id-type="pmid">35119459</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollstein</surname><given-names>T</given-names></name><name><surname>Schulte</surname><given-names>DM</given-names></name><name><surname>Schulz</surname><given-names>J</given-names></name><name><surname>Glück</surname><given-names>A</given-names></name><name><surname>Ziegler</surname><given-names>AG</given-names></name><name><surname>Bonifacio</surname><given-names>E</given-names></name><name><surname>Wendorff</surname><given-names>M</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Laudes</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Autoantibody-negative insulin-dependent diabetes mellitus after sars-cov-2 infection: a case report</article-title><source>Nature Metabolism</source><volume>2</volume><fpage>1021</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-00281-8</pub-id><pub-id pub-id-type="pmid">32879473</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>E</given-names></name><name><surname>Wist</surname><given-names>J</given-names></name><name><surname>Masuda</surname><given-names>R</given-names></name><name><surname>Lodge</surname><given-names>S</given-names></name><name><surname>Nitschke</surname><given-names>P</given-names></name><name><surname>Kimhofer</surname><given-names>T</given-names></name><name><surname>Loo</surname><given-names>RL</given-names></name><name><surname>Begum</surname><given-names>S</given-names></name><name><surname>Boughton</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Morillon</surname><given-names>A-C</given-names></name><name><surname>Chin</surname><given-names>S-T</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Ryan</surname><given-names>M</given-names></name><name><surname>Bong</surname><given-names>S-H</given-names></name><name><surname>Gay</surname><given-names>M</given-names></name><name><surname>Edgar</surname><given-names>DW</given-names></name><name><surname>Lindon</surname><given-names>JC</given-names></name><name><surname>Richards</surname><given-names>T</given-names></name><name><surname>Yeap</surname><given-names>BB</given-names></name><name><surname>Pettersson</surname><given-names>S</given-names></name><name><surname>Spraul</surname><given-names>M</given-names></name><name><surname>Schaefer</surname><given-names>H</given-names></name><name><surname>Lawler</surname><given-names>NG</given-names></name><name><surname>Gray</surname><given-names>N</given-names></name><name><surname>Whiley</surname><given-names>L</given-names></name><name><surname>Nicholson</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome</article-title><source>Journal of Proteome Research</source><volume>20</volume><fpage>3315</fpage><lpage>3329</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.1c00224</pub-id><pub-id pub-id-type="pmid">34009992</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussman</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention</article-title><source>Frontiers in Pharmacology</source><volume>11</volume><elocation-id>1169</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2020.01169</pub-id><pub-id pub-id-type="pmid">32848776</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo-Pujol</surname><given-names>J</given-names></name><name><surname>Moron-Lopez</surname><given-names>S</given-names></name><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Gonzalez-Aumatell</surname><given-names>A</given-names></name><name><surname>Carreras-Abad</surname><given-names>C</given-names></name><name><surname>Mendez</surname><given-names>M</given-names></name><name><surname>Rodrigo</surname><given-names>C</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Post COVID-19 condition in children and adolescents: an emerging problem</article-title><source>Frontiers in Pediatrics</source><volume>10</volume><elocation-id>894204</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2022.894204</pub-id><pub-id pub-id-type="pmid">35633949</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jason</surname><given-names>LA</given-names></name><name><surname>Cotler</surname><given-names>J</given-names></name><name><surname>Islam</surname><given-names>MF</given-names></name><name><surname>Furst</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>BZ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Predictors for developing severe myalgic encephalomyelitis/chronic fatigue syndrome following infectious mononucleosis</article-title><source>Journal of Rehabilitation Therapy</source><volume>4</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.29245/2767-5122/2021/1.1129</pub-id><pub-id pub-id-type="pmid">35350440</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Adekunle</surname><given-names>R</given-names></name><name><surname>Heather</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Cong</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Andersson</surname><given-names>LM</given-names></name><name><surname>Robertson</surname><given-names>J</given-names></name><name><surname>Gisslén</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity</article-title><source>Journal of Medical Virology</source><volume>95</volume><elocation-id>e28134</elocation-id><pub-id pub-id-type="doi">10.1002/jmv.28134</pub-id><pub-id pub-id-type="pmid">36086941</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>B</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Ha</surname><given-names>SE</given-names></name><name><surname>Zogg</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><name><surname>Ro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19</article-title><source>World Journal of Gastroenterology</source><volume>27</volume><fpage>2341</fpage><lpage>2352</lpage><pub-id pub-id-type="doi">10.3748/wjg.v27.i19.2341</pub-id><pub-id pub-id-type="pmid">34040326</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonigk</surname><given-names>D</given-names></name><name><surname>Werlein</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>PD</given-names></name><name><surname>Kauczor</surname><given-names>H-U</given-names></name><name><surname>Länger</surname><given-names>F</given-names></name><name><surname>Ackermann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pulmonary and systemic pathology in COVID-19—holistic pathological analyses</article-title><source>Deutsches Arzteblatt International</source><volume>119</volume><fpage>429</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.3238/arztebl.m2022.0231</pub-id><pub-id pub-id-type="pmid">35698804</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jose</surname><given-names>RJ</given-names></name><name><surname>Manuel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 cytokine storm: the interplay between inflammation and coagulation</article-title><source>The Lancet. Respiratory Medicine</source><volume>8</volume><fpage>e46</fpage><lpage>e47</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30216-2</pub-id><pub-id pub-id-type="pmid">32353251</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jud</surname><given-names>P</given-names></name><name><surname>Kessler</surname><given-names>HH</given-names></name><name><surname>Brodmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Case report: changes of vascular reactivity and arterial stiffness in a patient with covid-19 infection</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>8</volume><elocation-id>671669</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.671669</pub-id><pub-id pub-id-type="pmid">34055940</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaltsas</surname><given-names>G</given-names></name><name><surname>Vgontzas</surname><given-names>A</given-names></name><name><surname>Chrousos</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fatigue, endocrinopathies, and metabolic disorders</article-title><source>PM &amp; R</source><volume>2</volume><fpage>393</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/j.pmrj.2010.04.011</pub-id><pub-id pub-id-type="pmid">20656620</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>H</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Nawaz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study</article-title><source>Journal of Medical Microbiology</source><volume>69</volume><fpage>1114</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.001231</pub-id><pub-id pub-id-type="pmid">32783802</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Ji</surname><given-names>SW</given-names></name><name><surname>Park</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The development of irritable bowel syndrome after shigella infection: 3 year follow-up study</article-title><source>The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi</source><volume>47</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">16632982</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosuge</surname><given-names>M</given-names></name><name><surname>Ebina</surname><given-names>T</given-names></name><name><surname>Hibi</surname><given-names>K</given-names></name><name><surname>Tsukahara</surname><given-names>K</given-names></name><name><surname>Iwahashi</surname><given-names>N</given-names></name><name><surname>Gohbara</surname><given-names>M</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><name><surname>Okada</surname><given-names>K</given-names></name><name><surname>Morita</surname><given-names>S</given-names></name><name><surname>Umemura</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and takotsubo cardiomyopathy</article-title><source>European Heart Journal. Acute Cardiovascular Care</source><volume>1</volume><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1177/2048872612466790</pub-id><pub-id pub-id-type="pmid">24062927</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>BA</given-names></name><name><surname>Lim</surname><given-names>EY</given-names></name><name><surname>Mactavous</surname><given-names>L</given-names></name><name><surname>Team</surname><given-names>NB</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Doffinger</surname><given-names>R</given-names></name><name><surname>Bradley</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>KGC</given-names></name><name><surname>Sinclair</surname><given-names>J</given-names></name><name><surname>Matheson</surname><given-names>NJ</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name><name><surname>Wills</surname><given-names>MR</given-names></name><name><surname>Sithole</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Evidence of previous SARS-cov-2 infection in seronegative patients with long COVID</article-title><source>EBioMedicine</source><volume>81</volume><elocation-id>104129</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104129</pub-id><pub-id pub-id-type="pmid">35772216</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuchay</surname><given-names>MS</given-names></name><name><surname>Reddy</surname><given-names>PK</given-names></name><name><surname>Gagneja</surname><given-names>S</given-names></name><name><surname>Mathew</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19</article-title><source>Diabetes &amp; Metabolic Syndrome</source><volume>14</volume><fpage>2039</fpage><lpage>2041</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2020.10.015</pub-id><pub-id pub-id-type="pmid">33113470</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lala</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>KW</given-names></name><name><surname>Januzzi</surname><given-names>JL</given-names></name><name><surname>Russak</surname><given-names>AJ</given-names></name><name><surname>Paranjpe</surname><given-names>I</given-names></name><name><surname>Richter</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Somani</surname><given-names>S</given-names></name><name><surname>Van Vleck</surname><given-names>T</given-names></name><name><surname>Vaid</surname><given-names>A</given-names></name><name><surname>Chaudhry</surname><given-names>F</given-names></name><name><surname>De Freitas</surname><given-names>JK</given-names></name><name><surname>Fayad</surname><given-names>ZA</given-names></name><name><surname>Pinney</surname><given-names>SP</given-names></name><name><surname>Levin</surname><given-names>M</given-names></name><name><surname>Charney</surname><given-names>A</given-names></name><name><surname>Bagiella</surname><given-names>E</given-names></name><name><surname>Narula</surname><given-names>J</given-names></name><name><surname>Glicksberg</surname><given-names>BS</given-names></name><name><surname>Nadkarni</surname><given-names>G</given-names></name><name><surname>Mancini</surname><given-names>DM</given-names></name><name><surname>Fuster</surname><given-names>V</given-names></name><collab>Mount Sinai COVID Informatics Center</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection</article-title><source>Journal of the American College of Cardiology</source><volume>76</volume><fpage>533</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2020.06.007</pub-id><pub-id pub-id-type="pmid">32517963</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamers</surname><given-names>MM</given-names></name><name><surname>Beumer</surname><given-names>J</given-names></name><name><surname>van der Vaart</surname><given-names>J</given-names></name><name><surname>Knoops</surname><given-names>K</given-names></name><name><surname>Puschhof</surname><given-names>J</given-names></name><name><surname>Breugem</surname><given-names>TI</given-names></name><name><surname>Ravelli</surname><given-names>RBG</given-names></name><name><surname>Paul van Schayck</surname><given-names>J</given-names></name><name><surname>Mykytyn</surname><given-names>AZ</given-names></name><name><surname>Duimel</surname><given-names>HQ</given-names></name><name><surname>van Donselaar</surname><given-names>E</given-names></name><name><surname>Riesebosch</surname><given-names>S</given-names></name><name><surname>Kuijpers</surname><given-names>HJH</given-names></name><name><surname>Schipper</surname><given-names>D</given-names></name><name><surname>van de Wetering</surname><given-names>WJ</given-names></name><name><surname>de Graaf</surname><given-names>M</given-names></name><name><surname>Koopmans</surname><given-names>M</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Peters</surname><given-names>PJ</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-cov-2 productively infects human gut enterocytes</article-title><source>Science</source><volume>369</volume><fpage>50</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1126/science.abc1669</pub-id><pub-id pub-id-type="pmid">32358202</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauer</surname><given-names>AN</given-names></name><name><surname>Tenenbaum</surname><given-names>T</given-names></name><name><surname>Schroten</surname><given-names>H</given-names></name><name><surname>Schwerk</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The diverse cellular responses of the choroid plexus during infection of the central nervous system</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>314</volume><fpage>C152</fpage><lpage>C165</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00137.2017</pub-id><pub-id pub-id-type="pmid">29070490</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaVergne</surname><given-names>SM</given-names></name><name><surname>Stromberg</surname><given-names>S</given-names></name><name><surname>Baxter</surname><given-names>BA</given-names></name><name><surname>Webb</surname><given-names>TL</given-names></name><name><surname>Dutt</surname><given-names>TS</given-names></name><name><surname>Berry</surname><given-names>K</given-names></name><name><surname>Tipton</surname><given-names>M</given-names></name><name><surname>Haberman</surname><given-names>J</given-names></name><name><surname>Massey</surname><given-names>BR</given-names></name><name><surname>McFann</surname><given-names>K</given-names></name><name><surname>Alnachoukati</surname><given-names>O</given-names></name><name><surname>Zier</surname><given-names>L</given-names></name><name><surname>Heacock</surname><given-names>T</given-names></name><name><surname>Ebel</surname><given-names>GD</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M</given-names></name><name><surname>Dunn</surname><given-names>J</given-names></name><name><surname>Ryan</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A longitudinal SARS-cov-2 biorepository for COVID-19 survivors with and without post-acute sequelae</article-title><source>BMC Infectious Diseases</source><volume>21</volume><elocation-id>677</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-021-06359-2</pub-id><pub-id pub-id-type="pmid">34256735</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazartigues</surname><given-names>E</given-names></name><name><surname>Qadir</surname><given-names>MMF</given-names></name><name><surname>Mauvais-Jarvis</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endocrine significance of SARS-cov-2’s reliance on ACE2</article-title><source>Endocrinology</source><volume>161</volume><elocation-id>bqaa108</elocation-id><pub-id pub-id-type="doi">10.1210/endocr/bqaa108</pub-id><pub-id pub-id-type="pmid">32652001</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledford</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>How common is long COVID? why studies give different answers</article-title><source>Nature</source><volume>606</volume><fpage>852</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1038/d41586-022-01702-2</pub-id><pub-id pub-id-type="pmid">35725828</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Nallani</surname><given-names>R</given-names></name><name><surname>Cass</surname><given-names>L</given-names></name><name><surname>Bhalla</surname><given-names>V</given-names></name><name><surname>Chiu</surname><given-names>AG</given-names></name><name><surname>Villwock</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A systematic review of the neuropathologic findings of post-viral olfactory dysfunction: implications and novel insight for the COVID-19 pandemic</article-title><source>American Journal of Rhinology &amp; Allergy</source><volume>35</volume><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1177/1945892420957853</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>NF-kappab regulation in the immune system</article-title><source>Nature Reviews.Immunology</source><volume>2</volume><fpage>725</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1038/nri910</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Bai</surname><given-names>WZ</given-names></name><name><surname>Hashikawa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>The neuroinvasive potential of SARS-cov2 may play a role in the respiratory failure of COVID-19 patients</article-title><source>Journal of Medical Virology</source><volume>92</volume><fpage>552</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1002/jmv.25728</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zuo</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Deng</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>COVID-19 infection may cause ketosis and ketoacidosis</article-title><source>Diabetes, Obesity &amp; Metabolism</source><volume>22</volume><fpage>1935</fpage><lpage>1941</lpage><pub-id pub-id-type="doi">10.1111/dom.14057</pub-id><pub-id pub-id-type="pmid">32314455</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindan</surname><given-names>CE</given-names></name><name><surname>Mankad</surname><given-names>K</given-names></name><name><surname>Ram</surname><given-names>D</given-names></name><name><surname>Kociolek</surname><given-names>LK</given-names></name><name><surname>Silvera</surname><given-names>VM</given-names></name><name><surname>Boddaert</surname><given-names>N</given-names></name><name><surname>Stivaros</surname><given-names>SM</given-names></name><name><surname>Palasis</surname><given-names>S</given-names></name><name><surname>Group</surname><given-names>APC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neuroimaging manifestations in children with SARS-cov-2 infection: A multinational, multicentre collaborative study</article-title><source>The Lancet. Child &amp; Adolescent Health</source><volume>5</volume><fpage>167</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/S2352-4642(20)30362-X</pub-id><pub-id pub-id-type="pmid">33338439</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippi</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Henry</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis</article-title><source>Polish Archives of Internal Medicine</source><volume>130</volume><fpage>304</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.20452/pamw.15272</pub-id><pub-id pub-id-type="pmid">32231171</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PP</given-names></name><name><surname>Blet</surname><given-names>A</given-names></name><name><surname>Smyth</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>The science underlying COVID-19: implications for the cardiovascular system</article-title><source>Circulation</source><volume>142</volume><fpage>68</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.047549</pub-id><pub-id pub-id-type="pmid">32293910</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Lv</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Tong</surname><given-names>WM</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Mucus production stimulated by IFN-ahr signaling triggers hypoxia of COVID-19</article-title><source>Cell Research</source><volume>30</volume><fpage>1078</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-00435-z</pub-id><pub-id pub-id-type="pmid">33159154</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>QH</given-names></name><name><surname>Wang</surname><given-names>LR</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cen</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>YR</given-names></name><name><surname>Zhang</surname><given-names>LL</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>ZQ</given-names></name><name><surname>Wang</surname><given-names>YJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>One-Year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study</article-title><source>JAMA Neurology</source><volume>79</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2022.0461</pub-id><pub-id pub-id-type="pmid">35258587</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Morrone</surname><given-names>MC</given-names></name><name><surname>Patrono</surname><given-names>C</given-names></name><name><surname>Santoro</surname><given-names>MG</given-names></name><name><surname>Schiaffino</surname><given-names>S</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name><name><surname>Bussolati</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Long covid: where we stand and challenges ahead</article-title><source>Cell Death and Differentiation</source><volume>29</volume><fpage>1891</fpage><lpage>1900</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-01052-6</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matschke</surname><given-names>J</given-names></name><name><surname>Lütgehetmann</surname><given-names>M</given-names></name><name><surname>Hagel</surname><given-names>C</given-names></name><name><surname>Sperhake</surname><given-names>JP</given-names></name><name><surname>Schröder</surname><given-names>AS</given-names></name><name><surname>Edler</surname><given-names>C</given-names></name><name><surname>Mushumba</surname><given-names>H</given-names></name><name><surname>Fitzek</surname><given-names>A</given-names></name><name><surname>Allweiss</surname><given-names>L</given-names></name><name><surname>Dandri</surname><given-names>M</given-names></name><name><surname>Dottermusch</surname><given-names>M</given-names></name><name><surname>Heinemann</surname><given-names>A</given-names></name><name><surname>Pfefferle</surname><given-names>S</given-names></name><name><surname>Schwabenland</surname><given-names>M</given-names></name><name><surname>Sumner Magruder</surname><given-names>D</given-names></name><name><surname>Bonn</surname><given-names>S</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Püschel</surname><given-names>K</given-names></name><name><surname>Krasemann</surname><given-names>S</given-names></name><name><surname>Aepfelbacher</surname><given-names>M</given-names></name><name><surname>Glatzel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuropathology of patients with COVID-19 in germany: A post-mortem case series</article-title><source>The Lancet. Neurology</source><volume>19</volume><fpage>919</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(20)30308-2</pub-id><pub-id pub-id-type="pmid">33031735</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsubara</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Kauffman</surname><given-names>HL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nadaraj</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>C</given-names></name><name><surname>Paridon</surname><given-names>SM</given-names></name><name><surname>Fogel</surname><given-names>MA</given-names></name><name><surname>Quartermain</surname><given-names>MD</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Longitudinal assessment of cardiac outcomes of multisystem inflammatory syndrome in children associated with COVID-19 infections</article-title><source>Journal of the American Heart Association</source><volume>11</volume><elocation-id>e023251</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.121.023251</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarland</surname><given-names>AJ</given-names></name><name><surname>Yousuf</surname><given-names>MS</given-names></name><name><surname>Shiers</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neurobiology of SARS-cov-2 interactions with the peripheral nervous system: implications for COVID-19 and pain</article-title><source>Pain Reports</source><volume>6</volume><elocation-id>e885</elocation-id><pub-id pub-id-type="doi">10.1097/PR9.0000000000000885</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Enríquez</surname><given-names>MM</given-names></name><name><surname>Lopez-León</surname><given-names>S</given-names></name><name><surname>Carlos-Escalante</surname><given-names>JA</given-names></name><name><surname>Aponte-Torres</surname><given-names>Z</given-names></name><name><surname>Cuapio</surname><given-names>A</given-names></name><name><surname>Wegman-Ostrosky</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ACE2: the molecular doorway to SARS-cov-2</article-title><source>Cell &amp; Bioscience</source><volume>10</volume><elocation-id>148</elocation-id><pub-id pub-id-type="doi">10.1186/s13578-020-00519-8</pub-id><pub-id pub-id-type="pmid">33380340</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehandru</surname><given-names>S</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pathological sequelae of long-haul COVID</article-title><source>Nature Immunology</source><volume>23</volume><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-01104-y</pub-id><pub-id pub-id-type="pmid">35105985</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michelen</surname><given-names>M</given-names></name><name><surname>Manoharan</surname><given-names>L</given-names></name><name><surname>Elkheir</surname><given-names>N</given-names></name><name><surname>Cheng</surname><given-names>V</given-names></name><name><surname>Dagens</surname><given-names>A</given-names></name><name><surname>Hastie</surname><given-names>C</given-names></name><name><surname>O’Hara</surname><given-names>M</given-names></name><name><surname>Suett</surname><given-names>J</given-names></name><name><surname>Dahmash</surname><given-names>D</given-names></name><name><surname>Bugaeva</surname><given-names>P</given-names></name><name><surname>Rigby</surname><given-names>I</given-names></name><name><surname>Munblit</surname><given-names>D</given-names></name><name><surname>Harriss</surname><given-names>E</given-names></name><name><surname>Burls</surname><given-names>A</given-names></name><name><surname>Foote</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Carson</surname><given-names>G</given-names></name><name><surname>Olliaro</surname><given-names>P</given-names></name><name><surname>Sigfrid</surname><given-names>L</given-names></name><name><surname>Stavropoulou</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characterising long COVID: A living systematic review</article-title><source>BMJ Global Health</source><volume>6</volume><elocation-id>e005427</elocation-id><pub-id pub-id-type="doi">10.1136/bmjgh-2021-005427</pub-id><pub-id pub-id-type="pmid">34580069</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montezano</surname><given-names>AC</given-names></name><name><surname>Nguyen Dinh Cat</surname><given-names>A</given-names></name><name><surname>Rios</surname><given-names>FJ</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Angiotensin II and vascular injury</article-title><source>Current Hypertension Reports</source><volume>16</volume><fpage>431</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1007/s11906-014-0431-2</pub-id><pub-id pub-id-type="pmid">24760441</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morganstein</surname><given-names>T</given-names></name><name><surname>Haidar</surname><given-names>Z</given-names></name><name><surname>Trivlidis</surname><given-names>J</given-names></name><name><surname>Azuelos</surname><given-names>I</given-names></name><name><surname>Huang</surname><given-names>MJ</given-names></name><name><surname>Eidelman</surname><given-names>DH</given-names></name><name><surname>Baglole</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Involvement of the ACE2/ang- (1-7) /masr axis in pulmonary fibrosis: implications for COVID-19</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>12955</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222312955</pub-id><pub-id pub-id-type="pmid">34884756</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>C</given-names></name><name><surname>Giannitsis</surname><given-names>E</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Huber</surname><given-names>K</given-names></name><name><surname>Mair</surname><given-names>J</given-names></name><name><surname>Cullen</surname><given-names>L</given-names></name><name><surname>Hammarsten</surname><given-names>O</given-names></name><name><surname>Mills</surname><given-names>NL</given-names></name><name><surname>Mockel</surname><given-names>M</given-names></name><name><surname>Krychtiuk</surname><given-names>K</given-names></name><name><surname>Thygesen</surname><given-names>K</given-names></name><name><surname>Lindahl</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cardiovascular biomarkers in patients with COVID-19</article-title><source>European Heart Journal</source><volume>10</volume><fpage>310</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1093/ehjacc/zuab009</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalbandian</surname><given-names>A</given-names></name><name><surname>Sehgal</surname><given-names>K</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Madhavan</surname><given-names>MV</given-names></name><name><surname>McGroder</surname><given-names>C</given-names></name><name><surname>Stevens</surname><given-names>JS</given-names></name><name><surname>Cook</surname><given-names>JR</given-names></name><name><surname>Nordvig</surname><given-names>AS</given-names></name><name><surname>Shalev</surname><given-names>D</given-names></name><name><surname>Sehrawat</surname><given-names>TS</given-names></name><name><surname>Ahluwalia</surname><given-names>N</given-names></name><name><surname>Bikdeli</surname><given-names>B</given-names></name><name><surname>Dietz</surname><given-names>D</given-names></name><name><surname>Der-Nigoghossian</surname><given-names>C</given-names></name><name><surname>Liyanage-Don</surname><given-names>N</given-names></name><name><surname>Rosner</surname><given-names>GF</given-names></name><name><surname>Bernstein</surname><given-names>EJ</given-names></name><name><surname>Mohan</surname><given-names>S</given-names></name><name><surname>Beckley</surname><given-names>AA</given-names></name><name><surname>Seres</surname><given-names>DS</given-names></name><name><surname>Choueiri</surname><given-names>TK</given-names></name><name><surname>Uriel</surname><given-names>N</given-names></name><name><surname>Ausiello</surname><given-names>JC</given-names></name><name><surname>Accili</surname><given-names>D</given-names></name><name><surname>Freedberg</surname><given-names>DE</given-names></name><name><surname>Baldwin</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>A</given-names></name><name><surname>Brodie</surname><given-names>D</given-names></name><name><surname>Garcia</surname><given-names>CK</given-names></name><name><surname>Elkind</surname><given-names>MSV</given-names></name><name><surname>Connors</surname><given-names>JM</given-names></name><name><surname>Bilezikian</surname><given-names>JP</given-names></name><name><surname>Landry</surname><given-names>DW</given-names></name><name><surname>Wan</surname><given-names>EY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Post-acute COVID-19 syndrome</article-title><source>Nature Medicine</source><volume>27</volume><fpage>601</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01283-z</pub-id><pub-id pub-id-type="pmid">33753937</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MJ</given-names></name><name><surname>Bahl</surname><given-names>JS</given-names></name><name><surname>Buckley</surname><given-names>JD</given-names></name><name><surname>Thomson</surname><given-names>RL</given-names></name><name><surname>Davison</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evidence of altered cardiac autonomic regulation in myalgic Encephalomyelitis/Chronic fatigue syndrome: a systematic review and meta-analysis</article-title><source>Medicine</source><volume>98</volume><elocation-id>e17600</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000017600</pub-id><pub-id pub-id-type="pmid">31651868</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noval Rivas</surname><given-names>M</given-names></name><name><surname>Porritt</surname><given-names>RA</given-names></name><name><surname>Cheng</surname><given-names>MH</given-names></name><name><surname>Bahar</surname><given-names>I</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Multisystem inflammatory syndrome in children and long COVID: the SARS-cov-2 viral superantigen hypothesis</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>941009</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.941009</pub-id><pub-id pub-id-type="pmid">35874696</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oronsky</surname><given-names>B</given-names></name><name><surname>Larson</surname><given-names>C</given-names></name><name><surname>Hammond</surname><given-names>TC</given-names></name><name><surname>Oronsky</surname><given-names>A</given-names></name><name><surname>Kesari</surname><given-names>S</given-names></name><name><surname>Lybeck</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A review of persistent post-COVID syndrome (PPCS)</article-title><source>Clinical Reviews in Allergy &amp; Immunology</source><volume>64</volume><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s12016-021-08848-3</pub-id><pub-id pub-id-type="pmid">33609255</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osburn</surname><given-names>WO</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Yanek</surname><given-names>L</given-names></name><name><surname>Amat-Alcaron</surname><given-names>N</given-names></name><name><surname>Thiemann</surname><given-names>DR</given-names></name><name><surname>Cox</surname><given-names>AL</given-names></name><name><surname>Leucker</surname><given-names>TM</given-names></name><name><surname>Lowenstein</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19</article-title><source>PLOS ONE</source><volume>17</volume><elocation-id>e0268296</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0268296</pub-id><pub-id pub-id-type="pmid">35588115</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Shea</surname><given-names>JJ</given-names></name><name><surname>Schwartz</surname><given-names>DM</given-names></name><name><surname>Villarino</surname><given-names>AV</given-names></name><name><surname>Gadina</surname><given-names>M</given-names></name><name><surname>McInnes</surname><given-names>IB</given-names></name><name><surname>Laurence</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The JAK-STAT pathway: impact on human disease and therapeutic intervention</article-title><source>Annual Review of Medicine</source><volume>66</volume><fpage>311</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-051113-024537</pub-id><pub-id pub-id-type="pmid">25587654</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostergaard</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sars cov-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation</article-title><source>Physiological Reports</source><volume>9</volume><elocation-id>e14726</elocation-id><pub-id pub-id-type="doi">10.14814/phy2.14726</pub-id><pub-id pub-id-type="pmid">33523608</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozonoff</surname><given-names>A</given-names></name><name><surname>Schaenman</surname><given-names>J</given-names></name><name><surname>Jayavelu</surname><given-names>ND</given-names></name><name><surname>Milliren</surname><given-names>CE</given-names></name><name><surname>Calfee</surname><given-names>CS</given-names></name><name><surname>Cairns</surname><given-names>CB</given-names></name><name><surname>Kraft</surname><given-names>M</given-names></name><name><surname>Baden</surname><given-names>LR</given-names></name><name><surname>Shaw</surname><given-names>AC</given-names></name><name><surname>Krammer</surname><given-names>F</given-names></name><name><surname>van Bakel</surname><given-names>H</given-names></name><name><surname>Esserman</surname><given-names>DA</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Sesma</surname><given-names>AF</given-names></name><name><surname>Simon</surname><given-names>V</given-names></name><name><surname>Hafler</surname><given-names>DA</given-names></name><name><surname>Montgomery</surname><given-names>RR</given-names></name><name><surname>Kleinstein</surname><given-names>SH</given-names></name><name><surname>Levy</surname><given-names>O</given-names></name><name><surname>Bime</surname><given-names>C</given-names></name><name><surname>Haddad</surname><given-names>EK</given-names></name><name><surname>Erle</surname><given-names>DJ</given-names></name><name><surname>Pulendran</surname><given-names>B</given-names></name><name><surname>Nadeau</surname><given-names>KC</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Hough</surname><given-names>CL</given-names></name><name><surname>Messer</surname><given-names>WB</given-names></name><name><surname>Higuita</surname><given-names>NIA</given-names></name><name><surname>Metcalf</surname><given-names>JP</given-names></name><name><surname>Atkinson</surname><given-names>MA</given-names></name><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Corry</surname><given-names>D</given-names></name><name><surname>Kheradmand</surname><given-names>F</given-names></name><name><surname>Ehrlich</surname><given-names>LIR</given-names></name><name><surname>Melamed</surname><given-names>E</given-names></name><name><surname>McComsey</surname><given-names>GA</given-names></name><name><surname>Sekaly</surname><given-names>R</given-names></name><name><surname>Diray-Arce</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>B</given-names></name><name><surname>Augustine</surname><given-names>AD</given-names></name><name><surname>Reed</surname><given-names>EF</given-names></name><name><surname>Altman</surname><given-names>MC</given-names></name><name><surname>Becker</surname><given-names>PM</given-names></name><name><surname>Rouphael</surname><given-names>N</given-names></name><collab>IMPACC study group members</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study</article-title><source>EBioMedicine</source><volume>83</volume><elocation-id>104208</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104208</pub-id><pub-id pub-id-type="pmid">35952496</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pablos</surname><given-names>JL</given-names></name><name><surname>Galindo</surname><given-names>M</given-names></name><name><surname>Carmona</surname><given-names>L</given-names></name><name><surname>Lledó</surname><given-names>A</given-names></name><name><surname>Retuerto</surname><given-names>M</given-names></name><name><surname>Blanco</surname><given-names>R</given-names></name><name><surname>Gonzalez-Gay</surname><given-names>MA</given-names></name><name><surname>Martinez-Lopez</surname><given-names>D</given-names></name><name><surname>Castrejón</surname><given-names>I</given-names></name><name><surname>Alvaro-Gracia</surname><given-names>JM</given-names></name><name><surname>Fernández Fernández</surname><given-names>D</given-names></name><name><surname>Mera-Varela</surname><given-names>A</given-names></name><name><surname>Manrique-Arija</surname><given-names>S</given-names></name><name><surname>Mena Vázquez</surname><given-names>N</given-names></name><name><surname>Fernandez-Nebro</surname><given-names>A</given-names></name><collab>RIER Investigators Group</collab><collab>RIER investigators group</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study</article-title><source>Annals of the Rheumatic Diseases</source><volume>79</volume><fpage>1544</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2020-218296</pub-id><pub-id pub-id-type="pmid">32796045</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Anthony</surname><given-names>SM</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Cassell</surname><given-names>M</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS</article-title><source>PNAS</source><volume>117</volume><fpage>15902</fpage><lpage>15910</lpage><pub-id pub-id-type="doi">10.1073/pnas.2003432117</pub-id><pub-id pub-id-type="pmid">32571951</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parohan</surname><given-names>M</given-names></name><name><surname>Yaghoubi</surname><given-names>S</given-names></name><name><surname>Seraji</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies</article-title><source>European Heart Journal. Acute Cardiovascular Care</source><volume>9</volume><fpage>665</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1177/2048872620937165</pub-id><pub-id pub-id-type="pmid">32567326</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>JAS</given-names></name><name><surname>Rech</surname><given-names>TH</given-names></name><name><surname>Schwarz</surname><given-names>P</given-names></name><name><surname>de Oliveira</surname><given-names>ACT</given-names></name><name><surname>Vieceli</surname><given-names>T</given-names></name><name><surname>Moraes</surname><given-names>RB</given-names></name><name><surname>Sekine</surname><given-names>L</given-names></name><name><surname>Viana</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study</article-title><source>Journal of Thrombosis and Thrombolysis</source><volume>52</volume><fpage>482</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1007/s11239-021-02395-6</pub-id><pub-id pub-id-type="pmid">33599858</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlis</surname><given-names>RH</given-names></name><name><surname>Santillana</surname><given-names>M</given-names></name><name><surname>Ognyanova</surname><given-names>K</given-names></name><name><surname>Safarpour</surname><given-names>A</given-names></name><name><surname>Lunz Trujillo</surname><given-names>K</given-names></name><name><surname>Simonson</surname><given-names>MD</given-names></name><name><surname>Green</surname><given-names>J</given-names></name><name><surname>Quintana</surname><given-names>A</given-names></name><name><surname>Druckman</surname><given-names>J</given-names></name><name><surname>Baum</surname><given-names>MA</given-names></name><name><surname>Lazer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Prevalence and correlates of long COVID symptoms among US adults</article-title><source>JAMA Network Open</source><volume>5</volume><elocation-id>e2238804</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.38804</pub-id><pub-id pub-id-type="pmid">36301542</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>MS</given-names></name><name><surname>Kristiansen</surname><given-names>MF</given-names></name><name><surname>Hanusson</surname><given-names>KD</given-names></name><name><surname>Foldbo</surname><given-names>BM</given-names></name><name><surname>Danielsen</surname><given-names>ME</given-names></name><name><surname>Á Steig</surname><given-names>B</given-names></name><name><surname>Gaini</surname><given-names>S</given-names></name><name><surname>Strøm</surname><given-names>M</given-names></name><name><surname>Weihe</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months’ follow-up</article-title><source>International Journal of Infectious Diseases</source><volume>122</volume><fpage>437</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2022.06.031</pub-id><pub-id pub-id-type="pmid">35753603</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piazza</surname><given-names>G</given-names></name><name><surname>Campia</surname><given-names>U</given-names></name><name><surname>Hurwitz</surname><given-names>S</given-names></name><name><surname>Snyder</surname><given-names>JE</given-names></name><name><surname>Rizzo</surname><given-names>SM</given-names></name><name><surname>Pfeferman</surname><given-names>MB</given-names></name><name><surname>Morrison</surname><given-names>RB</given-names></name><name><surname>Leiva</surname><given-names>O</given-names></name><name><surname>Fanikos</surname><given-names>J</given-names></name><name><surname>Nauffal</surname><given-names>V</given-names></name><name><surname>Almarzooq</surname><given-names>Z</given-names></name><name><surname>Goldhaber</surname><given-names>SZ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Registry of arterial and venous thromboembolic complications in patients with COVID-19</article-title><source>Journal of the American College of Cardiology</source><volume>76</volume><fpage>2060</fpage><lpage>2072</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2020.08.070</pub-id><pub-id pub-id-type="pmid">33121712</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>CA</given-names></name><name><surname>Preston-Hurlburt</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Aschner</surname><given-names>CB</given-names></name><name><surname>Cheshenko</surname><given-names>N</given-names></name><name><surname>Galen</surname><given-names>B</given-names></name><name><surname>Garforth</surname><given-names>SJ</given-names></name><name><surname>Herrera</surname><given-names>NG</given-names></name><name><surname>Jangra</surname><given-names>RK</given-names></name><name><surname>Morano</surname><given-names>NC</given-names></name><name><surname>Orner</surname><given-names>E</given-names></name><name><surname>Sy</surname><given-names>S</given-names></name><name><surname>Chandran</surname><given-names>K</given-names></name><name><surname>Dziura</surname><given-names>J</given-names></name><name><surname>Almo</surname><given-names>SC</given-names></name><name><surname>Ring</surname><given-names>A</given-names></name><name><surname>Keller</surname><given-names>MJ</given-names></name><name><surname>Herold</surname><given-names>KC</given-names></name><name><surname>Herold</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Immune responses to SARS-cov-2 infection in hospitalized pediatric and adult patients</article-title><source>Science Translational Medicine</source><volume>12</volume><elocation-id>eabd5487</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abd5487</pub-id><pub-id pub-id-type="pmid">32958614</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>DCH</given-names></name><name><surname>Ho</surname><given-names>YS</given-names></name><name><surname>Chiu</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>HL</given-names></name><name><surname>Chang</surname><given-names>RCC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>57</volume><fpage>30</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.07.015</pub-id><pub-id pub-id-type="pmid">26363665</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porritt</surname><given-names>RA</given-names></name><name><surname>Paschold</surname><given-names>L</given-names></name><name><surname>Rivas</surname><given-names>MN</given-names></name><name><surname>Cheng</surname><given-names>MH</given-names></name><name><surname>Yonker</surname><given-names>LM</given-names></name><name><surname>Chandnani</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>M</given-names></name><name><surname>Simnica</surname><given-names>D</given-names></name><name><surname>Schultheiß</surname><given-names>C</given-names></name><name><surname>Santiskulvong</surname><given-names>C</given-names></name><name><surname>Van Eyk</surname><given-names>J</given-names></name><name><surname>McCormick</surname><given-names>JK</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name><name><surname>Bahar</surname><given-names>I</given-names></name><name><surname>Binder</surname><given-names>M</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hla class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e146614</elocation-id><pub-id pub-id-type="doi">10.1172/JCI146614</pub-id><pub-id pub-id-type="pmid">33705359</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proal</surname><given-names>AD</given-names></name><name><surname>VanElzakker</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms</article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>698169</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.698169</pub-id><pub-id pub-id-type="pmid">34248921</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puntmann</surname><given-names>VO</given-names></name><name><surname>Carerj</surname><given-names>ML</given-names></name><name><surname>Wieters</surname><given-names>I</given-names></name><name><surname>Fahim</surname><given-names>M</given-names></name><name><surname>Arendt</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>J</given-names></name><name><surname>Shchendrygina</surname><given-names>A</given-names></name><name><surname>Escher</surname><given-names>F</given-names></name><name><surname>Vasa-Nicotera</surname><given-names>M</given-names></name><name><surname>Zeiher</surname><given-names>AM</given-names></name><name><surname>Vehreschild</surname><given-names>M</given-names></name><name><surname>Nagel</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)</article-title><source>JAMA Cardiology</source><volume>5</volume><fpage>1265</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2020.3557</pub-id><pub-id pub-id-type="pmid">32730619</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Niloofa</surname><given-names>R</given-names></name><name><surname>Jayarajah</surname><given-names>U</given-names></name><name><surname>De Mel</surname><given-names>S</given-names></name><name><surname>Abeysuriya</surname><given-names>V</given-names></name><name><surname>Seneviratne</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hematological abnormalities in COVID-19: a narrative review</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>104</volume><fpage>1188</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.20-1536</pub-id><pub-id pub-id-type="pmid">33606667</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswamy</surname><given-names>A</given-names></name><name><surname>Brodsky</surname><given-names>NN</given-names></name><name><surname>Sumida</surname><given-names>TS</given-names></name><name><surname>Comi</surname><given-names>M</given-names></name><name><surname>Asashima</surname><given-names>H</given-names></name><name><surname>Hoehn</surname><given-names>KB</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><name><surname>Ravindra</surname><given-names>NG</given-names></name><name><surname>Bishai</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Lau</surname><given-names>W</given-names></name><name><surname>Sellers</surname><given-names>B</given-names></name><name><surname>Bansal</surname><given-names>N</given-names></name><name><surname>Guerrerio</surname><given-names>P</given-names></name><name><surname>Unterman</surname><given-names>A</given-names></name><name><surname>Habet</surname><given-names>V</given-names></name><name><surname>Rice</surname><given-names>AJ</given-names></name><name><surname>Catanzaro</surname><given-names>J</given-names></name><name><surname>Chandnani</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>M</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Dela Cruz</surname><given-names>CS</given-names></name><name><surname>Tsang</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Kleinstein</surname><given-names>SH</given-names></name><name><surname>van Dijk</surname><given-names>D</given-names></name><name><surname>Pierce</surname><given-names>RW</given-names></name><name><surname>Hafler</surname><given-names>DA</given-names></name><name><surname>Lucas</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Immune dysregulation and autoreactivity correlate with disease severity in SARS-cov-2-associated multisystem inflammatory syndrome in children</article-title><source>Immunity</source><volume>54</volume><fpage>1083</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.04.003</pub-id><pub-id pub-id-type="pmid">33891889</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>GM</given-names></name><name><surname>Razzaghi</surname><given-names>H</given-names></name><name><surname>Lorman</surname><given-names>V</given-names></name><name><surname>Mejias</surname><given-names>A</given-names></name><name><surname>Pajor</surname><given-names>NM</given-names></name><name><surname>Thacker</surname><given-names>D</given-names></name><name><surname>Webb</surname><given-names>R</given-names></name><name><surname>Dickinson</surname><given-names>K</given-names></name><name><surname>Bailey</surname><given-names>LC</given-names></name><name><surname>Jhaveri</surname><given-names>R</given-names></name><name><surname>Christakis</surname><given-names>DA</given-names></name><name><surname>Bennett</surname><given-names>TD</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Forrest</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Clinical features and burden of postacute sequelae of SARS-cov-2 infection in children and adolescents</article-title><source>JAMA Pediatrics</source><volume>176</volume><fpage>1000</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2022.2800</pub-id><pub-id pub-id-type="pmid">35994282</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasa</surname><given-names>S</given-names></name><name><surname>Nora-Krukle</surname><given-names>Z</given-names></name><name><surname>Henning</surname><given-names>N</given-names></name><name><surname>Eliassen</surname><given-names>E</given-names></name><name><surname>Shikova</surname><given-names>E</given-names></name><name><surname>Harrer</surname><given-names>T</given-names></name><name><surname>Scheibenbogen</surname><given-names>C</given-names></name><name><surname>Murovska</surname><given-names>M</given-names></name><name><surname>Prusty</surname><given-names>BK</given-names></name><collab>European Network on ME/CFS</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</article-title><source>Journal of Translational Medicine</source><volume>16</volume><elocation-id>268</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-018-1644-y</pub-id><pub-id pub-id-type="pmid">30285773</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawal</surname><given-names>G</given-names></name><name><surname>Yadav</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Post-intensive care syndrome: an overview</article-title><source>Journal of Translational Internal Medicine</source><volume>5</volume><fpage>90</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1515/jtim-2016-0016</pub-id><pub-id pub-id-type="pmid">28721340</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimoldi</surname><given-names>SF</given-names></name><name><surname>Scherrer</surname><given-names>U</given-names></name><name><surname>Messerli</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Secondary arterial hypertension: when, who, and how to screen?</article-title><source>European Heart Journal</source><volume>35</volume><fpage>1245</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/eht534</pub-id><pub-id pub-id-type="pmid">24366917</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riphagen</surname><given-names>S</given-names></name><name><surname>Gomez</surname><given-names>X</given-names></name><name><surname>Gonzalez-Martinez</surname><given-names>C</given-names></name><name><surname>Wilkinson</surname><given-names>N</given-names></name><name><surname>Theocharis</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hyperinflammatory shock in children during COVID-19 pandemic</article-title><source>Lancet</source><volume>395</volume><fpage>1607</fpage><lpage>1608</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31094-1</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM</given-names></name><name><surname>Qasmieh</surname><given-names>SA</given-names></name><name><surname>Kulkarni</surname><given-names>SG</given-names></name><name><surname>Teasdale</surname><given-names>CA</given-names></name><name><surname>Jones</surname><given-names>H</given-names></name><name><surname>McNairy</surname><given-names>M</given-names></name><name><surname>Borrell</surname><given-names>LN</given-names></name><name><surname>Nash</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The epidemiology of long COVID in US adults</article-title><source>Clinical Infectious Diseases</source><volume>1</volume><elocation-id>ciac961</elocation-id><pub-id pub-id-type="doi">10.1093/cid/ciac961</pub-id><pub-id pub-id-type="pmid">36542514</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronco</surname><given-names>C</given-names></name><name><surname>Reis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Kidney involvement in COVID-19 and rationale for extracorporeal therapies</article-title><source>Nature Reviews.Nephrology</source><volume>16</volume><fpage>308</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1038/s41581-020-0284-7</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossier</surname><given-names>BC</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Devuyst</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The hypertension pandemic: an evolutionary perspective</article-title><source>Physiology</source><volume>32</volume><fpage>112</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1152/physiol.00026.2016</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubino</surname><given-names>F</given-names></name><name><surname>Amiel</surname><given-names>SA</given-names></name><name><surname>et</surname><given-names>P</given-names></name><name><surname>Alberti</surname><given-names>G</given-names></name><name><surname>Bornstein</surname><given-names>S</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Mingrone</surname><given-names>G</given-names></name><name><surname>Boehm</surname><given-names>B</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Chai</surname><given-names>Z</given-names></name><name><surname>Del Prato</surname><given-names>S</given-names></name><name><surname>Ji</surname><given-names>L</given-names></name><name><surname>Hopkins</surname><given-names>D</given-names></name><name><surname>Herman</surname><given-names>WH</given-names></name><name><surname>Khunti</surname><given-names>K</given-names></name><name><surname>Mbanya</surname><given-names>JC</given-names></name><name><surname>Renard</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>New-onset diabetes in covid-19</article-title><source>The New England Journal of Medicine</source><volume>383</volume><fpage>789</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2018688</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabroe</surname><given-names>I</given-names></name><name><surname>Parker</surname><given-names>LC</given-names></name><name><surname>Dower</surname><given-names>SK</given-names></name><name><surname>Whyte</surname><given-names>MKB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The role of TLR activation in inflammation</article-title><source>The Journal of Pathology</source><volume>214</volume><fpage>126</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1002/path.2264</pub-id><pub-id pub-id-type="pmid">18161748</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadanandam</surname><given-names>A</given-names></name><name><surname>Bopp</surname><given-names>T</given-names></name><name><surname>Dixit</surname><given-names>S</given-names></name><name><surname>Knapp</surname><given-names>D</given-names></name><name><surname>Emperumal</surname><given-names>CP</given-names></name><name><surname>Vergidis</surname><given-names>P</given-names></name><name><surname>Rajalingam</surname><given-names>K</given-names></name><name><surname>Melcher</surname><given-names>A</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients</article-title><source>Cell Death Discovery</source><volume>6</volume><elocation-id>141</elocation-id><pub-id pub-id-type="doi">10.1038/s41420-020-00376-x</pub-id><pub-id pub-id-type="pmid">33293514</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname><given-names>BE</given-names></name><name><surname>Celikbilek</surname><given-names>A</given-names></name><name><surname>Kocak</surname><given-names>Y</given-names></name><name><surname>Saltoglu</surname><given-names>GT</given-names></name><name><surname>Konar</surname><given-names>NM</given-names></name><name><surname>Hizmali</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms</article-title><source>Journal of the Neurological Sciences</source><volume>439</volume><elocation-id>120324</elocation-id><pub-id pub-id-type="doi">10.1016/j.jns.2022.120324</pub-id><pub-id pub-id-type="pmid">35752131</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakr</surname><given-names>Y</given-names></name><name><surname>Giovini</surname><given-names>M</given-names></name><name><surname>Leone</surname><given-names>M</given-names></name><name><surname>Pizzilli</surname><given-names>G</given-names></name><name><surname>Kortgen</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Tonetti</surname><given-names>T</given-names></name><name><surname>Duclos</surname><given-names>G</given-names></name><name><surname>Zieleskiewicz</surname><given-names>L</given-names></name><name><surname>Buschbeck</surname><given-names>S</given-names></name><name><surname>Ranieri</surname><given-names>VM</given-names></name><name><surname>Antonucci</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review</article-title><source>Annals of Intensive Care</source><volume>10</volume><elocation-id>124</elocation-id><pub-id pub-id-type="doi">10.1186/s13613-020-00741-0</pub-id><pub-id pub-id-type="pmid">32953201</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>A</given-names></name><name><surname>Magro</surname><given-names>DO</given-names></name><name><surname>Evangelista-Poderoso</surname><given-names>R</given-names></name><name><surname>Saad</surname><given-names>MJA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications</article-title><source>Diabetology &amp; Metabolic Syndrome</source><volume>13</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1186/s13098-021-00639-2</pub-id><pub-id pub-id-type="pmid">33648564</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathish</surname><given-names>T</given-names></name><name><surname>Anton</surname><given-names>MC</given-names></name><name><surname>Sivakumar</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>New-onset diabetes in “long COVID.”</article-title><source>Journal of Diabetes</source><volume>13</volume><fpage>693</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.13187</pub-id><pub-id pub-id-type="pmid">33893710</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathish</surname><given-names>T</given-names></name><name><surname>Chandrika Anton</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Newly diagnosed diabetes in patients with mild to moderate COVID-19</article-title><source>Diabetes &amp; Metabolic Syndrome</source><volume>15</volume><fpage>569</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2021.02.034</pub-id><pub-id pub-id-type="pmid">33706188</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathish</surname><given-names>T</given-names></name><name><surname>Kapoor</surname><given-names>N</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Tapp</surname><given-names>RJ</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021c</year><article-title>Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis</article-title><source>Diabetes, Obesity &amp; Metabolism</source><volume>23</volume><fpage>870</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1111/dom.14269</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherbakov</surname><given-names>N</given-names></name><name><surname>Szklarski</surname><given-names>M</given-names></name><name><surname>Hartwig</surname><given-names>J</given-names></name><name><surname>Sotzny</surname><given-names>F</given-names></name><name><surname>Lorenz</surname><given-names>S</given-names></name><name><surname>Meyer</surname><given-names>A</given-names></name><name><surname>Grabowski</surname><given-names>P</given-names></name><name><surname>Doehner</surname><given-names>W</given-names></name><name><surname>Scheibenbogen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome</article-title><source>ESC Heart Failure</source><volume>7</volume><fpage>1064</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1002/ehf2.12633</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schieffer</surname><given-names>E</given-names></name><name><surname>Schieffer</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The rationale for the treatment of long-covid symptoms - A cardiologist’s view</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>9</volume><elocation-id>992686</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2022.992686</pub-id><pub-id pub-id-type="pmid">36186977</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultheiss</surname><given-names>C</given-names></name><name><surname>Willscher</surname><given-names>E</given-names></name><name><surname>Paschold</surname><given-names>L</given-names></name><name><surname>Gottschick</surname><given-names>C</given-names></name><name><surname>Klee</surname><given-names>B</given-names></name><name><surname>Henkes</surname><given-names>SS</given-names></name><name><surname>Bosurgi</surname><given-names>L</given-names></name><name><surname>Dutzmann</surname><given-names>J</given-names></name><name><surname>Sedding</surname><given-names>D</given-names></name><name><surname>Frese</surname><given-names>T</given-names></name><name><surname>Girndt</surname><given-names>M</given-names></name><name><surname>Höll</surname><given-names>JI</given-names></name><name><surname>Gekle</surname><given-names>M</given-names></name><name><surname>Mikolajczyk</surname><given-names>R</given-names></name><name><surname>Binder</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19</article-title><source>Cell Reports. Medicine</source><volume>3</volume><elocation-id>100663</elocation-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100663</pub-id><pub-id pub-id-type="pmid">35732153</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sestan</surname><given-names>M</given-names></name><name><surname>Marinović</surname><given-names>S</given-names></name><name><surname>Kavazović</surname><given-names>I</given-names></name><name><surname>Cekinović</surname><given-names>Đ</given-names></name><name><surname>Wueest</surname><given-names>S</given-names></name><name><surname>Turk Wensveen</surname><given-names>T</given-names></name><name><surname>Brizić</surname><given-names>I</given-names></name><name><surname>Jonjić</surname><given-names>S</given-names></name><name><surname>Konrad</surname><given-names>D</given-names></name><name><surname>Wensveen</surname><given-names>FM</given-names></name><name><surname>Polić</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity</article-title><source>Immunity</source><volume>49</volume><fpage>164</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.05.005</pub-id><pub-id pub-id-type="pmid">29958802</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settanni</surname><given-names>CR</given-names></name><name><surname>Ianiro</surname><given-names>G</given-names></name><name><surname>Ponziani</surname><given-names>FR</given-names></name><name><surname>Bibbò</surname><given-names>S</given-names></name><name><surname>Segal</surname><given-names>JP</given-names></name><name><surname>Cammarota</surname><given-names>G</given-names></name><name><surname>Gasbarrini</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanisms</article-title><source>World Journal of Gastroenterology</source><volume>27</volume><fpage>7433</fpage><lpage>7445</lpage><pub-id pub-id-type="doi">10.3748/wjg.v27.i43.7433</pub-id><pub-id pub-id-type="pmid">34887641</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>BH</given-names></name><name><surname>Stiles</surname><given-names>LE</given-names></name><name><surname>Bourne</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>EA</given-names></name><name><surname>Shibao</surname><given-names>CA</given-names></name><name><surname>Okamoto</surname><given-names>LE</given-names></name><name><surname>Garland</surname><given-names>EM</given-names></name><name><surname>Gamboa</surname><given-names>A</given-names></name><name><surname>Diedrich</surname><given-names>A</given-names></name><name><surname>Raj</surname><given-names>V</given-names></name><name><surname>Sheldon</surname><given-names>RS</given-names></name><name><surname>Biaggioni</surname><given-names>I</given-names></name><name><surname>Robertson</surname><given-names>D</given-names></name><name><surname>Raj</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The face of postural tachycardia syndrome-insights from a large cross-sectional online community-based survey</article-title><source>Journal of Internal Medicine</source><volume>286</volume><fpage>438</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1111/joim.12895</pub-id><pub-id pub-id-type="pmid">30861229</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, china</article-title><source>JAMA Cardiology</source><volume>5</volume><fpage>802</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2020.0950</pub-id><pub-id pub-id-type="pmid">32211816</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Toyoda</surname><given-names>S</given-names></name><name><surname>Nishitani</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Kita</surname><given-names>S</given-names></name><name><surname>Fukuhara</surname><given-names>A</given-names></name><name><surname>Shimomura</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SARS-cov-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1</article-title><source>Metabolism</source><volume>133</volume><elocation-id>155236</elocation-id><pub-id pub-id-type="doi">10.1016/j.metabol.2022.155236</pub-id><pub-id pub-id-type="pmid">35688210</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidarta-Oliveira</surname><given-names>D</given-names></name><name><surname>Jara</surname><given-names>CP</given-names></name><name><surname>Ferruzzi</surname><given-names>AJ</given-names></name><name><surname>Skaf</surname><given-names>MS</given-names></name><name><surname>Velander</surname><given-names>WH</given-names></name><name><surname>Araujo</surname><given-names>EP</given-names></name><name><surname>Velloso</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-cov-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>19522</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-76488-2</pub-id><pub-id pub-id-type="pmid">33177594</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva Andrade</surname><given-names>B</given-names></name><name><surname>Siqueira</surname><given-names>S</given-names></name><name><surname>de Assis Soares</surname><given-names>WR</given-names></name><name><surname>de Souza Rangel</surname><given-names>F</given-names></name><name><surname>Santos</surname><given-names>NO</given-names></name><name><surname>Dos Santos Freitas</surname><given-names>A</given-names></name><name><surname>Ribeiro da Silveira</surname><given-names>P</given-names></name><name><surname>Tiwari</surname><given-names>S</given-names></name><name><surname>Alzahrani</surname><given-names>KJ</given-names></name><name><surname>Góes-Neto</surname><given-names>A</given-names></name><name><surname>Azevedo</surname><given-names>V</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Barh</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms</article-title><source>Viruses</source><volume>13</volume><elocation-id>700</elocation-id><pub-id pub-id-type="doi">10.3390/v13040700</pub-id><pub-id pub-id-type="pmid">33919537</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sneller</surname><given-names>MC</given-names></name><name><surname>Liang</surname><given-names>CJ</given-names></name><name><surname>Marques</surname><given-names>AR</given-names></name><name><surname>Chung</surname><given-names>JY</given-names></name><name><surname>Shanbhag</surname><given-names>SM</given-names></name><name><surname>Fontana</surname><given-names>JR</given-names></name><name><surname>Raza</surname><given-names>H</given-names></name><name><surname>Okeke</surname><given-names>O</given-names></name><name><surname>Dewar</surname><given-names>RL</given-names></name><name><surname>Higgins</surname><given-names>BP</given-names></name><name><surname>Tolstenko</surname><given-names>K</given-names></name><name><surname>Kwan</surname><given-names>RW</given-names></name><name><surname>Gittens</surname><given-names>KR</given-names></name><name><surname>Seamon</surname><given-names>CA</given-names></name><name><surname>McCormack</surname><given-names>G</given-names></name><name><surname>Shaw</surname><given-names>JS</given-names></name><name><surname>Okpali</surname><given-names>GM</given-names></name><name><surname>Law</surname><given-names>M</given-names></name><name><surname>Trihemasava</surname><given-names>K</given-names></name><name><surname>Kennedy</surname><given-names>BD</given-names></name><name><surname>Shi</surname><given-names>V</given-names></name><name><surname>Justement</surname><given-names>JS</given-names></name><name><surname>Buckner</surname><given-names>CM</given-names></name><name><surname>Blazkova</surname><given-names>J</given-names></name><name><surname>Moir</surname><given-names>S</given-names></name><name><surname>Chun</surname><given-names>T-W</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A longitudinal study of COVID-19 sequelae and immunity: baseline findings</article-title><source>Annals of Internal Medicine</source><volume>175</volume><fpage>969</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.7326/M21-4905</pub-id><pub-id pub-id-type="pmid">35605238</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Israelow</surname><given-names>B</given-names></name><name><surname>Lu-Culligan</surname><given-names>A</given-names></name><name><surname>Prado</surname><given-names>AV</given-names></name><name><surname>Skriabine</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Weizman</surname><given-names>OE</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Szigeti-Buck</surname><given-names>K</given-names></name><name><surname>Yasumoto</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Castaldi</surname><given-names>C</given-names></name><name><surname>Heltke</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>E</given-names></name><name><surname>Wheeler</surname><given-names>J</given-names></name><name><surname>Alfajaro</surname><given-names>MM</given-names></name><name><surname>Levavasseur</surname><given-names>E</given-names></name><name><surname>Fontes</surname><given-names>B</given-names></name><name><surname>Ravindra</surname><given-names>NG</given-names></name><name><surname>Van Dijk</surname><given-names>D</given-names></name><name><surname>Mane</surname><given-names>S</given-names></name><name><surname>Gunel</surname><given-names>M</given-names></name><name><surname>Ring</surname><given-names>A</given-names></name><name><surname>Kazmi</surname><given-names>SAJ</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Wilen</surname><given-names>CB</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Plu</surname><given-names>I</given-names></name><name><surname>Haik</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>JL</given-names></name><name><surname>Louvi</surname><given-names>A</given-names></name><name><surname>Farhadian</surname><given-names>SF</given-names></name><name><surname>Huttner</surname><given-names>A</given-names></name><name><surname>Seilhean</surname><given-names>D</given-names></name><name><surname>Renier</surname><given-names>N</given-names></name><name><surname>Bilguvar</surname><given-names>K</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuroinvasion of Sars-Cov-2 in Human and Mouse Brain</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.25.169946</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>WJ</given-names></name><name><surname>Hui</surname><given-names>CKM</given-names></name><name><surname>Hull</surname><given-names>JH</given-names></name><name><surname>Birring</surname><given-names>SS</given-names></name><name><surname>McGarvey</surname><given-names>L</given-names></name><name><surname>Mazzone</surname><given-names>SB</given-names></name><name><surname>Chung</surname><given-names>KF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses</article-title><source>The Lancet. Respiratory Medicine</source><volume>9</volume><fpage>533</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(21)00125-9</pub-id><pub-id pub-id-type="pmid">33857435</pub-id></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotzny</surname><given-names>F</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Capelli</surname><given-names>E</given-names></name><name><surname>Castro-Marrero</surname><given-names>J</given-names></name><name><surname>Steiner</surname><given-names>S</given-names></name><name><surname>Murovska</surname><given-names>M</given-names></name><name><surname>Scheibenbogen</surname><given-names>C</given-names></name><collab>European Network on ME/CFS EUROMENE</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Myalgic Encephalomyelitis/Chronic fatigue syndrome-evidence for an autoimmune disease</article-title><source>Autoimmunity Reviews</source><volume>17</volume><fpage>601</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2018.01.009</pub-id><pub-id pub-id-type="pmid">29635081</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefano</surname><given-names>GB</given-names></name><name><surname>Büttiker</surname><given-names>P</given-names></name><name><surname>Weissenberger</surname><given-names>S</given-names></name><name><surname>Ptacek</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Esch</surname><given-names>T</given-names></name><name><surname>Bilfinger</surname><given-names>TV</given-names></name><name><surname>Raboch</surname><given-names>J</given-names></name><name><surname>Kream</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Biomedical perspectives of acute and chronic neurological and neuropsychiatric sequelae of COVID-19</article-title><source>Current Neuropharmacology</source><volume>20</volume><fpage>1229</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.2174/1570159X20666211223130228</pub-id><pub-id pub-id-type="pmid">34951387</pub-id></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>DG</given-names></name><name><surname>Ng</surname><given-names>RH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Kornilov</surname><given-names>SA</given-names></name><name><surname>Scherler</surname><given-names>K</given-names></name><name><surname>Pavlovitch-Bedzyk</surname><given-names>AJ</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Lausted</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Fallen</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>CL</given-names></name><name><surname>Baloni</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Duvvuri</surname><given-names>VR</given-names></name><name><surname>Anderson</surname><given-names>KG</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Duncombe</surname><given-names>CJ</given-names></name><name><surname>McCulloch</surname><given-names>DJ</given-names></name><name><surname>Rostomily</surname><given-names>C</given-names></name><name><surname>Troisch</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Mackay</surname><given-names>S</given-names></name><name><surname>DeGottardi</surname><given-names>Q</given-names></name><name><surname>May</surname><given-names>DH</given-names></name><name><surname>Taniguchi</surname><given-names>R</given-names></name><name><surname>Gittelman</surname><given-names>RM</given-names></name><name><surname>Klinger</surname><given-names>M</given-names></name><name><surname>Snyder</surname><given-names>TM</given-names></name><name><surname>Roper</surname><given-names>R</given-names></name><name><surname>Wojciechowska</surname><given-names>G</given-names></name><name><surname>Murray</surname><given-names>K</given-names></name><name><surname>Edmark</surname><given-names>R</given-names></name><name><surname>Evans</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Rowen</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Chour</surname><given-names>W</given-names></name><name><surname>Algren</surname><given-names>HA</given-names></name><name><surname>Berrington</surname><given-names>WR</given-names></name><name><surname>Wallick</surname><given-names>JA</given-names></name><name><surname>Cochran</surname><given-names>RA</given-names></name><name><surname>Micikas</surname><given-names>ME</given-names></name><collab>ISB-Swedish COVID-19 Biobanking Unit</collab><name><surname>Wrin</surname><given-names>T</given-names></name><name><surname>Petropoulos</surname><given-names>CJ</given-names></name><name><surname>Cole</surname><given-names>HR</given-names></name><name><surname>Fischer</surname><given-names>TD</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Hoon</surname><given-names>DSB</given-names></name><name><surname>Price</surname><given-names>ND</given-names></name><name><surname>Subramanian</surname><given-names>N</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name><name><surname>Hadlock</surname><given-names>J</given-names></name><name><surname>Magis</surname><given-names>AT</given-names></name><name><surname>Ribas</surname><given-names>A</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Boyd</surname><given-names>SD</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Chu</surname><given-names>H</given-names></name><name><surname>Hood</surname><given-names>L</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Greenberg</surname><given-names>PD</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Goldman</surname><given-names>JD</given-names></name><name><surname>Heath</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Multiple early factors anticipate post-acute COVID-19 sequelae</article-title><source>Cell</source><volume>185</volume><fpage>881</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.01.014</pub-id><pub-id pub-id-type="pmid">35216672</pub-id></element-citation></ref><ref id="bib191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Nirantharakumar</surname><given-names>K</given-names></name><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Myles</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Gokhale</surname><given-names>KM</given-names></name><name><surname>Taverner</surname><given-names>T</given-names></name><name><surname>Chandan</surname><given-names>JS</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Simms-Williams</surname><given-names>N</given-names></name><name><surname>Shah</surname><given-names>AD</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Kidy</surname><given-names>F</given-names></name><name><surname>Okoth</surname><given-names>K</given-names></name><name><surname>Hotham</surname><given-names>R</given-names></name><name><surname>Bashir</surname><given-names>N</given-names></name><name><surname>Cockburn</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>SI</given-names></name><name><surname>Turner</surname><given-names>GM</given-names></name><name><surname>Gkoutos</surname><given-names>GV</given-names></name><name><surname>Aiyegbusi</surname><given-names>OL</given-names></name><name><surname>McMullan</surname><given-names>C</given-names></name><name><surname>Denniston</surname><given-names>AK</given-names></name><name><surname>Sapey</surname><given-names>E</given-names></name><name><surname>Lord</surname><given-names>JM</given-names></name><name><surname>Wraith</surname><given-names>DC</given-names></name><name><surname>Leggett</surname><given-names>E</given-names></name><name><surname>Iles</surname><given-names>C</given-names></name><name><surname>Marshall</surname><given-names>T</given-names></name><name><surname>Price</surname><given-names>MJ</given-names></name><name><surname>Marwaha</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>EH</given-names></name><name><surname>Jackson</surname><given-names>LJ</given-names></name><name><surname>Matthews</surname><given-names>KL</given-names></name><name><surname>Camaradou</surname><given-names>J</given-names></name><name><surname>Calvert</surname><given-names>M</given-names></name><name><surname>Haroon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Symptoms and risk factors for long COVID in non-hospitalized adults</article-title><source>Nature Medicine</source><volume>28</volume><fpage>1706</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01909-w</pub-id><pub-id pub-id-type="pmid">35879616</pub-id></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudre</surname><given-names>CH</given-names></name><name><surname>Murray</surname><given-names>B</given-names></name><name><surname>Varsavsky</surname><given-names>T</given-names></name><name><surname>Graham</surname><given-names>MS</given-names></name><name><surname>Penfold</surname><given-names>RS</given-names></name><name><surname>Bowyer</surname><given-names>RC</given-names></name><name><surname>Pujol</surname><given-names>JC</given-names></name><name><surname>Klaser</surname><given-names>K</given-names></name><name><surname>Antonelli</surname><given-names>M</given-names></name><name><surname>Canas</surname><given-names>LS</given-names></name><name><surname>Molteni</surname><given-names>E</given-names></name><name><surname>Modat</surname><given-names>M</given-names></name><name><surname>Jorge Cardoso</surname><given-names>M</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Ganesh</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Nguyen</surname><given-names>LH</given-names></name><name><surname>Drew</surname><given-names>DA</given-names></name><name><surname>Astley</surname><given-names>CM</given-names></name><name><surname>Joshi</surname><given-names>AD</given-names></name><name><surname>Merino</surname><given-names>J</given-names></name><name><surname>Tsereteli</surname><given-names>N</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Gomez</surname><given-names>MF</given-names></name><name><surname>Duncan</surname><given-names>EL</given-names></name><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>FMK</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Chan</surname><given-names>AT</given-names></name><name><surname>Wolf</surname><given-names>J</given-names></name><name><surname>Ourselin</surname><given-names>S</given-names></name><name><surname>Spector</surname><given-names>T</given-names></name><name><surname>Steves</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Author correction: attributes and predictors of long COVID</article-title><source>Nature Medicine</source><volume>27</volume><elocation-id>1116</elocation-id><pub-id pub-id-type="doi">10.1038/s41591-021-01361-2</pub-id><pub-id pub-id-type="pmid">34045738</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sze</surname><given-names>S</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Ong</surname><given-names>CK</given-names></name><name><surname>Pareek</surname><given-names>M</given-names></name><name><surname>Squire</surname><given-names>IB</given-names></name><name><surname>Clark</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Overstimulation of the ergoreflex-A possible mechanism to explain symptoms in long COVID</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>9</volume><elocation-id>940832</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2022.940832</pub-id><pub-id pub-id-type="pmid">35911550</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanni</surname><given-names>SE</given-names></name><name><surname>Fabro</surname><given-names>AT</given-names></name><name><surname>de Albuquerque</surname><given-names>A</given-names></name><name><surname>Ferreira</surname><given-names>EVM</given-names></name><name><surname>Verrastro</surname><given-names>CGY</given-names></name><name><surname>Sawamura</surname><given-names>MVY</given-names></name><name><surname>Ribeiro</surname><given-names>SM</given-names></name><name><surname>Baldi</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pulmonary fibrosis secondary to COVID-19: a narrative review</article-title><source>Expert Review of Respiratory Medicine</source><volume>15</volume><fpage>791</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1080/17476348.2021.1916472</pub-id><pub-id pub-id-type="pmid">33902377</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tansey</surname><given-names>CM</given-names></name><name><surname>Louie</surname><given-names>M</given-names></name><name><surname>Loeb</surname><given-names>M</given-names></name><name><surname>Gold</surname><given-names>WL</given-names></name><name><surname>Muller</surname><given-names>MP</given-names></name><name><surname>de Jager</surname><given-names>J</given-names></name><name><surname>Cameron</surname><given-names>JI</given-names></name><name><surname>Tomlinson</surname><given-names>G</given-names></name><name><surname>Mazzulli</surname><given-names>T</given-names></name><name><surname>Walmsley</surname><given-names>SL</given-names></name><name><surname>Rachlis</surname><given-names>AR</given-names></name><name><surname>Mederski</surname><given-names>BD</given-names></name><name><surname>Silverman</surname><given-names>M</given-names></name><name><surname>Shainhouse</surname><given-names>Z</given-names></name><name><surname>Ephtimios</surname><given-names>IE</given-names></name><name><surname>Avendano</surname><given-names>M</given-names></name><name><surname>Downey</surname><given-names>J</given-names></name><name><surname>Styra</surname><given-names>R</given-names></name><name><surname>Yamamura</surname><given-names>D</given-names></name><name><surname>Gerson</surname><given-names>M</given-names></name><name><surname>Stanbrook</surname><given-names>MB</given-names></name><name><surname>Marras</surname><given-names>TK</given-names></name><name><surname>Phillips</surname><given-names>EJ</given-names></name><name><surname>Zamel</surname><given-names>N</given-names></name><name><surname>Richardson</surname><given-names>SE</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Herridge</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome</article-title><source>Archives of Internal Medicine</source><volume>167</volume><fpage>1312</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1001/archinte.167.12.1312</pub-id><pub-id pub-id-type="pmid">17592106</pub-id></element-citation></ref><ref id="bib196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarentino</surname><given-names>AL</given-names></name><name><surname>Maley</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>A comparison of the substrate specificities of endo-beta-N-acetylglucosaminidases from streptomyces griseus and diplococcus pneumoniae</article-title><source>Biochemical and Biophysical Research Communications</source><volume>67</volume><fpage>455</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/0006-291x(75)90337-x</pub-id><pub-id pub-id-type="pmid">1016</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>W</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Sweetman</surname><given-names>E</given-names></name><name><surname>Helliwell</surname><given-names>A</given-names></name><name><surname>Peppercorn</surname><given-names>K</given-names></name><name><surname>Edgar</surname><given-names>C</given-names></name><name><surname>Blair</surname><given-names>A</given-names></name><name><surname>Chatterjee</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses</article-title><source>Frontiers in Neurology</source><volume>13</volume><elocation-id>877772</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2022.877772</pub-id><pub-id pub-id-type="pmid">35693009</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>MZ</given-names></name><name><surname>Poh</surname><given-names>CM</given-names></name><name><surname>Rénia</surname><given-names>L</given-names></name><name><surname>MacAry</surname><given-names>PA</given-names></name><name><surname>Ng</surname><given-names>LFP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The trinity of COVID-19: immunity, inflammation and intervention</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0311-8</pub-id><pub-id pub-id-type="pmid">32346093</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tergaonkar</surname><given-names>V</given-names></name><name><surname>Correa</surname><given-names>RG</given-names></name><name><surname>Ikawa</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Distinct roles of ikappab proteins in regulating constitutive NF-kappab activity</article-title><source>Nature Cell Biology</source><volume>7</volume><fpage>921</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1038/ncb1296</pub-id><pub-id pub-id-type="pmid">16136188</pub-id></element-citation></ref><ref id="bib200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teuwen</surname><given-names>LA</given-names></name><name><surname>Geldhof</surname><given-names>V</given-names></name><name><surname>Pasut</surname><given-names>A</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19: the vasculature unleashed</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>389</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0343-0</pub-id><pub-id pub-id-type="pmid">32439870</pub-id></element-citation></ref><ref id="bib201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>EJ</given-names></name><name><surname>Williams</surname><given-names>DM</given-names></name><name><surname>Walker</surname><given-names>AJ</given-names></name><name><surname>Mitchell</surname><given-names>RE</given-names></name><name><surname>Niedzwiedz</surname><given-names>CL</given-names></name><name><surname>Yang</surname><given-names>TC</given-names></name><name><surname>Huggins</surname><given-names>CF</given-names></name><name><surname>Kwong</surname><given-names>ASF</given-names></name><name><surname>Silverwood</surname><given-names>RJ</given-names></name><name><surname>Di Gessa</surname><given-names>G</given-names></name><name><surname>Bowyer</surname><given-names>RCE</given-names></name><name><surname>Northstone</surname><given-names>K</given-names></name><name><surname>Hou</surname><given-names>B</given-names></name><name><surname>Green</surname><given-names>MJ</given-names></name><name><surname>Dodgeon</surname><given-names>B</given-names></name><name><surname>Doores</surname><given-names>KJ</given-names></name><name><surname>Duncan</surname><given-names>EL</given-names></name><name><surname>Williams</surname><given-names>FMK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>3528</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-30836-0</pub-id></element-citation></ref><ref id="bib202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tita</surname><given-names>AT</given-names></name><name><surname>Szychowski</surname><given-names>JM</given-names></name><name><surname>Boggess</surname><given-names>K</given-names></name><name><surname>Dugoff</surname><given-names>L</given-names></name><name><surname>Sibai</surname><given-names>B</given-names></name><name><surname>Lawrence</surname><given-names>K</given-names></name><name><surname>Hughes</surname><given-names>BL</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Aagaard</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>RK</given-names></name><name><surname>Gibson</surname><given-names>K</given-names></name><name><surname>Haas</surname><given-names>DM</given-names></name><name><surname>Plante</surname><given-names>L</given-names></name><name><surname>Metz</surname><given-names>T</given-names></name><name><surname>Casey</surname><given-names>B</given-names></name><name><surname>Esplin</surname><given-names>S</given-names></name><name><surname>Longo</surname><given-names>S</given-names></name><name><surname>Hoffman</surname><given-names>M</given-names></name><name><surname>Saade</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Treatment for mild chronic hypertension during pregnancy</article-title><source>The New England Journal of Medicine</source><volume>386</volume><fpage>1781</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2201295</pub-id></element-citation></ref><ref id="bib203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tittel</surname><given-names>SR</given-names></name><name><surname>Rosenbauer</surname><given-names>J</given-names></name><name><surname>Kamrath</surname><given-names>C</given-names></name><name><surname>Ziegler</surname><given-names>J</given-names></name><name><surname>Reschke</surname><given-names>F</given-names></name><name><surname>Hammersen</surname><given-names>J</given-names></name><name><surname>Monkemoller</surname><given-names>K</given-names></name><name><surname>Pappa</surname><given-names>A</given-names></name><name><surname>Kapellen</surname><given-names>T</given-names></name><name><surname>Holl</surname><given-names>RW</given-names></name><name><surname>Initiative</surname><given-names>DPV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in germany?</article-title><source>Diabetes Care</source><volume>43</volume><fpage>e172</fpage><lpage>e173</lpage><pub-id pub-id-type="doi">10.2337/dc20-1633</pub-id></element-citation></ref><ref id="bib204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toniolo</surname><given-names>S</given-names></name><name><surname>Scarioni</surname><given-names>M</given-names></name><name><surname>Di Lorenzo</surname><given-names>F</given-names></name><name><surname>Hort</surname><given-names>J</given-names></name><name><surname>Georges</surname><given-names>J</given-names></name><name><surname>Tomic</surname><given-names>S</given-names></name><name><surname>Nobili</surname><given-names>F</given-names></name><name><surname>Frederiksen</surname><given-names>KS</given-names></name><collab>Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care</article-title><source>Journal of Alzheimer’s Disease</source><volume>82</volume><fpage>883</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.3233/JAD-210335</pub-id><pub-id pub-id-type="pmid">34092646</pub-id></element-citation></ref><ref id="bib205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Totura</surname><given-names>AL</given-names></name><name><surname>Whitmore</surname><given-names>A</given-names></name><name><surname>Agnihothram</surname><given-names>S</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Katze</surname><given-names>MG</given-names></name><name><surname>Heise</surname><given-names>MT</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection</article-title><source>MBio</source><volume>6</volume><elocation-id>e00638</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00638-15</pub-id><pub-id pub-id-type="pmid">26015500</pub-id></element-citation></ref><ref id="bib206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Boyd</surname><given-names>MOE</given-names></name><name><surname>Guzik</surname><given-names>T</given-names></name><name><surname>Padmanabhan</surname><given-names>S</given-names></name><name><surname>McCallum</surname><given-names>L</given-names></name><name><surname>Delles</surname><given-names>C</given-names></name><name><surname>Mark</surname><given-names>PB</given-names></name><name><surname>Petrie</surname><given-names>JR</given-names></name><name><surname>Rios</surname><given-names>F</given-names></name><name><surname>Montezano</surname><given-names>AC</given-names></name><name><surname>Sykes</surname><given-names>R</given-names></name><name><surname>Berry</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cardiovascular and renal risk factors and complications associated with COVID-19</article-title><source>CJC Open</source><volume>3</volume><fpage>1257</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/j.cjco.2021.05.020</pub-id></element-citation></ref><ref id="bib207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>L</given-names></name><name><surname>Fogarty</surname><given-names>H</given-names></name><name><surname>Dyer</surname><given-names>A</given-names></name><name><surname>Martin-Loeches</surname><given-names>I</given-names></name><name><surname>Bannan</surname><given-names>C</given-names></name><name><surname>Nadarajan</surname><given-names>P</given-names></name><name><surname>Bergin</surname><given-names>C</given-names></name><name><surname>O’Farrelly</surname><given-names>C</given-names></name><name><surname>Conlon</surname><given-names>N</given-names></name><name><surname>Bourke</surname><given-names>NM</given-names></name><name><surname>Ward</surname><given-names>SE</given-names></name><name><surname>Byrne</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>K</given-names></name><name><surname>O’Connell</surname><given-names>N</given-names></name><name><surname>O’Sullivan</surname><given-names>JM</given-names></name><name><surname>Ni Cheallaigh</surname><given-names>C</given-names></name><name><surname>O’Donnell</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response</article-title><source>Journal of Thrombosis and Haemostasis: JTH</source><volume>19</volume><fpage>1064</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1111/jth.15267</pub-id></element-citation></ref><ref id="bib208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trasande</surname><given-names>L</given-names></name><name><surname>Zoeller</surname><given-names>RT</given-names></name><name><surname>Hass</surname><given-names>U</given-names></name><name><surname>Kortenkamp</surname><given-names>A</given-names></name><name><surname>Grandjean</surname><given-names>P</given-names></name><name><surname>Myers</surname><given-names>JP</given-names></name><name><surname>DiGangi</surname><given-names>J</given-names></name><name><surname>Hunt</surname><given-names>PM</given-names></name><name><surname>Rudel</surname><given-names>R</given-names></name><name><surname>Sathyanarayana</surname><given-names>S</given-names></name><name><surname>Bellanger</surname><given-names>M</given-names></name><name><surname>Hauser</surname><given-names>R</given-names></name><name><surname>Legler</surname><given-names>J</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Heindel</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Burden of disease and costs of exposure to endocrine disrupting chemicals in the european union: an updated analysis</article-title><source>Andrology</source><volume>4</volume><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1111/andr.12178</pub-id></element-citation></ref><ref id="bib209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trieu</surname><given-names>C</given-names></name><name><surname>Sunil</surname><given-names>B</given-names></name><name><surname>Ashraf</surname><given-names>AP</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><name><surname>Yarbrough</surname><given-names>A</given-names></name><name><surname>Pinninti</surname><given-names>S</given-names></name><name><surname>Boppana</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-cov-2 infection in hospitalized children with type 1 and type 2 diabetes</article-title><source>Journal of Clinical &amp; Translational Endocrinology</source><volume>26</volume><elocation-id>100271</elocation-id><pub-id pub-id-type="doi">10.1016/j.jcte.2021.100271</pub-id></element-citation></ref><ref id="bib210"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trimboli</surname><given-names>P</given-names></name><name><surname>Camponovo</surname><given-names>C</given-names></name><name><surname>Scappaticcio</surname><given-names>L</given-names></name><name><surname>Bellastella</surname><given-names>G</given-names></name><name><surname>Piccardo</surname><given-names>A</given-names></name><name><surname>Rotondi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Thyroid sequelae of COVID-19: A systematic review of reviews</article-title><source>Reviews in Endocrine &amp; Metabolic Disorders</source><volume>22</volume><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1007/s11154-021-09653-1</pub-id></element-citation></ref><ref id="bib211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unsworth</surname><given-names>R</given-names></name><name><surname>Wallace</surname><given-names>S</given-names></name><name><surname>Oliver</surname><given-names>NS</given-names></name><name><surname>Yeung</surname><given-names>S</given-names></name><name><surname>Kshirsagar</surname><given-names>A</given-names></name><name><surname>Naidu</surname><given-names>H</given-names></name><name><surname>Kwong</surname><given-names>RMW</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Logan</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>New-Onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K</article-title><source>Diabetes Care</source><volume>43</volume><fpage>e170</fpage><lpage>e171</lpage><pub-id pub-id-type="doi">10.2337/dc20-1551</pub-id><pub-id pub-id-type="pmid">32816997</pub-id></element-citation></ref><ref id="bib212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Campen</surname><given-names>CLMC</given-names></name><name><surname>Verheugt</surname><given-names>FWA</given-names></name><name><surname>Rowe</surname><given-names>PC</given-names></name><name><surname>Visser</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography</article-title><source>Clinical Neurophysiology Practice</source><volume>5</volume><fpage>50</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.cnp.2020.01.003</pub-id><pub-id pub-id-type="pmid">32140630</pub-id></element-citation></ref><ref id="bib213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanElzakker</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis</article-title><source>Medical Hypotheses</source><volume>81</volume><fpage>414</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/j.mehy.2013.05.034</pub-id><pub-id pub-id-type="pmid">23790471</pub-id></element-citation></ref><ref id="bib214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vella</surname><given-names>LA</given-names></name><name><surname>Giles</surname><given-names>JR</given-names></name><name><surname>Baxter</surname><given-names>AE</given-names></name><name><surname>Oldridge</surname><given-names>DA</given-names></name><name><surname>Diorio</surname><given-names>C</given-names></name><name><surname>Kuri-Cervantes</surname><given-names>L</given-names></name><name><surname>Alanio</surname><given-names>C</given-names></name><name><surname>Pampena</surname><given-names>MB</given-names></name><name><surname>Wu</surname><given-names>JE</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>YJ</given-names></name><name><surname>Anderson</surname><given-names>EM</given-names></name><name><surname>Gouma</surname><given-names>S</given-names></name><name><surname>McNerney</surname><given-names>KO</given-names></name><name><surname>Chase</surname><given-names>J</given-names></name><name><surname>Burudpakdee</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Apostolidis</surname><given-names>SA</given-names></name><name><surname>Huang</surname><given-names>AC</given-names></name><name><surname>Mathew</surname><given-names>D</given-names></name><name><surname>Kuthuru</surname><given-names>O</given-names></name><name><surname>Goodwin</surname><given-names>EC</given-names></name><name><surname>Weirick</surname><given-names>ME</given-names></name><name><surname>Bolton</surname><given-names>MJ</given-names></name><name><surname>Arevalo</surname><given-names>CP</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name><name><surname>Jasen</surname><given-names>CJ</given-names></name><name><surname>Conrey</surname><given-names>PE</given-names></name><name><surname>Sayed</surname><given-names>S</given-names></name><name><surname>Giannini</surname><given-names>HM</given-names></name><name><surname>D’Andrea</surname><given-names>K</given-names></name><name><surname>Meyer</surname><given-names>NJ</given-names></name><name><surname>Behrens</surname><given-names>EM</given-names></name><name><surname>Bassiri</surname><given-names>H</given-names></name><name><surname>Hensley</surname><given-names>SE</given-names></name><name><surname>Henrickson</surname><given-names>SE</given-names></name><name><surname>Teachey</surname><given-names>DT</given-names></name><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><collab>UPenn COVID Processing Unit</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19</article-title><source>Science Immunology</source><volume>6</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.abf7570</pub-id><pub-id pub-id-type="pmid">33653907</pub-id></element-citation></ref><ref id="bib215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vellanki</surname><given-names>P</given-names></name><collab>Umpierrez GE - Center ofDiabetes and Metabolism, Emory University School of Medicine</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Diabetic ketoacidosis risk during the COVID-19 pandemic</article-title><source>The Lancet. Diabetes &amp; Endocrinology</source><volume>9</volume><fpage>643</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(21)00241-2</pub-id><pub-id pub-id-type="pmid">34481553</pub-id></element-citation></ref><ref id="bib216"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdecchia</surname><given-names>P</given-names></name><name><surname>Reboldi</surname><given-names>G</given-names></name><name><surname>Cavallini</surname><given-names>C</given-names></name><name><surname>Mazzotta</surname><given-names>G</given-names></name><name><surname>Angeli</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus</article-title><source>Giornale Italiano Di Cardiologia</source><volume>21</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1714/3343.33127</pub-id><pub-id pub-id-type="pmid">32310915</pub-id></element-citation></ref><ref id="bib217"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallentin</surname><given-names>L</given-names></name><name><surname>Lindbäck</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>N</given-names></name><name><surname>Hijazi</surname><given-names>Z</given-names></name><name><surname>Eikelboom</surname><given-names>JW</given-names></name><name><surname>Ezekowitz</surname><given-names>MD</given-names></name><name><surname>Granger</surname><given-names>CB</given-names></name><name><surname>Lopes</surname><given-names>RD</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Oldgren</surname><given-names>J</given-names></name><name><surname>Siegbahn</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Angiotensin-Converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation</article-title><source>European Heart Journal</source><volume>41</volume><fpage>4037</fpage><lpage>4046</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehaa697</pub-id><pub-id pub-id-type="pmid">32984892</pub-id></element-citation></ref><ref id="bib218"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed</article-title><source>Diabetes Research and Clinical Practice</source><volume>162</volume><elocation-id>108118</elocation-id><pub-id pub-id-type="doi">10.1016/j.diabres.2020.108118</pub-id><pub-id pub-id-type="pmid">32179126</pub-id></element-citation></ref><ref id="bib219"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>EY</given-names></name><name><surname>Mao</surname><given-names>T</given-names></name><name><surname>Klein</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Huck</surname><given-names>JD</given-names></name><name><surname>Jaycox</surname><given-names>JR</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Israelow</surname><given-names>B</given-names></name><name><surname>Wong</surname><given-names>P</given-names></name><name><surname>Coppi</surname><given-names>A</given-names></name><name><surname>Lucas</surname><given-names>C</given-names></name><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>JE</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Perotti</surname><given-names>ES</given-names></name><name><surname>Zheng</surname><given-names>NS</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Campbell</surname><given-names>M</given-names></name><name><surname>Fournier</surname><given-names>JB</given-names></name><name><surname>Wyllie</surname><given-names>AL</given-names></name><name><surname>Vogels</surname><given-names>CBF</given-names></name><name><surname>Ott</surname><given-names>IM</given-names></name><name><surname>Kalinich</surname><given-names>CC</given-names></name><name><surname>Petrone</surname><given-names>ME</given-names></name><name><surname>Watkins</surname><given-names>AE</given-names></name><collab>Yale IMPACT Team</collab><name><surname>Dela Cruz</surname><given-names>C</given-names></name><name><surname>Farhadian</surname><given-names>SF</given-names></name><name><surname>Schulz</surname><given-names>WL</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Grubaugh</surname><given-names>ND</given-names></name><name><surname>Ko</surname><given-names>AI</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name><name><surname>Ring</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diverse functional autoantibodies in patients with COVID-19</article-title><source>Nature</source><volume>595</volume><fpage>283</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03631-y</pub-id><pub-id pub-id-type="pmid">34010947</pub-id></element-citation></ref><ref id="bib220"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Diabetes risk rises after COVID, massive study finds</article-title><source>Nature</source><volume>1</volume><elocation-id>e912</elocation-id><pub-id pub-id-type="doi">10.1038/d41586-022-00912-y</pub-id><pub-id pub-id-type="pmid">35361939</pub-id></element-citation></ref><ref id="bib221"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>AB</given-names></name><name><surname>Carr</surname><given-names>MR</given-names></name><name><surname>Rigsby</surname><given-names>CK</given-names></name><name><surname>Rychlik</surname><given-names>K</given-names></name><name><surname>Rowley</surname><given-names>AH</given-names></name><name><surname>Robinson</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study</article-title><source>Journal of Cardiovascular Magnetic Resonance</source><volume>23</volume><elocation-id>86</elocation-id><pub-id pub-id-type="doi">10.1186/s12968-021-00786-5</pub-id><pub-id pub-id-type="pmid">34193197</pub-id></element-citation></ref><ref id="bib222"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>CH</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Peh</surname><given-names>SC</given-names></name><name><surname>Korteweg</surname><given-names>C</given-names></name><name><surname>McNutt</surname><given-names>MA</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pathology of the thyroid in severe acute respiratory syndrome</article-title><source>Human Pathology</source><volume>38</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.humpath.2006.06.011</pub-id><pub-id pub-id-type="pmid">16996569</pub-id></element-citation></ref><ref id="bib223"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisberg</surname><given-names>SP</given-names></name><name><surname>Connors</surname><given-names>TJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Baldwin</surname><given-names>MR</given-names></name><name><surname>Lin</surname><given-names>W-H</given-names></name><name><surname>Wontakal</surname><given-names>S</given-names></name><name><surname>Szabo</surname><given-names>PA</given-names></name><name><surname>Wells</surname><given-names>SB</given-names></name><name><surname>Dogra</surname><given-names>P</given-names></name><name><surname>Gray</surname><given-names>J</given-names></name><name><surname>Idzikowski</surname><given-names>E</given-names></name><name><surname>Stelitano</surname><given-names>D</given-names></name><name><surname>Bovier</surname><given-names>FT</given-names></name><name><surname>Davis-Porada</surname><given-names>J</given-names></name><name><surname>Matsumoto</surname><given-names>R</given-names></name><name><surname>Poon</surname><given-names>MML</given-names></name><name><surname>Chait</surname><given-names>M</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Horvat</surname><given-names>B</given-names></name><name><surname>Decimo</surname><given-names>D</given-names></name><name><surname>Hudson</surname><given-names>KE</given-names></name><name><surname>Zotti</surname><given-names>FD</given-names></name><name><surname>Bitan</surname><given-names>ZC</given-names></name><name><surname>La Carpia</surname><given-names>F</given-names></name><name><surname>Ferrara</surname><given-names>SA</given-names></name><name><surname>Mace</surname><given-names>E</given-names></name><name><surname>Milner</surname><given-names>J</given-names></name><name><surname>Moscona</surname><given-names>A</given-names></name><name><surname>Hod</surname><given-names>E</given-names></name><name><surname>Porotto</surname><given-names>M</given-names></name><name><surname>Farber</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Distinct antibody responses to SARS-cov-2 in children and adults across the COVID-19 clinical spectrum</article-title><source>Nature Immunology</source><volume>22</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-00826-9</pub-id><pub-id pub-id-type="pmid">33154590</pub-id></element-citation></ref><ref id="bib224"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wirth</surname><given-names>KJ</given-names></name><name><surname>Scheibenbogen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</article-title><source>Journal of Translational Medicine</source><volume>19</volume><elocation-id>162</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-021-02833-2</pub-id><pub-id pub-id-type="pmid">33882940</pub-id></element-citation></ref><ref id="bib225"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SW</given-names></name><name><surname>Fan</surname><given-names>BE</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Chia</surname><given-names>YW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>St-Segment elevation myocardial infarction in post-COVID-19 patients: a case series</article-title><source>Annals of the Academy of Medicine, Singapore</source><volume>50</volume><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.47102/annals-acadmedsg.202175</pub-id><pub-id pub-id-type="pmid">34100519</pub-id></element-citation></ref><ref id="bib226"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wostyn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 and chronic fatigue syndrome: is the worst yet to come?</article-title><source>Medical Hypotheses</source><volume>146</volume><elocation-id>110469</elocation-id><pub-id pub-id-type="doi">10.1016/j.mehy.2020.110469</pub-id><pub-id pub-id-type="pmid">33401106</pub-id></element-citation></ref><ref id="bib227"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>XO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Th17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib</article-title><source>Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi</source><volume>53</volume><fpage>368</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2020.03.005</pub-id><pub-id pub-id-type="pmid">32205092</pub-id></element-citation></ref><ref id="bib228"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RNA-GPS Predicts SARS-Cov-2 RNA Localization to Host Mitochondria and Nucleolus</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.04.28.065201</pub-id></element-citation></ref><ref id="bib229"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Coumoul</surname><given-names>X</given-names></name><name><surname>Grandjean</surname><given-names>P</given-names></name><name><surname>Barouki</surname><given-names>R</given-names></name><name><surname>Audouze</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach</article-title><source>Environment International</source><volume>157</volume><elocation-id>106232</elocation-id><pub-id pub-id-type="doi">10.1016/j.envint.2020.106232</pub-id><pub-id pub-id-type="pmid">33223326</pub-id></element-citation></ref><ref id="bib230"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Bowe</surname><given-names>B</given-names></name><name><surname>Al-Aly</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>6571</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26513-3</pub-id><pub-id pub-id-type="pmid">34772922</pub-id></element-citation></ref><ref id="bib231"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>T</given-names></name><name><surname>Al-Aly</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Nirmatrelvir and the risk of post-acute sequelae of COVID-19</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2022.11.03.22281783</pub-id></element-citation></ref><ref id="bib232"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaméogo</surname><given-names>NV</given-names></name><name><surname>Mbaye</surname><given-names>A</given-names></name><name><surname>Kagambèga</surname><given-names>LJ</given-names></name><name><surname>Diack</surname><given-names>B</given-names></name><name><surname>Pessinaba</surname><given-names>S</given-names></name><name><surname>Hakim</surname><given-names>R</given-names></name><name><surname>Ndiaye</surname><given-names>MB</given-names></name><name><surname>Bodian</surname><given-names>M</given-names></name><name><surname>Diao</surname><given-names>M</given-names></name><name><surname>Sow</surname><given-names>DD</given-names></name><name><surname>Kane</surname><given-names>M</given-names></name><name><surname>Kane</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pulmonary embolism mimicking acute anterior myocardial infarction: diagnostic trap</article-title><source>Annales de Cardiologie et D’angeiologie</source><volume>60</volume><fpage>169</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.ancard.2010.12.011</pub-id><pub-id pub-id-type="pmid">21272851</pub-id></element-citation></ref><ref id="bib233"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The pathogenesis and treatment of the ` cytokine stor’' in COVID-19</article-title><source>The Journal of Infection</source><volume>80</volume><fpage>607</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.037</pub-id><pub-id pub-id-type="pmid">32283152</pub-id></element-citation></ref><ref id="bib234"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments</article-title><source>Infectious Diseases</source><volume>53</volume><fpage>737</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1080/23744235.2021.1924397</pub-id><pub-id pub-id-type="pmid">34024217</pub-id></element-citation></ref><ref id="bib235"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonker</surname><given-names>LM</given-names></name><name><surname>Gilboa</surname><given-names>T</given-names></name><name><surname>Ogata</surname><given-names>AF</given-names></name><name><surname>Senussi</surname><given-names>Y</given-names></name><name><surname>Lazarovits</surname><given-names>R</given-names></name><name><surname>Boribong</surname><given-names>BP</given-names></name><name><surname>Bartsch</surname><given-names>YC</given-names></name><name><surname>Loiselle</surname><given-names>M</given-names></name><name><surname>Rivas</surname><given-names>MN</given-names></name><name><surname>Porritt</surname><given-names>RA</given-names></name><name><surname>Lima</surname><given-names>R</given-names></name><name><surname>Davis</surname><given-names>JP</given-names></name><name><surname>Farkas</surname><given-names>EJ</given-names></name><name><surname>Burns</surname><given-names>MD</given-names></name><name><surname>Young</surname><given-names>N</given-names></name><name><surname>Mahajan</surname><given-names>VS</given-names></name><name><surname>Hajizadeh</surname><given-names>S</given-names></name><name><surname>Lopez</surname><given-names>XIH</given-names></name><name><surname>Kreuzer</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name><name><surname>Martinez</surname><given-names>EE</given-names></name><name><surname>Han</surname><given-names>I</given-names></name><name><surname>Griswold</surname><given-names>K</given-names><suffix>Jr</suffix></name><name><surname>Barry</surname><given-names>NC</given-names></name><name><surname>Thompson</surname><given-names>DB</given-names></name><name><surname>Church</surname><given-names>G</given-names></name><name><surname>Edlow</surname><given-names>AG</given-names></name><name><surname>Haas</surname><given-names>W</given-names></name><name><surname>Pillai</surname><given-names>S</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name><name><surname>Alter</surname><given-names>G</given-names></name><name><surname>Walt</surname><given-names>DR</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e149633</elocation-id><pub-id pub-id-type="doi">10.1172/JCI149633</pub-id><pub-id pub-id-type="pmid">34032635</pub-id></element-citation></ref><ref id="bib236"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Worlock</surname><given-names>KB</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Lindeboom</surname><given-names>RGH</given-names></name><name><surname>Butler</surname><given-names>CR</given-names></name><name><surname>Kumasaka</surname><given-names>N</given-names></name><name><surname>Dominguez Conde</surname><given-names>C</given-names></name><name><surname>Mamanova</surname><given-names>L</given-names></name><name><surname>Bolt</surname><given-names>L</given-names></name><name><surname>Richardson</surname><given-names>L</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Madissoon</surname><given-names>E</given-names></name><name><surname>Barnes</surname><given-names>JL</given-names></name><name><surname>Allen-Hyttinen</surname><given-names>J</given-names></name><name><surname>Kilich</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>BC</given-names></name><name><surname>de Wilton</surname><given-names>A</given-names></name><name><surname>Wilbrey-Clark</surname><given-names>A</given-names></name><name><surname>Sungnak</surname><given-names>W</given-names></name><name><surname>Pett</surname><given-names>JP</given-names></name><name><surname>Weller</surname><given-names>J</given-names></name><name><surname>Prigmore</surname><given-names>E</given-names></name><name><surname>Yung</surname><given-names>H</given-names></name><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>Saleh</surname><given-names>A</given-names></name><name><surname>Saigal</surname><given-names>A</given-names></name><name><surname>Chu</surname><given-names>V</given-names></name><name><surname>Cohen</surname><given-names>JM</given-names></name><name><surname>Cane</surname><given-names>C</given-names></name><name><surname>Iordanidou</surname><given-names>A</given-names></name><name><surname>Shibuya</surname><given-names>S</given-names></name><name><surname>Reuschl</surname><given-names>A-K</given-names></name><name><surname>Herczeg</surname><given-names>IT</given-names></name><name><surname>Argento</surname><given-names>AC</given-names></name><name><surname>Wunderink</surname><given-names>RG</given-names></name><name><surname>Smith</surname><given-names>SB</given-names></name><name><surname>Poor</surname><given-names>TA</given-names></name><name><surname>Gao</surname><given-names>CA</given-names></name><name><surname>Dematte</surname><given-names>JE</given-names></name><collab>NU SCRIPT Study Investigators</collab><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>Bowyer</surname><given-names>GS</given-names></name><name><surname>Coates</surname><given-names>M</given-names></name><name><surname>Clatworthy</surname><given-names>MR</given-names></name><name><surname>Calero-Nieto</surname><given-names>FJ</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>O’Callaghan</surname><given-names>C</given-names></name><name><surname>Sebire</surname><given-names>NJ</given-names></name><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>De Coppi</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>CM</given-names></name><name><surname>Misharin</surname><given-names>AV</given-names></name><name><surname>Janes</surname><given-names>SM</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Nikolić</surname><given-names>MZ</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Local and systemic responses to SARS-cov-2 infection in children and adults</article-title><source>Nature</source><volume>602</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04345-x</pub-id><pub-id pub-id-type="pmid">34937051</pub-id></element-citation></ref><ref id="bib237"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousif</surname><given-names>E</given-names></name><name><surname>Premraj</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A review of long COVID with a special focus on its cardiovascular manifestations</article-title><source>Cureus</source><volume>14</volume><elocation-id>e31933</elocation-id><pub-id pub-id-type="doi">10.7759/cureus.31933</pub-id><pub-id pub-id-type="pmid">36582565</pub-id></element-citation></ref><ref id="bib238"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zachariah</surname><given-names>U</given-names></name><name><surname>Nair</surname><given-names>SC</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Balasubramanian</surname><given-names>KA</given-names></name><name><surname>Mackie</surname><given-names>I</given-names></name><name><surname>Elias</surname><given-names>E</given-names></name><name><surname>Eapen</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting raised von willebrand factor levels and macrophage activation in severe COVID-19: consider low volume plasma exchange and low dose steroid</article-title><source>Thrombosis Research</source><volume>192</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1016/j.thromres.2020.05.001</pub-id><pub-id pub-id-type="pmid">32403033</pub-id></element-citation></ref><ref id="bib239"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zha</surname><given-names>D</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Vascular endothelial glycocalyx damage and potential targeted therapy in COVID-19</article-title><source>Cells</source><volume>11</volume><elocation-id>1972</elocation-id><pub-id pub-id-type="doi">10.3390/cells11121972</pub-id><pub-id pub-id-type="pmid">35741101</pub-id></element-citation></ref><ref id="bib240"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>JW</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>GQ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality</article-title><source>International Journal of Antimicrobial Agents</source><volume>55</volume><elocation-id>105954</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105954</pub-id><pub-id pub-id-type="pmid">32234467</pub-id></element-citation></ref><ref id="bib241"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nlrp3 inflammasome-A key player in antiviral responses</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>211</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00211</pub-id><pub-id pub-id-type="pmid">32133002</pub-id></element-citation></ref><ref id="bib242"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>R</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Xiang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Tu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title><source>The Lancet</source><volume>395</volume><fpage>1054</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30566-3</pub-id></element-citation></ref><ref id="bib243"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zisis</surname><given-names>SN</given-names></name><name><surname>Durieux</surname><given-names>JC</given-names></name><name><surname>Mouchati</surname><given-names>C</given-names></name><name><surname>Perez</surname><given-names>JA</given-names></name><name><surname>McComsey</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: A multicenter study from A large national health research network</article-title><source>Open Forum Infectious Diseases</source><volume>9</volume><elocation-id>fac228</elocation-id><pub-id pub-id-type="doi">10.1093/ofid/ofac228</pub-id><pub-id pub-id-type="pmid">35818362</pub-id></element-citation></ref><ref id="bib244"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-ncov infection</article-title><source>Frontiers of Medicine</source><volume>14</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1007/s11684-020-0754-0</pub-id><pub-id pub-id-type="pmid">32170560</pub-id></element-citation></ref></ref-list></back></article>